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Abstract
The  crystallins  are  the  primary  proteins  of  the  eye  lens  and  are  largely
responsible  for  its  high  transparency,  high  refractive  index  and  long-term
stability.  While  the crystallin proteins are often able to remain stable for the
lifetime of an individual, the lack of protein turnover in the lens means they are
subject to a wide range of age-related, post-translational modifications. These
modifications build up over the protein’s life and many are correlated with lens
opacification and cataract-related blindness. This thesis details the investigation
of  several  such  age-related  modifications,  characterising  their  effect  on
crystallin protein structure, function and stability.
Chapter  3 investigates  the  structures  of  several  short  peptides that  are  the
product  of  truncations  in  crystallin  proteins.  The  crystallins  undergo
spontaneous  peptide  cleavage  events  as  the  lens  ages  via  several  non-
enzymatic pathways. One common such truncation pathway involves an N,O-
acyl  shift  that  can  occur  at  the  N-terminal  side  of  serine  residues.  This
rearrangement is responsible for the appearance of several short peptides in
the lens as it ages, such as  αA-crystallin 55-65 (LDSGISEVR), βA3-crystallin
200-215 (SHAQTSQIQSIRRIQQ) and γS-crystallin 167-178 (SPAVQSFRRIVE).
In this study these three peptides  were characterised structurally using NMR
spectroscopy. 
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Both βA3 200-215 and γS 167-178 are proposed to interact with the membrane
of lens fibre cells, upon which they undergo a change in secondary structure.
NMR spectroscopy was performed on both of these peptides under membrane-
mimicking  solvent  conditions  with  the  aim  of  characterising  this  structural
change.  Based  on  NMR secondary  chemical  shifts  and  NOE connectivities
along their backbones, both peptides possess a region of secondary structure in
their centre. Solution structures where generated using torsion angle dynamics
simulation based on NMR-derived restraints, showing a short turn-like nascent
helix in the  γS-crystallin peptide and a longer region of well-defined α-helix in
the  βA3-crystallin  peptide.  The  stable  structures  of  these  peptides  under
membrane-like conditions may permit peptide infiltration into the walls of lens
fibre cells and contribute to age-related damage.
The αA-crystallin 55-65 fragment was likewise structurally characterised using
NMR  spectroscopy.  This  peptide  contains  a  major  site  of  aspartic  acid
isomerisation at Asp58 and both L- and D- isoforms of aspartic and isoaspartic
acid  are common in  aged lenses at  this  location.  Structures for  this  protein
fragment containing each of these isomers were generated from NMR-derived
restraints. The native L-Asp containing peptide exhibited a region of turn-like
structure  in  its  central  region  and  the  presence  of  non-native  aspartic  acid
isomers caused a loss of structure and an increase in disorder.  It  was also
found that aspartic and isoaspartic acid residues are readily distinguishable via
their characteristic NMR spectroscopic NOE patterns. 
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Chapter  4 details the biophysical characterisation of deamidated γS-crystallin.
Deamidation is a spontaneous chemical modification that converts Asn and Gln
residues to Asp and Glu via a cyclic succinimide intermediate. The deamidation
of Asn76 in human γS-crystallin to Asp is correlated with age-related cataract
formation but is also common in healthy lenses. Biophysical characterisation
was  performed  on  wild  type  and  N76D  γS-crystallin  using  turbidity
measurements  to  monitor  aggregation,  intrinsic  fluorescence  and  circular
dichroism spectroscopy to determine the folded state and NMR spectroscopy
for identifying local changes in structure. Protein mass was determined using
multi-angle  light  scattering  and analytical  ultracentrifugation  methods.  It  was
found that, relative to the wild type protein, deamidation at Asn76 in γS-crystallin
causes an increase in the thermal stability and resistance to thermally induced
aggregation alongside a decrease in stability to denaturants, a propensity to
aggregate  rapidly  once  destabilised  and  a  tendency  to  form  a  dimer.  The
apparent  increase  in  thermal  stability  upon  deamidation  is  attributed  to  the
formation of dimer, which prevents the unfolding of the inherently less stable
monomer. Overall, it was found that deamidation of Asn76 causes a decrease in
stability of γS-crystallin but this is offset by an increased tendency for dimer
formation.
Chapter  5 describes  the  structural  and  functional  characterisation  of
deamidated  αA-crystallin.  Deamidation  of  Gln147  in  human  αA-crystallin  to
glutamic acid is common in aged lenses and may have a causative effect in
cataract formation. The α-crystallins are small heat-shock proteins that act as
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molecular chaperones to prevent aggregation of proteins under stress and are
the  major  defence  against  protein  unfolding  and  aggregation  in  the  lens.
Deamidated  αA-crystallin  was  structurally  characterised  using  a  variety  of
biophysical  methods,  including  NMR,  circular  dichroism  and  intrinsic
fluorescence  spectroscopy,  and  the  effect  of  deamidation  on  the  protein's
chaperone  ability  was  determined  for  several  aggregating  model  system.
Deamidated αA-crystallin generally exhibited slightly reduced chaperone ability
and a small loss of overall structure while also showing an increase in thermal
stability and an increased tendency to form larger oligomers. It  is  likely that
deamidation at Gln147 causes a loss of structure in the protein's  central  α-
crystallin domain that leads to a slight loss of function but also increases the
protein's  tendency  to  form  large  oligomers.  Such  a  loss  of  function  could
combine  with  other  sources  of  age-related  damage  to  the  crystallins  to
contribute to lens opacification.
Each of the age-related post-translational modifications examined in this thesis
has a potentially negative influence on lens supramolecular protein structure
and  therefore  contributes  to  cataract  formation.  However,  none  of  these
modifications results in a disproportionate loss of function or stability. It is likely
that modifications such as these act cumulatively in the lens to generate overall
instability.  As  modifications  build  up  in  the  lens  with  age,  the  likelihood  of
damage  resulting  in  protein  unfolding  and  aggregation  increases.  Protein
aggregates  cause light  scattering  which  contribute  to  lens  opacification  and
hence cataract.
vi
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Chapter 1: Introduction and Overview:
Structure and Biophysical Properties of the Ageing
Eye Lens
Vision is one of the most important of the human senses, one that is relied upon
constantly in daily life. The loss of sight is typically considered a major disability,
but there are unfortunately many circumstances that can lead to eye damage
and loss of vision. This organ is highly fragile and prone to damage from injury;
however, blindness is also associated with genetic mutations, various diseases
and, perhaps most commonly,  ageing1.  Cataract is by far the most common
cause  of  blindness  in  humans,  responsible  for  51  %  of  cases  of  visual
impalement worldwide2. Cataract is characterised by a clouding of the eye lens
that reduces the quantity of light reaching the retina. Lens opacification from
cataract  often results  in  a  gradual  loss of  perception of  contrast  and colour
intensity  and  an  increased  sensitivity  to  glare  from  bright  lights.  This
progression  eventually  causes  a  total  loss  of  sight  if  allowed  to  develop
untreated3.
Age related cataract is often the result of protein misfolding4. Over time, proteins
are subject to a wide range of post-translational modifications that can reduce
their stability and promote aggregation5–7. The crystallin proteins of the lens are
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particularly  long-lived  and  any  age-related  damage  they  suffer  typically
accumulates. Cataract occurs when these proteins aggregate into large bodies
which  cause  light  scattering  and  loss  of  visual  acuity8.  While  the  lens  has
systems  to  prevent  protein  aggregation9,10,  the  build-up  of  damaging
modifications  over  time  will  eventually  overwhelm  them  and  aggregate
formation  results.  Cataract  has  become  an  inevitable  reality  of  ageing,
especially as the lifetimes of individuals increases11. Currently, the only effective
treatment for cataract-related blindness is surgical removal of the clouded lens
and replacement with a prosthesis2. This is naturally an invasive procedure that
requires a highly  skilled surgeon to  perform,  and is  thus not  always readily
available in poorer regions of the world12. It is possible that by studying the eye
lens specific cataract-inducing modifications could be identified and therapeutic
treatments developed to target them.
1.1: Vision and the Eye
The eye is the organ of vision. It is a complex arrangement of parts that directs
light  from the  external  environment  to  the  light-sensitive  cells  of  the  retina,
converting it into nerve signals13,14. To be fully functional the human eye relies
upon an interconnected series of components (Figure  1.1), all  of which must
function in harmony to provide vision15. The outermost section of the eye is the
cornea,  a  layer  of  transparent  tissue that  covers  the  anterior  chamber.  The
cornea  acts  as  the  eye's  first  focusing  component,  using  its  shape  and
2
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refractive index to direct light through the iris into the pupil16. The cornea also
acts  as  a  protective  layer  for  the  eye,  triggering  a  blinking  response  when
touched. The anterior chamber is the region between the cornea and iris. It is
filled with the aqueous humour, a plasma like fluid that defines the shape of the
region14,17. 
The pupil is an aperture defined by the iris that allows light to enter the eye 18.
Thus, the size of the pupil is determined by contractions of the iris in response
to the intensity of light hitting the retina, giving the eye control over light level
and preventing damage to the light sensitive cells via over-stimulation19,20. The
iris itself is a pigmented circular structure that acts as diaphragm. It consists of
fibrillar stroma that are connected to a sphincter muscle that contracts the pupil
and a dilator muscle that radially enlarges it 14. The iris consists of two layers, an
3
Figure 1.1: Diagram of the human eye. Individual major lens components have been labelled15.
1.1: Vision and the Eye
inner layer of highly pigmented epithelial cells and an outer non-pigmented layer
that projects the dilator muscles. The colour of the lens is determined by the
concentration of  melanin in the epithelium and the scattering of  light  by the
stroma21.
The primary instrument for focusing light in the eye is the lens4,22. The lens sits
immediately behind the iris where it can focus incoming light to form a clear
image on the retina. The lens exhibits a high transparency, a high refractive
index  and  has flexibility  that  allows  the  attached  ciliary  muscles  to  alter  its
curvature23,24. As a result the eye can adjust the focal length of the lens to form a
real image of objects at various distances with high quality and minimal light
scattering25,26. The bulk of the eye ball is composed of the vitreous humour, a
transparent gel that takes up the space between the lens and the retina27. This
fluid is similar in composition to the aqueous humour but has a lower water
content and contains a network of collagen type II  fibres that causes a high
viscosity16,28. The vitreous humour has a higher refractive index than water but is
primarily  considered  to  be  structural  in  nature  rather  than  acting  as  a  final
focusing component. The retina itself consists of light sensitive tissue that coats
the interior surface of the eyeball25. Light striking the retina triggers a series of
electrochemical events that result in nerve impulses being sent to the visual
centres of the brain via the optic nerve. The two layers of the retina consist of a
pigmented layer  of  melanin-rich  epithelial  cells  and a layer  of  light-sensitive
neurons interconnected by synapses29.
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There are many diseases that deleteriously affect vision and many of these are
a product of ageing13. The vitreous humour is one example of a region that is
strongly affected by age27,30. This gel is stagnant and is not replenished over
time like the aqueous humour, meaning that material such as blood or cellular
debris  that  invade  this  region  remain  there  unless  removed  surgically.
Furthermore, the collagen fibres that permeate the gel can aggregate over time
causing light scattering which degrades vision quality16,27. Likewise, the retina is
susceptible to age-related macular degeneration which can involve either debris
becoming lodged behind the retina or new blood vessels growing behind the
retina from the choroid29,31.  In  both cases,  this causes the retina to  become
detached and results in loss of vision in the centre of the eye. However, one of
the most interesting and well-studied eye components with regards to ageing is
the  lens,  opacification  of  which  leads  to  impaired  vision  that  characterises
cataract4,11,22,23. 
1.2: Lens Structure and Ageing
Eye lenses of all mammals are composed of fibre cells arranged in concentric
layers around a central nucleus8 (Figure  1.2). The outward facing edge of the
lens consists of a mono-layer of epithelial  cells in contact with the iris, from
which  new  fibre  cells  develop  as  the  lens  grows  over  the  lifetime  of  the
individual11,23.  The lens epithelial  cells are the only part  of  the lens that has
metabolic activity32. New cells develop from the epithelial layer via mitosis from
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which they then differentiate into fibre cells33. As the new fibre cells develop they
express  large  amounts  of  crystallin  proteins  that  are  responsible  for  the
refractive index and transparency of the lens34,35. Newly differentiated fibre cells
migrate towards the lens equator where they undergo denucleation and lose
their internal sub-cellular structures33,36. The fibre cells ultimately form multiple
layers stacked around the central nucleus of the lens. The newest fibre cells
surround the periphery with the oldest cells occurring in the central region of the
lens that is formed in utero22. 
The long, elongated lens
fibre  cells  form  densely
packed  onion-like  layers.
The cells can be upwards
of 10mm long in a mature
lens  and  maintain  their
shape  via  an  extensive
cytoskeleton37.
The  cytoskeletal  structure  of  these  cells  is  vital  for  transparency  as  lenses
lacking  key  filament  proteins  are  opaque  despite  the  fibre  cells  maintaining
typical morphology38. In order to act as an effective optical focusing device, the
lens must  maintain several  unique properties.  The lens must  display a high
transparency in the visual wavelengths, have a high refractive index in order to
6
Figure  1.2: Cross-section  of  the  human  eye  lens  showing
layers of lens fibre cells, the epithelial cell layer and the lens
nucleus. Fibre cells differentiate form the epithelial layer and
migrate to  the lens equator.  Mature fibre cells  elongate and
undergo denucleation8
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bend light  at  as  large an angle  as  possible,  and a  degree of  flexibility  that
permits changes in focal length4,26. The transparency of the eye lens is limited
primarily by the absorption and light scattering of the components of the lens
fibre cells23. In healthy eye lenses, absorption and light scattering are negligible.
The periphery of the lens exhibits substantial diffraction due to the difference
between the refractive index of the fibre cell membrane and the cytoplasm. This
is less of an issue along the optical axis of the lens due to curvature of the
individual fibre cell layers and is absent in the lens nucleus where the refractive
index of the membranes is almost equal to that of the cytoplasm39.
The lens achieves a high refractive index due to the very high concentration of
proteins  expressed  in  the  fibre  cells34.  Lens  crystallins  show high  refractive
index increments compared to other proteins, due to large quantities of aromatic
and sulphurous residues40, and show strong absorbance of UV radiation35,41. In
humans the fibre cells exhibit a protein concentration of ~300 mg ml -1 uniformly
throughout the lens4. The composition and concentration of the proteins found
in the eye lens of other species varies greatly but in all cases these proteins are
assigned  to  a  super-family  known  as  the  crystallins.  All  vertebrate  species
express at least α, β and γ crystallin subtypes in their eye lenses and in humans
these are the only crystallin sub-types42. It is the structure and stability of the
crystallins that define many of the important properties of the eye lens.
The  lens  maintains  its  transparency  and  refractive  index  due  to  its  unique
biophysical characteristics. Light scattering is proportional to the size of objects
7
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encountered and their  difference compared to  their  surroundings26,43,  and as
such the lens has maximised its transparency by eliminating almost all cellular
structures36.  When  a  fibre  cell  differentiates  from  the  epithelial  layer,  it
expresses  crystallin  proteins  in  high  concentration  and  then  undergoes
degradation of all organelles and large cell structures. The bulk of the eye lens
has no blood supply, no cellular structures such as mitochondria, nucleus, or
ribosome, and exhibits no metabolic activity32,33. While this lack of organelle-like
sub-structure means the lens fibre cells have exceptional transmissive optical
properties it also means once they have matured they have very little capacity
to  recycle  or  repair  damaged  proteins  and  no  capacity  to  express  new
protein4,44.
The long life of the fibre cells is one of the defining features of the eye lens45.
Due to the lack of protein turnover in the lens fibre cells, crystallin proteins must
last the lifetime of each individual. Thus, modified and damaged proteins build
up in the lens over the lifetime of an individual, particularly in the nucleus as it is
the  oldest  lens  region  and  corresponds  to  the  foetal  lens5,7.  The  protein
composition of a young lens can be very different to that of an aged lens. The
aged eye is prone to diseases that result in loss of vision, the most common of
which is cataract in the nucleus of the lens5,8,46,47. 
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Cataract is characterised as an opacity in the normally highly transparent lens
of the eye4. In general, this opacity can be the result of disruption in the ordered
packing of the lens fibre cells or from the formation of large structures within the
cells due to a disruption in local ordered protein structure8,11. In the latter case,
this  disruption  is  often  caused  by  the  formation  of  high  molecular  weight
structures consisting of aggregated crystallin proteins48. Such structures exhibit
increased  light  scattering,  which  reduces  lens  transparency  and  eventually
causes loss of  vision.  Age-related nuclear  cataract  is  a  common disease of
ageing  and  is  highly  correlated  with  fibre  cell  crystallin  protein
aggregation4,11,27,49.
Lens fibre cells express the crystallin proteins in high concentrations during their
development34.  The  crystallins  form  a  wide  range  of  oligomeric  structures,
ranging  from  monomers  in  the  case  of  the  γ-crystallins4,  from  dimers  to
octamers in  the case of  the  β-crystallins6,50,51,  and up to  60-mers  for  the α-
crystallins10. Larger oligomers are more common towards the centre of the lens
and the smaller dimers and monomers make up the bulk of the protein found in
the lens cortex. Overall, the polydisperse nature of the lens proteins makes the
lens remarkably glass-like and highly resistant to crystallisation22.
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Unfortunately,  the  high  protein  concentrations  necessary  to  create  the  high
refractive index material of the lens is also exactly the type of environment that
promotes protein aggregation8,52. While the lens has many systems and special
characteristics that are engineered to prevent this aggregation the effectiveness
of these systems tends to diminish as the lens ages4,9,53. Over time, proteins
tend  to  accumulate  post-translational  modifications,  due  to  either  external
damage such as  UV radiation  exposure  or  exposure  to  heat,  or  by  one  of
several  spontaneous  chemical  modification  pathways  to  which  crystallin
proteins  are  susceptible5,6.  Cataract  formation  is  typically  the  result  of  such
damage building up to a point where individual proteins are no longer able to
maintain their structure or solubility8,54. Local regions of highly stressed protein
can randomly self-associate into aggregates that grow in size as more protein
unfold  and  associate.  Eventually  damage  and  stress  will  cause  protein
precipitation  within  the  lens  fibre  cells  with  these  aggregates  acting  as
nucleation sites for further growth. The formation of protein aggregates in the
eye lens disrupts the uniformity and transparency of the lens medium leading to
light scattering and loss of visual acuity. In general the larger the size of protein
aggregates the greater the light scattering they cause5,55.
Although  described  by  a  single  term,  cataracts  can  have  many  underlying
causes.  Eye  lens  transparency  depends  on  lens  proteins  maintaining  their
ordered structure. Exposing lens proteins to any sources that damages them, or
promotes their unfolding, will tend to promote opacification. Cataract has been
known to be caused by genetic factors and mutations that produce less stable
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proteins56,  diseases  such  as  diabetes57 and  fibre  cell  protoplasm  phase
separation  which  produces  reversible  “cold  cataracts”58.  The  most  common
factor associated with the formation of cataract, however, is age4,5,11,49. 
1.4: Lens Protein Folding and Aggregation
The function  of  globular  proteins  is  defined by  their  native  structure.  Under
normal  circumstances,  a  protein  will  fold  after  it  is  expressed  on  the
polyribosome,  forming a  well  defined tertiary structure usually  delineated by
exposure of hydrophilic surfaces and sequestration of hydrophobic residues into
its interior48. 
Figure  1.3 shows a  schematic
for  the  typical  folding  of  a
polypeptide  chain.  Following
expression  a  protein  exists  in
an unfolded state and will  fold
into its native folded form via a
series  of  partially  folded
intermediate  steps48.  While  in
these  intermediately  folded
states a protein will often have
its hydrophobic core exposed to
11
Figure  1.3:  Protein  folding,  unfolding  and  off-folding
pathways9
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solution  making  it  unstable  and  rendering  it  prone  to  aggregation48.  Under
normal circumstances proteins fold rapidly from an unstructured chain to their
native  states  and  thus  avoid  mutual  interaction  between  partially  unfolded
intermediates. When proteins are exposed to stress conditions, however, the
equilibrium between  the  native  and  unfolded  states  is  disrupted  which  can
cause the  protein  to  occupy these intermediate  states  for  longer  periods of
time9,59.
Physiological  stress  is  a  general  term for  changes  in  the  environment  of  a
protein that encourages it to unfold from its native state60. Common causes of
stress are elevated temperature,  changes in  pH or  exposure to  reducing or
oxidising  agents.  Other  stress  conditions  include  chemical  alteration  of  the
protein,  exposure  to  metal  ions,  the  disruption  of  quaternary  structure  and
breaking of inter-residue bonds4,7.  Whatever the root cause, the presence of
stress means that a protein will tend to remain in a partially folded intermediate
state for longer which increases the possibility of mutual interaction with another
partially  folded  intermediate.  This  interaction  will  potentially  result  in  protein
aggregation48,60.
Protein  aggregation  can  take  on  two  forms,  highly  disordered  amorphous
aggregation and highly ordered amyloid fibrils61,62. Amorphous aggregates form
when  partially  unfolded  proteins  cluster  together.  When  a  partially  unfolded
protein has its hydrophobic core exposed to solution it will experience an affinity
for other hydrophobic regions such as the exposed cores of other proteins. As
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these protein clusters increase in size they become less soluble and eventually
precipitate48.  Amorphous  aggregation  and  its  subsequent  precipitation  is
generally  irreversible  and  protein  in  this  state  is  entirely  inactive.  However,
amorphous aggregates are believed to be non-toxic to cells and not a significant
contributor to protein folding diseases60.
Amyloid  fibrils  are  a  highly  ordered  form  of  protein  aggregate  which  are
characterised by their β-sheet rich, long, needle-like structure. The amyloid fibril
off-folding  pathway  begins  when  unstable,  partially  folded  protein  begins  to
partially take up the highly stable β-sheet conformation61. Other partially folded
intermediates that interact with the β-sheet region will also fold into a β-sheet
due to the mutual stability of this conformation. As this aggregate gets larger it
begins to  act  as a nucleus for  an  amyloid  fibril  and any unstable  protein  it
encounters will tend take on a β-sheet structure and attach to its end. These
aggregates are highly stable and, unlike an amorphous aggregate, will promote
unfolding and aggregation in other proteins63,64.  Amyloid fibrils are associated
with many diseases, particularly age-related neurodegenerative disorders such
as Alzheimer's and Parkinson's disease65,66.
The light scattering that characterises cataract disease is generally believed to
be the result of the formation of amorphous aggregates4,5. When the crystallin
proteins are exposed to sufficient stress-inducing modifications, they will unfold
and randomly associate to form these large structures. This would not constitute
a problem in most tissues as this form of aggregate is readily degraded but in
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the  lens  there  are  no  mechanisms  for  breaking  up  and  recycling  these
structures. As a result,  the lens fibre cells must rely entirely on preventative
mechanisms against  protein  aggregation,  such  as  high  protein  stability  and
large concentrations of molecular chaperone protein36,67.
1.5: Small Heat-Shock Proteins
The  small  heat-shock  proteins  (sHsp)  are  a  group  of  molecular  chaperone
proteins that are ubiquitous in all  organisms59,68.  The role of the sHsps is to
prevent  aggregation  of  other  proteins  under  stress  conditions.  Proteins  that
perform the heat shock function are found in all forms of life and have a highly
conserved  sequence  and  structure  across  species69.  All  sHsps  are
characterised by the presence of a well-structured central region termed the α-
crystallin domain68. This central domain exhibits a β-sheet rich immunoglobulin
fold, the structure of which is important for the activity for these proteins. This
central structured domain is flanked by N- and C- terminal regions which show
differing degrees of structure between species68,70,71. The expression of sHsps is
substantially up-regulated in response to heat stress conditions59,72.  They are
highly efficient chaperones which act to prevent protein aggregation by binding
to unfolded and partially folded proteins, preventing their association with other
unstable proteins73.  In  this  way these proteins act  as a first  line of  defence
against protein unfolding and aggregation9,59. 
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Figure  1.4 is a schematic diagram of sHsp chaperone action. Under normal
physiological  conditions,  sHsps  exist  bundled  into  large  stable  oligomers
containing  many  subunits.  Upon  encountering  physiological  stress  these
oligomers become unstable and sHsp dimers dissociate into solution74,75. The
active sHsp dimer interacts with partially folded proteins to ensure continued
solubility  and  prevent  further  unfolding  and  aggregation73.  While  this  action
prevents the formation of both amorphous aggregates and amyloid fibrils the
sHsps have no mechanism for restoring a protein to its native fold and rely on
other energy driven processes to recycle any proteins that it  binds, such as
Hsp7076.  While sHsps are an organism's first  line of defence against protein
aggregation, they are also associated with a variety of protein folding diseases.
It is common to find sHsp incorporated into the amyloid fibril rich plaques found
in the brains of  victims of neurodegenerative disease65.  The causes of  such
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Figure 1.4: Overview of sHsp interaction with amorphously aggregating proteins9
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aggregation are not fully understood nor are the exact mechanisms behind the
chaperone action of these proteins, making sHsp's an important field of active
research77–80.
1.6: The Crystallin Proteins
The lens fibre cells express very high concentrations of highly soluble protein as
they develop. In all species these proteins are classified as the crystallins, of
which there are many taxon specific subtypes81. All vertebrates express the α, β
and γ crystallins in the lens and in mammals these are the only members of the
class present82. Crystallin proteins assemble into various oligomers of different
size and show many weak crystallin-crystallin interactions, resulting in a highly
polydisperse cell protoplasm that is resistant to crystallisation43,67. In humans all
of these proteins are lens fibre cell specific except for αB-crystallin, which is
ubiquitous  in  all  tissues  where  it  functions  as  a  stress-inducible  molecular
chaperone10. All crystallins are characterised by high solubility and high stability
as they must last the lifetime of the lens4,45.
The  cytoplasmic  protein  of  the  mammalian  eye  can  be  separated  into  its
components via size exclusion chromatography83 as shown in Figure  1.5. The
α-, β- and γ crystallins separate from one another, forming distinct fractions. The
α-  and  β-crystallins  further  separate  into  high-  and  low-mass  species,  the
separation  of  which  is  highly  buffer-dependent  as  these  species  are  in  a
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concentration-dependent  equilibrium  with  one  another84.  This  was  ultimately
found to be a result of the polydisperse oligomer formation exhibited by the α-
and β-crystallins. 
The classification of mammalian eye lens proteins was initially made on the
basis of net charge and molecular mass85. Initially, the α, β and γ crystallins
were believed to be individual proteins but this nomenclature now serves as the
basis for classifying the three human lens protein families42,86. γS-Crystallin was
originally classified as a β-crystallin as it elutes at a higher apparent mass than
the other γ-crystallins but was later found to be much more closely related to the
γ-crystallins on the basis of sequence data, and has since been reclassified87,88.
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Crystallin Residues Mass (Da) pI SwissProt247 PDB248 OMIM249
αA 173 19,909 5.6 P02489 - 123 580
αB 175 20,159 6.8 P02511 - 123 590
βB1 251 27,892 8.6 P53674 I0KI 600 929
βB2 204 23,249 6.5 P43320 1YTQ 123 620
βB3 211 24, 230 5.9 P26998 3QK3 123 630
βA1 198 23,191 6.4 P05813 - 123 610
βA2 196 21,964 5.9 P53672 - 600 836
βA3 215 25,150 5.7 P05813 - 123 610
βA4 195 22,240 5.8 P53673 3LWK 123 631
γS 177 20,875 6.4 P22914 2M3T 123 730
γA 173 20,761 7.8 P11844 - 123 660
γB 174 20,776 7.0 P07316 2JDF 123 670
γC 173 20,747 7.0 P07316 - 123 680
γD 173 20,607 7.2 P07320 1HK0 123 690
γE Gene inactive in humans
γF Gene inactive in humans
Table 1.1: Physical properties and database entries of the human eye lens crystallins4,9. 
1.6: The Crystallin Proteins
1.6.1 α-Crystallin
In humans the α-crystallins consists of two related proteins, αA and αB, which
co-associate in vivo10. These two proteins share roughly 60% sequence identity,
have high structural similarity and share the same function. Both α-crystallins
are sHsps but only αB-crystallin is stress inducible in other tissues of the body
meaning that αA expression is limited to the eye lens78,89. Figure 1.6 shows the
general  structure  of  a  sHsp monomer  as  a  homology model  of  human αB-
crystallin compared with the x-ray crystal structures of wheat sHsp 16.9 and
bacterial sHsp 16.590.
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Figure 1.5: Chromatogram of lens fibre cells cytoplasm from bovine eye lens separated with gel
filtration chromatography. Significant protein groups are marked. α- and β-crystallin separate
into high and low mass elution peaks corresponding to different oligomeric species and γS-
crystallin elutes separately to the other γ-crystallins.
1.6.1 α-Crystallin
sHsps are characterised by a conserved central α-crystallin domain flanked an
unstructured C-terminal and a variable N-terminal region9,10,75. The α-crystallin
domain  resembles  an  immunoglobulin  fold  in  structure  as  seen  from X-ray
crystallography  and  NMR  derived  structures  of  truncated  human  αB-
crystallin70,71 and from sHsps of other species90. The α-crystallin domain consists
of  a  β-sandwich  structure  of  12  β-strands,  of  which  two  are  shared  by  an
adjacent  dimerisation partner70.  The α-crystallins form dimeric  species which
together assemble into oligomers composed of this base dimer unit74.  These
typically consist of 3 dimer pairs arranged in a ring from which the hexamers
then can further oligomerise to form a grouping of 40-60 units depending on the
conditions9. These large-scale structures are highly polydisperse and dynamic
with  individual  dimers  able  to  freely  associate  and  disassociate  from  the
oligomer. The C-terminal  region of  sHsps contains a conserved hydrophobic
'IXI'  motif  which binds to a hydrophobic pocket  of  the α-crystallin domain of
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Figure 1.6: General structure of small-heat shock proteins. The homology modelled structure of
αB-crystallin (red) is overlaid onto the x-ray crystall structures of two related proteins, wheat
sHsp 16.9 (green) and bacterial sHsp 16.5 (blue)90.
1.6.1 α-Crystallin
adjacent  dimers  and  is  proposed  to  influence  subunit  dissociation  under
conditions of stress70.  α-Crystallins are differentiated from other sHsps by the
presence of a highly dynamic unstructured C-terminal extension of 10-12 amino
acids which contributes to the high solubility of these proteins and the loss of
this region greatly reduces their stability9,91,92.
1.6.2 βγ-crystallins
The β- and γ-crystallins are related proteins that act as structural elements in
the lens. They have a major role in generating the lens's high transparency and
high refractive index40,67. This protein family is believed to have originated from
primordial  archaeabacteria as single domain Ca2+ binding proteins93,94. The βγ-
crystallins are ubiquitous in the eyes of mammals and in humans they account
for ~50% of the cytoplasmic proteins by weight4,82. The β- and γ-crystallins are
closely related protein families and they possess a similar structural fold, i.e. a
two-domain tertiary structure that roughly divides the peptide chain into halves.
Each domain is  comprised of  two β-sheet  rich “Greek-key”  motifs  with  8 β-
strands per domain.
These proteins pack densely together into the supra-molecular structures via
intermolecular  cross-domain  interactions.  The  primary  distinguishing
characteristic  between  the  β-  and  γ-crystallins  is  that  under  physiological
conditions the β-crystallins self assemble into oligomers of between 2 and 8
subunits50,51 whereas  the  γ-crystallins  are  largely  monomeric4.  Both  the  β-
20
1.6.2 βγ-crystallins
21
Figure 1.7: The structures of selected crystallin proteins. (a) NMR derived structure of human
γS-crystallin two domain monomer (PDB 2M3T). Crystal structure of bovine βB2-crystallin (b)
dimer  (PDB  1BLB)  and  (c) tetramenr  (PDB  2BB2)  showing  domain  sharing  and  lattice
structures.
(a)
(b)
(c)
1.6.2 βγ-crystallins
crystallin  oligomers  and  the  γ-crystallins  monomers  are  stabilised  by
hydrophobic  interactions  between  the  N-  and  C-  terminal  domains.  The βγ-
crystallins are primarily responsible for the refractive index of the lens and tend
to  have  an  above  average  number  of  residues  with  high  refractive  index
increments, i.e. aromatic (tyrosine, tryptophan and phenylalanine) and sulphur
containing (cysteine and methionine) amino acids35,40. The highly soluble, highly
stable, poly-disperse nature of these proteins also minimises aggregation and
crystallisation in the lens, ensuring high transparency81,82. The structure of the β-
crystallins shows distinct differences to the γ-crystallins with the presence of
long flexible peptide extensions at the N-termini. Otherwise, the structures show
a close relationship, with similar folds in the C- and N-terminal domains and
similar  inter-domain  interactions.  The  cause  for  β-crystallins  showing
preferential inter-molecular interaction compared to the intra-molecular domain
pairing  in  the  γ-crystallins  arises  from  the  conformation  and  length  of  the
domain  linker  peptides.  The  inter-domain  interface  in  these  proteins  is
composed  of  clusters  of  hydrophobic  residues  flanked  by  pairs  of  polar
groups95.
1.6.3 β-Crystallin
The β-crystallins are divided into acidic βA1, βA2, βA3 and βA4 and basic βB1,
βB2 and βB3 proteins4. The βA1 and βA3 crystallins are coded by the same
gene and differ only in the length of the N-terminus as the βB3 expression is
initiated by an earlier start location96. These two proteins are expressed early in
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the development of the lens and are found primarily in the nucleus, whereas
βB2-crystallin  is  expressed throughout  all  stages of  eye lens growth from a
separate gene34. βB2-crystallin notably shows significantly less modification with
age  and  a  far  greater  solubility  then  the  other  βγ-crystallins  and  has  been
suggested  to  act  as  a  stabiliser  for  the  other  lens  proteins97.  The  acidic  β-
crystallins are expressed throughout the eye lens in humans except for βA2,
which appears in only trace quantities when compared to other mammals4. βB1-
and  βB3-crystallin form  into  high  mass  oligomers  such  as  hexamers  and
octamers which are primarily located in the older cells of the nucleus34,98. The
younger fibre cells tend to express more dimeric βB2-crystallin and monomeric
γS-crystallin, resulting in somewhat of a gradient with larger oligomers found in
the centre of the eye lens which are replaced by dimers and monomers at the
edge of the lens22.
1.6.4 γ-Crystallin
There are seven γ-crystallin genes in mammals42. The first six of these, γA to γF,
are closely related and highly similar in sequence. The genes for these proteins
appear in a single cluster and show 70-98% similarity, but in humans the γE and
γF genes are inactive82. The seventh γ-crystallin, γS, is more distantly related to
the others88. It exhibits a unique four amino acid long N-terminus, it lacks the
two  residue  C-terminus  of  the  other  six  and  has  a  1-2  amino  acid  longer
connecting loop between the two domains4. γS-Crystallin is induced last during
fibre cell development and is not present in the immature cells of the cortex34,44.
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The γA-D crystallins are similar to the βB1- and βB3-crystallins in that they are
expressed early in the lens development, with γC and γD most abundant, and
are found primarily in the nucleus of the eye lens44.
γS-Crystallin is the primary eye lens crystallin which is expressed post-natally44.
It has high structural homology to the other γ-crystallins but is found primarily in
the water rich cortex of the eye lens. Due to its chromatographic properties γS-
crystallin was originally classified as a β-crystallin (βS), but once the genetic
sequence of  the  crystallins  was  understood  it  was  re-classified  as  an early
evolutionary offshoot of  the γ-crystallins87,88.  The sequence of γS-crystallin is
highly conserved throughout all vertebrates and is regarded as one of the more
important  proteins  in  the  lens  structure4,99.  The  crystallisation  of  human γS-
crystallin  has  yet  to  be  achieved  but  a  structure  determined  by  NMR
spectroscopy is available100.
1.7: Post-Translational Modification
The lack of protein turnover in the lens results in a unique situation not seen in
most other bodily tissues. Over time, proteins in any tissue can be subjected to
a wide variety of irreversible modifications, due to enzymatic processes or via
spontaneous pathways4,5,7,49,101. In the eye lens, the lack of protein expression or
turnover  means  that  instead  of  these  modified  proteins  being  repaired  or
replaced they tend to accumulate. Being by far the predominant lens proteins,
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the modification of the crystallins can be extensive. Crystallins are all  highly
water soluble upon expression but over time as post-translational modification
occurs they are altered both structurally and functionally as well as becoming
colourised. Loss of solubility occurs and they become prone to aggregation45.
Eventually the formation of large, poorly-soluble aggregates results in extensive
light scattering8.
Cataract  formation  is  highly  correlated  with  age.  However,  crystallins  often
show post-translation modifications even when young and aged. Furthermore,
cataract free eye lenses can exhibit  extensive protein modification5,101. Young
lenses are often subject to early oxidation, phosphorylation and methylation,
whereas healthy aged lenses show extensive modification but,  compared to
cataractous lenses, typically have less overall oxidation and less deamidation at
certain  specific  locations5,46,101.  There  are  many  specific  modifications  in
cataractous lenses that are not present in normal healthy aged lenses102 and it
is  these  in  particular  that  are  of  interest  for  identifying  specific  causes  for
cataract  formation  and  finding  targets  for  developing  treatments  or
preventatives.  Because  the  proteins  in  the  lens  have  a  significantly  longer
lifespans than most other proteins in the body103, they have the opportunity to
undergo a wide range of modifications and rearrangements that do not normally
occur in other tissues.  The range of possible post-translational  modifications
found in aged protein is extensive and the crystallins exhibit different changes
over their lifetimes101,102,104. The precise effect of post-translational modifications
on crystallin structure and function is an active field of research and there is
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debate in the literature in regards to their relative impact on age-related cataract
formation7,46,105–108. A survey of such modifications follows.
1.7.1 Truncation
Over  time,  proteins  are  susceptible  to  truncation  events7.  Proteases  are
common throughout tissues where they cleave polypeptides into fragments at
specified  sites109 and  represent  the  basis  of  natural  protein  degradation
pathways110.  Crystallins  undergo a  number  of  C-  and N-terminal  truncations
which can have a major effect  on their  stability and solubility5,92,111.  Some of
these truncations can be attributed to  protease activity  as small  amounts of
these enzymes (e.g. calpain) are found in the eye of animals112. However, in the
nucleus of the human lens all enzymes are inactive113 which means that non-
enzymatic  pathways  are  the  most  likely  explanation  for  the  truncation  of
crystallins from aged eyes, of which there are several114,115.
One example of a pathway for spontaneous protein cleavage involves an N, O-
acyl shift at serine residues116, the products of which are encountered frequently
in  the  aged eye lens.  The mechanism for  this  rearrangement,  as  shown in
Figure  1.8, results from attack of the serine side-chain hydroxyl group on the
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Figure 1.8: Mechanism for spontaneous cleavage of peptide chains at serine residues116. 
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preceding  backbone  amide.  The  subsequent  hydrolysis  and  peptide  chain
cleavage  are  analogous  to  the  intein  protein  splicing  mechanism117.  This
reaction is spontaneous, but slow, at neutral pH and physiological temperatures,
however  reaction  rate  increases  with  temperature116,  exposure  to  an  acidic
environment118 and the presence of trace metal ions119. It is also probable that
this  truncation occurs for  threonine residues as peptides beginning at  these
residues have been observed in the lens106. Protein truncations attributed to this
mechanism  are  common  in  both  aged  and  cataractous  eye  lenses.  Thus,
cleavage of the C-terminus of βA3 crystallin at Ser199106 and γS crystallin at
Ser167120 is  common in aged human lenses. Likewise, N-terminal  truncation
before αB crystallin Ser19 and between Ser59 and Ser75 of βA1 crystallin have
been  found121.  There  is  also  evidence  for  a  slow,  spontaneous  truncation
process that  occurs at  asparaginyl  residues in  the lens,  with the membrane
protein  aquaporin  0  showing extensive  C-terminal  truncation  at  Asn246 and
Asn259 with age122,123.
It  is  proposed  that  these  modifications  result  in  a  loss  of  crystallin  protein
solubility  and  a  disruption  of  local  structure.  Thus,  the  build-up  of  such
modifications has the potential to cause protein aggregation and precipitation.
The presence of truncated proteins and the resultant peptides in cataractous
lenses lends credence to this idea120,121.   Additionally, it  has been found that
some small peptides cleaved from the N- or C-termini of lens proteins interact
with  fibre  cell  membranes,  in  some  cases  binding  strongly120,  potentially
weakening the cell walls and leading to the formation of membrane pores. Thus,
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the peptide products of these spontaneous truncation events may disrupt the
structure of lens crystallins and affect lens fibre cell organisation.
1.7.2 Deamidation
The  deamidation  post-translational  modification  is  another  spontaneous
rearrangement  commonly  found  in  the  older  proteins  of  the  body.  This
modification is so ubiquitous in longer lived tissues that it is considered one of
the factors limiting protein lifetimes124. Deamidation is one of the most common
post-translational modification in the eye lens, occurring early in life and building
up with age101,105,125,126.  There are some sites of deamidation that occur more
frequently in cataract affected lenses compared to healthy lenses of the same
age102. Deamidation modifies asparagine and glutamine residues by hydrolysing
the amide side chain, producing the corresponding carboxylic acid residue127.
The major effect of this modification is the introduction of a negative charge at a
formerly neutral location in a protein and thus it has the potential to destabilise
protein structures in the vicinity, including in the lens crystallins105,125.
Deamidation  is  a  slow spontaneous  rearrangement  that  occurs  via  a  cyclic
succinimide intermediate resulting from the attack by the Asn/Gln side-chain on
the backbone amide to form a cyclic succinimide with the loss of ammonia128.
The ring then hydrolyses to  form the corresponding carboxyl  residue,  either
aspartate  or  glutamate.  Figure  1.9 shows  the  deamidation  pathway  for
asparagine. Both asparagine and aspartic acid are capable of ring-closure to
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form a  succinimide  intermediate  with  the  intermediate  ring  opening  in  both
directions  to  subsequently  produce  the  aspartate  and  isoaspartate
residues105,126. The nature of the residue adjacent to the Asn/Gln is an important
factor for the rate of modification and propensity for deamidation. Sequences of
Asn-Gly are known to be highly susceptible to deamidation, to the extent that it
can be difficult to express recombinantly proteins that contain this sequence128.
Likewise, deamidation in older proteins is often found adjacent to serine, glycine
and  histidine  residues129 and  surface  exposed  sites  can  be  particularly
susceptible to modification130. Deamidation affects all of the structural proteins in
aged eye lenses, but each is modified to a different extent. For example, βB2-
crystallin shows deamidation at only one site and only at 3-12% abundance
even after 60 years of age whereas γS-crystallin has up to 20% deamidation at
some residues, such as Asn76, by as early as 15 years of age and 50-60%
deamidation in cataractous lenses101,102.
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Figure  1.9: Mechanism of  deamidation  and  isomerisation  in  asparagine  and  aspartic  acid
residues showing both possible isomer products128
1.7.3 Racemisation
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The  conversion  of  L-amino  acids  to  their  D-enantiomer  is  common  in
cataractous  lenses131.  The  amino  acids  that  make  up  proteins  are
predominantly, except for the non-chiral glycine, expressed as enantiomericly
pure L-isomers. Over time, these chiral centres will undergo racemisation as the
amino acids convert from pure L-isomers to a mixture of L- and D-isomers132.
Racemisation is typically very slow but depends a great deal on the specific
amino  acids  as  well  as  external  effects  such  as  temperature  and  radiation
exposure115,133.  In  normal  healthy  tissues,  the  constant  recycling  of  proteins
means that significant quantities of D-isomers are unable to build up. However,
in dead tissues or among particularly long-lived proteins the ratio of L- to D-
isomers will slowly approach parity134. The rate of conversion of L- to D-isomers
in proteins is predictable to the extent that the post-mortem age of biological
samples can be estimated by measuring the ratio of isomers using racemisation
dating133,135. This is also true for proteins that do not undergo turnover such as
eye  lens  crystallins,  tooth  dentin  or  elastin  from  ligaments136,137.  Eye  lens
proteins have been shown to undergo racemisation at many sites and these
locations  can  be  highly  sequence  dependent  and  are  often  found  in
unstructured regions131,138. Crystallins in healthy aged eyes exhibit racemisation
at 4.5% of all serine residues and 9% of asparagine residues, corresponding to
an average of  two D-amino acids  per  protein131.  Racemisation  of  threonine,
glutamine, glutamic acid and phenylalanine residues have also been observed,
but  to  a  smaller  degree  which  is  attributed  to  incidental  exposure  to  high
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temperatures of the intact lenses during life. Cataractous lenses show a rate of
racemisation in serine, aspartic acid, asparagine and threonine residues that is
significantly higher than healthy, age-matched lenses131. 
The racemisation  of  asparagine and aspartic  acid  is  a  special  case.  These
residues show the largest tendency to racemise of any amino acid in the eye
due to the existence of a chemical pathway that allows for steric inversion105,129.
This  is  the  same rearrangement  that  causes deamidation via  a succinimide
intermediate  ring  opening  (Figure  1.9).  This  ring  opening,  which  is  already
capable of forming the structural isomer isoaspartate, can cause the amino acid
to form a D-enantiomer, with one possible product of this interconversion being
a D-isoaspartate residue, equivalent to a Dβ-amino acid139.  Both αA-crystallin
Asp151 and γS-crystallin Asn76 are reported to undergo gradual racemisation
over their lifetime with γS-crystallin Asn76 showing particularly high modification
in cataractous lenses102. Of the 13 asparaginyl residues of αB-crystallin, Asp36
and Asp62 show extensive racemisation in aged lenses compared to young
ones,  a  pattern  repeated  with  the  βB2-crystallin  Asp4  residue132,140.  In  αA-
crystallin, Asp151 and 58 are highly modified in older eyes but the racemisation
of these residues can first appear at a young age141,142. Other studies suggest
that  the  Asp151  is  the  primary  site  of  racemisation  in  αA-crystallin,  due  to
sensitivity  to  radiation  damage  from  both  UV-B141 and  gamma  radiation143.
Serine residues are also highly susceptible to racemisation which may be the
result of alpha proton abstraction115. Specific sites of serine racemisation in αA-
crystallin include Ser59 and 62 with 35% D-amino acid formation144.
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1.7.4 Oxidation
Oxidation appears to be a common modification in aggregated protein extracted
from cataractous lenses and is especially common in nuclear cataract46,145. To
protect  against  oxidation,  the  lens  naturally  contains  high  concentrations  of
antioxidants,  particularly  glutathione,  and  possesses  several  systems  for
oxidation defence and repair that maintain redox homeostasis146–148. As the lens
ages, these systems lose effectiveness and the concentration of antioxidants
falls,  resulting  in  an  increase  in  oxidation  over  time149.  The  amino  acids
tryptophan, cysteine and methionine are commonly subject to oxidation in the
lens8,150.  Oxidation  of  cysteine  residues  is  particularly  common,  with  the
modification  first  observed  in  the  early  stages  of  cataract  formation  and
increasing in prevalence as cataract progresses, to the extent that >90% of
residues are modified in advanced cases151,152.  Similarly, methionine residues
exhibit  up to 50% oxidation upon the appearance of cataract and even non-
cataractous lenses can have up to 37% oxidised methionine151,153.  Tryptophan
residues  also  show  significant  oxidation  in  cataract-affected  lenses  when
compared to healthy lenses and several particular tryptophan sites have been
identified where oxidation is highly correlated with cataract, such as Trp192 in
βB1-crystallin5. A similar high instance of oxidation for Met-68 in αB-crystallin
has  been  reported  in  cataractous  lenses7.  The  oxidation-mimicking  W42Q
mutant of  γD-crystallin shows reduced thermal stability and aggregates readily
in the presence WT  γD-crystallin154.  Likewise, the presence of oxidised  βA3-
crystallin peptide (152-166) increases aggregation in both  α- and γ-crystallin
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bovine  lens  fractions155.  The  oxidation  of  proteins  in  the  lens  promotes  the
formation  of  covalent  cross-links  and  the  accumulation  of  mixed  disulphide
species  8.  Highly  oxidised  proteins  typically  make  up  a  large  proportion  of
insoluble and urea-soluble protein fractions of cataractous lenses7,46
1.7.5 Other Chemical Modifications
The crystallins are prone to a wide range of chemical modifications such as
phosphorylation  and  glycosylation4.  Many  proteins  also  undergo
phosphorylation  over  time,  particularly  at  serine  residues.  However,  this
modification  is  less  correlated  with  cataract  than  many  of  the  others5.
Phosphorylation is common to αA- and αB-crystallin at a number of locations
and  can  either  increase  or  reduce  its  chaperone  activity  depending  on  the
location  and  the  nature  of  the  target  protein55,156–158.  The  other  eye  lens
crystallins are less noted for undergoing phosphorylation. Cysteine residues are
also prone to methylation over time and this modification is common in the eye
lens.  Some  prominent  locations  of  crystallin  cysteine  methylation  appear  in
cataract-affected eye lenses but this modification is also common in both aged
healthy  lenses  and  young  lenses5.  Interestingly  the  methylation  of  cysteine
residues in γS-crystallin occurs early in life and is maximised well before any
occurrence of cataract and therefore appears to play little or no contributory role
to  lens  opacification159.  Glycosylation  of  the  crystallin  proteins  appears  in
cataract associated with diabetes160. The glycosylation at the delta carbon atom
of lysine residues with glucose 6-phosphate has been reported and leads to
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increased  aggregate  formation  via  oxidation  of  cysteine  and  methionine
residues57. As the aged crystallins become affected by these modifications, their
structure can become disrupted, potentially exposing hydrophobic regions of the
proteins to the aqueous solvent, encouraging random interactions between the
crystallins8,9. The formation of large protein aggregates increases light scattering
and reduces vision quality and leads to opacification26. 
1.8: Eye Lens Research
The study of the eye lens as it ages is an active field of research. Cataract is
one of the most common diseases of ageing, which while treatable via surgical
intervention, is often untreated in poorer parts of the world12. A primary focus of
eye lens research is the identification of specific sites where modification has a
disproportionate  effect  on  protein  stability  and  cataract  formation.  Upon
identification of such sites, there exists the potential for developing therapeutic
treatments for cataract, thereby minimising, or even eliminating, the need for
surgery8.
Studies of the aged eye lens can usually be divided into one of two categories,
those that involve mass screening of age-related changes to proteins gathered
from whole lenses, and those that involve careful study of changes made to a
single type of protein observed in isolation. For studies of the former, the first
step  in  identifying  modification  sites  involves  large-scale  separation  and
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identification of eye-lens protoplasm proteins. These proteins, especially those
found in older lenses, are usually subject to multiple modifications and isolating
the effect of individual changes can be very difficult. As such, studies on bulk
lens protoplasm usually focus on identifying modification sites and determining
the  variance  of  modification  with  age.  Studies  like  these  identify  sites  of
modification that occur with high frequency in aged lenses and identify which
post-translational  modifications  have  high  correlation  with  cataract
disease102,143,144.
With  regard  to  the  latter,  some  age-related  modifications  are  able  to  be
generated in isolation, free of competing modifications, through  in vitro study
involving recombinantly expressed proteins. For example, any truncated protein
can  be  easily  expressed  by  equivalent  deletion  of  base-pairs  in  a  plasmid
vector84,  and  the  truncated  short  peptides  these  events  produce  can  be
synthesised120. Likewise, deamidated proteins can be expressed by substitution
of  Asn/Gln  residues  for  Asp/Glu161.  Chemical  modifications,  such  as
phosphorylation, oxidation and methylation, can be performed  in vitro as well
but usually not in a site-specific manner157. 
Whole lens studies have the advantage of producing results directly applicable
to  the  real  physiological  circumstances of  cataract  formation,  but  fine  detail
regarding the effects of individual modifications on protein structure and stability
is  inaccessible.  Conversely,  in  vitro protein  studies  allow  for  the  fine
examination of individual chemical changes to the stability of the crystallins, but
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such  results  may  not  be  generally  relevant  to  the  highly  crowded  and
extensively  modified  environment  of  the  lens.  As  such,  these  two  research
approaches work best in cooperation, with whole lens studies identifying targets
for specific protein characterisation projects, the results of which in-turn inform
the  relationship  between  post-translational  modifications  and  lens  crystallin
stability.
The  studies  included  in  this  thesis  involve  characterisation  of  specific  post-
translational modifications in crystallins that are implicated in cataract. These
include studies of synthesised peptide fragments of eye lens crystallin proteins
that correspond to truncation products or have modification sites included in
their sequence, and recombinantly expressed deamidation mutants of intact eye
lens crystallin  proteins  to  study the  effect  on  their  structure  and function  of
specific sites in isolation.
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2.1: Materials
2.1.1 Reagents and Consumables
All reagents used were of analytical grade. 
Supplied  by  Sigma-Aldrich:  Dithiothreitol  (DTT),  Sodium Deoxycholate,
Isopropyl  β-D-1-thiogalactopyranoside  (IPTG),  4-(2-Aminoethyl)
benzenesulfonyl  fluoride  hydrochloride (AEBSF), Sodium  Azide,  Sodium
dodecyl  sulfate  (SDS),  Brilliant  Blue  FCF,  Insulin  (from  bovine  pancreas),
Alcohol Dehydrogenase (from saccharomyes cerevisiae),  α-Lactalbumin (from
bovine  milk),  Deoxyribonuclease  (frombavine  pancreas),  Turbonuclease
enzyme solution, M9 Metal Salts (Appendix 3). 
Supplied By Bacto Australia: Yeast Extract, Tryptone, Agar. 
Supplied by Cambridge Isotope Laboratory: 15N Amonium Chloride, Deuterated
Trifluroethanol (TFE) Heavy Water (D2O). 
Supplied by Ameresco inc: Tris, Tris.HCl. 
Supplied  by  Univar:  Sodium  Hydroxide,  Ethylenediaminetetraacetic  acid
(EDTA), Hydrochloric Acid. 
Supplied by Merck & Co. : Glacial Acetic Acid, Ethanol, Methanol. 
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Supplied by Chem Supply Australia: Urea, Sodium Chloride, Sodium Phosphate
monobasic, Sodium Phosphate dibasic.
2.1.2 Buffer Preparation
Buffers and bulk solutions were prepared from stock reagents using water from
a  Milli-Q  Reagent  Water  System.  Buffer  pH  was  determined  using  a  Hach
HQ411d pH/mV meter and filtered via ultrafiltration through a Millipore SV 8μm
membrane. Buffer compositions are described in Appendix 3.
2.1.3 Peptide Acquisition
Peptides corresponding to the βA3-crystallin 200-215 and γS-crystallin 166-178
were  synthesised by  GLS peptide  synthesis,  Shanghai,  China for  Dr  Roger
Truscott  (University  of  Wollongong)  who  kindly  supplied  them  for  our
experiments.  Synthesis of the four aspartic acid isomer containing peptides of
αA-crystallin 57-65 were performed by Peptide 2.0 (Chantilly, Virginia, USA) for
Dr Andrew Aquillina (University of Wollongong) who kindly supplied them for our
experiments.
2.1.4 Protein Gene Synthesis
The gene sequences for WT human αA- and γS-crystallin were synthesised by
and sub-cloned into a pET-43.1a(+) plasmid vector between Nco I and Xho I
restriction  sites  by  GenScript  USA inc  based on human genes CRYAA and
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CRYGS from NCBI gene data bank162. Genes encoding Q147E αA- and N76D
γS-crystallin were obtained by point mutation of the WT genes, also performed
by GenScript  USA inc. pET-43.1a plasmid vector  was kindly  supplied by Dr
Steven  Polyak  of  the  Molecular  and  Cellular  Biology  Department  of  The
University of Adelaide.
2.2: Protein Expression
2.2.1 Recombinant Protein Expression
Single colonies of transformed BL21(DE3) cells were used to inoculate starter
culture of 20ml LB cell growth media (Appendix 3) containing 100μM ampicillin.
Starter culture was incubated at 37°C with shaking at 200 rpm for 16-18 hours
then added to a large scale culture consisting of 1L LB media containing 100μM
ampicillin. The large scale culture was incubated until cell density as A600 was
~0.8  upon  which  protein  expression  was  induced  with  0.5mM  IPTG.  Cell
cultures were then allowed to express for 16 hours at 20°C before being pelted
at 5000g and 4°C for 15 minutes using a Hitachi VX22G centrifuge and 59A
rotor.
2.2.2 Isotope Labelled Expression
Expression of  15N labelled γS-crystallin used the same method as large scale
expression  of  unlabelled  protein  except  for  using  an  M9  minimal  media
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(Appendix 3). Inoculated starter culture of 20ml of LB was incubated for 16-18
hours and then added to 500ml M9 cell media. The large culture was incubated
at 37°C until cell density as A600 was ~0.8 after 8 hours. Protein expression was
induced with 0.5mM IPTG and allowed to express for 20 hours at 20°C.
2.3: Protein Purification
2.3.1 Cell Lysis and Purification Preparation
Cell pellet from recombinant expression was re-suspended in 20ml lysis buffer
consisting of 50mM Tris pH 8.5, 125μM AEBSF and 2μL Turbonuclease enzyme
solution,  with the addition of  25mg sodium deoxycholate in the case of  αA-
crystallin.  Cells  were  lysed via  sonic  agitation  at  4°C using  an Omin Sonic
Ruptor  400  and  an  OR-T-375  sonic  horn  tip  at  50% power  for  6  minutes.
Resulting lysate was centrifuged at 10,000g and 4°C for 30 minutes using a
Hitachi VX22G centrifuge and R15A rotor.
2.3.2 Ion Exchange Chromatography
Cell lysate from αA- and γS-crystallin recombinant expression was purified via
anion exchange chromatography. Chromatography was performed using a GE
ÄKTA pure FPLC system over a GE HiPrep 16/60 DEAE FF anion exchange
chromatography column. Elution buffers for ion gradient were 50mM Tris pH 8.5
with 0M NaCl starting buffer and 1M NaCl high ion strength buffer. Column was
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equilibrated with starting buffer and loaded with 30ml lysate via sample pump.
Column was washed with  1 column volume of  starting  buffer  followed by  a
gradient of 0M to 1M NaCl over 8 column volumes. αA-Crystallin typically eluted
after 4 column volumes and γS-crystallin after 1. Contents of each fraction was
determined via SDS PAGE and those containing desired protein were combined
and  concentrated  to  1ml  using  Millipore  Amicon  Ultra-15  10,000  NMWL
centrifuge concentrator tubes.
2.3.3 Gel Filtration Chromatography
Concentrated elution fraction containing αA-crystallin were further purified using
gel  filtration  chromatography  over  a  GE 10/60  superdex-300  size  exclusion
column. The column was equilibrated in 50mM phosphate 100mM NaCl buffer
at pH 7.4 and loaded with 1ml of protein sample via capillary loop. The protein
was eluted from the column with 1.5 column volumes of buffer and typically
eluted after 0.4 volumes. 
γS-Crystallin samples were similarly purified via gel filtration chromatography
over a GE HiLoad 16/600 superdex-75 pg size exclusion column. The column
was  equilibrated  with  50mM phosphate  100mM NaCl  buffer  at  pH  7.4  and
loaded with 1ml of protein sample via capillary loop. The protein was eluted
from the column with 1.5 column volumes of buffer and typically eluted after
0.55  volumes.  The  fractions  were  analysed  using  SDS  PAGE  and  those
containing desired protein were buffer exchanged into milli-Q water and freeze-
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dried.
2.3.4 SDS PAGE
Gel electrophoresis was performed using Novex Blot 4-12% Bis Tris plus, 15
well precast gels and mini gel tank (Life Technologies). Protein samples of 20μL
were combined with 5μL of Blot 5x gel loading buffer and heated at 100°C for 5
minutes. Samples were loaded into individual wells of precast gel and run with a
constant  voltage  of  150V  for  45  minutes  in  Bolt  MES  running  buffer  (Life
Technologies)  using  Nacalai  Tesque  broad  range  protein  ladder  one  as  a
standard marker.
2.4: Spectroscopic Analysis
All protein concentrations were determined by absorbance at 280nm using a
Nanodrop UV/Vis spectrometer based on calculated theoretical molar extinction
coefficients for each protein.
2.4.1 UV/Vis, Fluorescence and CD Spectroscopy
All  UV/Vis,  fluorescence and circular  dichroism spectroscopy was performed
using  an  Applied  Photophisics  Chirascan  spectrophotometer  with  scanning
emission  monochromater  attachment  and  a  Quantum  Northwest  TC  125
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temperature controller. Temperature ramped experiments were performed from
30 to 90°C in 1° steps with 2 min equilibrium time each step.
UV/vis spectra were recorded using a Helma semi-micro cuvette with 10mm
pathlength for αA- and γS-crystallin. Both proteins were recorded at 1mg/ml in
50mM phosphate 100mM NaCl pH 7.5 buffer. Spectra were acquired between
200 and 350nm with a 1nm step.
CD spectra  were  of  γS-crystallin  were  recorded  using  Helma quartz  micro-
cuvettes with 1mm pathlength. Protein at 0.5mg/ml in 25mM phosphate buffer
pH 7.4 recorded as elipticity from 180-260nm in steps of 0.2nm.
Intrinsic  Fluorescence  spectra  of  γS-crystallin  were  recorded  using  Helma
quartz fluorescence micro-cuvettes with 10mm absorption and 4mm emission
pathlength. Proteins were at 0.5mg/ml in 50mM phosphate buffer 100mM NaCl
pH 7.4 recorded at excitation of 295nm and emission from 300 to 400nm in 1
nm steps with fluorescence photomultiplier 97% sensitivity and 10mm slit width.
2.4.2 UV/Vis and Fluorescence Assays
Kinetic aggregation assays were performed on a Biotek Synergy 2 microplate
reader. Turbidity assays were performed by measuring solution absorbance at
360nm  using  Novagen  96  well  microplate.  Fluorescence  assays  were
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performed using filters of 284±5 excitation 360±20 emission for intrinsic and
440±20  excitation  460±20  emission  for  thioflavin-T dye  binding  in  Novagen
flouresence 96 well microplates.
γS-Crystallin intrinsic fluorescence assays were performed at 0.5mg/ml of both
WT and N76D protein in 50mM phosphate 100mM NaCl pH 7.4 buffer with
varying  GndCl  concentration  in  each  microplate  well  from  0-5M.  Total
fluorescence emission of each well was determined at temperatures from 25-
60°C in 5° increments with 30 minute equilibration time at each step. 
γS-Crystallin kinetics aggregation assays were tracked by turbidity change and
performed at 1mg/ml of both WT and N76D protein in 50mM phosphate 100mM
NaCl pH 7.4 at 55°C, with 200μL per well. Aggregation was assayed against
various concentrations of stock bovine eye lens α-crystallin low mass fraction,
from 0.01 to 3.16mg/ml on an exponentially increasing scale. Solution turbidity
readings were taken every two minutes for 8 hours with light shaking before
each reading.
Insulin amorphous aggregation assays were performed at  0.25mg/ml protein
50mM phosphate 100mM NaCl pH 7.4 with 10mM dithiotheitol reducing agent
at  37°C,  with  200μL  per  well.  Aggregation  was  assayed  against  varying
concentrations of both WT and Q147E αA-crystallin from 0.032 to 1mg/ml on an
exponentially  increasing  scale.  The solution  turbidity  of  each  well  was read
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every minute over 2 hours.
Fibrilar insulin aggregation assays were performed with 0.5mg/ml protein in pH2
HCl/H2O at  60°C  using  100μM  thioflavin-T  dye  with  200μL  in  each  well.
Aggregation  was  assayed  against  varying  concentrations  of  both  WT  and
Q147E αA-crystallin  from 0.016  to  0.5mg/ml  on  an  exponentially  increasing
scale.  The flourescence of each well was read every 2 minutes over 6 hours.
α-Lactalbumin amorphous aggregation assays were performed 2mg/ml protein
in  50mM phosphate  100mM NaCl  buffer  at  pH 7.4  with  20mM dithiothreitol
reducing agent and 2mM EDTA at 37˚C with 200μL in each well. Aggregation
was  assayed  against  varying  concentrations  of  both  WT  and  Q147E  αA-
crystallin from 0.032 to 1mg/ml on an exponentially increasing scale. Solution
turbidity readings were taken every two minutes for 10 hours with light shaking
before each reading.
Alcohol  dehydrogenase amorphous aggregation assays were performed with
0.5mg/ml of protein in 50mM phosphate 100mM NaCl buffer pH 7.4 with 2mM
EDTA at  45˚C,  with  200μL in  each  well.  Aggregation  was  assayed  against
varying  concentrations  of  both  WT and  Q147E  αA-crystallin  from  0.032  to
1mg/ml on an exponentially increasing scale. Solution turbidity readings were
taken every 5 minutes for 20 hours with constant moderate shaking. 
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2.5.1 SEC-MALLS
Size-exclusion chromatography, multi-angle laser light scattering (SEC-MALLS)
experiments  were  carried  out  using  a  Wyatt  Heleos  Dawn8+  Laser  Light
Scattering device and a Wyatt Optilab rEX refractive index detector with sample
separated over a GE HiLoad 16/600 superdex-75 pg size exclusion column.
The  column was  equilibrated  for  2  column  volumes  with  50mM  phosphate
100mM NaCl pH 7.4 buffer. Protein sample of 1ml at 5mg/ml was injected onto
the column and eluted with 1.5 column volumes of buffer at 1ml/min. MALLS
device  detectors  were  normalised  using  monomeric  bovine-serum  albumin
(BSA - Sigma Co) dissolved at 10mg/ml in phosphate buffered saline (PBS) as
the isotropic scattering agent.  Results  were analysed using ASTRA software
provided with the HELEOS II instrument
2.5.2 Analytical Ultracentrifugation
AUC  experiments  were  performed  using  a  Beckman  XLA  analytical
ultracentrifuge  with  an  AnTi50  eight  hole  rotor  filled  with  epon  filled  double
sector centrepieces.  Experimental  results were processed using the SEDFIT
software suite163.
Sedimentation  velocity  experiments  were  recorded  at  40,000  rpm  with
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measurements taken every 5 minutes. Protein samples were at 0.6mg/ml in
50mM phosphate  100mM NaCl  buffer  at  pH 7.4  and  20°C.  The  mass  and
quantity of species in solution was determined by fitting centrifugation curved to
a two species system using numerical solution for the Lemm equation
Sedimentation  equilibrium  experiments  were  performed  for  γS-crystallin  at
7000rpm and 12,000rpm with  a  protein  concentration  of 0.6mg/ml  in  50mM
phosphate buffer, 100mM NaCl pH 7.4, 20°C. Data were fitted to a two-species
equilibrium to calculate the  dimerisation constant with monomer mass set at
20.6 kDa.
2.6: NMR Spectroscopy
1H NMR experiments were performed on αA-crystallin 57-65 peptides in 10%
2H2O /90% 
1H2O 50mM phosphate buffer at pH 7.4 using 5 mm P-535 NMR
tubes (Wilmad-Labglass, Quantum Scientific). All NMR spectra were acquired at
600  MHz  with  a  sweep  width  of  7002  Hz,  the  first  round  of  which  were
performed at 25°C and the second at 5°C. The 25°C spectra were acquired on
a Varian Inova-600 NMR spectrometer equipped with a pulsed-field gradient 5
mm probe  and  processed  using  VnmrJ  (version  2.2d).  These  spectra  were
referenced to the residual water resonance at 4.79 ppm. All NMR spectra at 5°C
were acquired using a Brucker Anova 600 MHz spectrometer equipped with an
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Avance  II  console  and  TCI  cryoprobe,  processed  using  Topspin  3.2  and
referenced  to  the  residual  water  peak  at  4.99  ppm.  Through-bond  (scalar)
connectivities  were  obtained  from  Total  Correlation  Spectroscopy  (TOCSY)
experiments  with  a  spin-lock  period  of  60  ms.  Through-space connectivities
were obtained for all peptides using Rotating-frame Overhauser Enhancement
Spectroscopy (ROESY) experiments with a mixing time of 300 ms. All spectra
were visualized and assigned in CCPN (version 2.3)164. 
1H and  13C  NMR experiments were  performed on  γS-Crystallin 167-179 and
βA3-Crystallin 199-215 in v:v 80% deuterated trifluroethanol (dTFE) and 20%
water  using 5 mm P-535 NMR tubes (Wilmad-Labglass, Quantum Scientific).
All 1H-NMR spectra were acquired at 600 MHz and 25°C on a Varian Inova-600
NMR  spectrometer  equipped  with  a  pulsed-field  gradient  5  mm  probe.  All
spectral chemical shifts were referenced to the residual TFE CH2 resonance at
3.88 ppm in proton and 61.5 ppm in carbon. 1H-1H Through-bond connectivities
were obtained from Total Correlation Spectroscopy (TOCSY) experiments with a
spin-lock  period  of  60  ms  and  Double  Quantum  Filtered  Correlation
Spectroscopy (DQCOSY) experiments. 1H-13C through bond connectivities were
obtained from Heteronuclear Single Quantum Correlation spectroscopy (HSQC)
and Hetronuclear Multiple Bond Correlation Spectroscopy (HMBC). Through-
space connectivities were obtained for all peptides using Nuclear Overhauser
Effect Spectroscopy (NOESY) experiments. All spectra were processed using
VnmrJ (version 2.2d) and visualised in CCPNMR (version 2.3)164. 
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1H and 15N NMR experiments were performed on γS-Crystallin WT and N76D at
2.5mM in 10%  2H2O /90%  
1H2O 25mM phosphate buffer at  pH 6. All  NMR
spectra were acquired at 800MHz using a Brucker AV800 NMR spectrometer
with TCI cryoprobe, proceed using Topspin 3.2.
1H15N HSQC spectra were performed with  a spectral  width of  16ppm in  the
proton dimension with a transmitter offset of 4.679ppm and spectral width of
50ppm in the nitrogen dimension with a transmitter offset of 120ppm, a dwell
time of 39μs and a receiver gain of 64. 1H TOCSY spectra were performed with
a spectral width 11.4ppm and a transmitter offset of 4.698ppm. The spectrum
was taken with a receiver gain of 64, a dwell time of 55μs and a mixing time of
60ms.  1H15N TOCSY-HSQC spectral width of 10ppm in the proton dimension
with a transmitter offset of 4.8ppm and spectral width of 36ppm in the nitrogen
dimension with a transmitter offset of 120ppm, a dwell time of 62.4μs and a
receiver gain of 64 
2.7: Structure Calculations
Structural  calculations  from  NMR  data  for  αA-crystallin  57-65  Asp  isomer
peptides, βA3-crystallin 200-215 and γS-crystallin 167-178 were performed in
Aria (version 2.3)165 using CNS solve (version 1.21)166 software suites. Chemical
shift  matched  restraints  and  NOE  distance  restraints  were  derived  from
CCPNmr164 and dihedral  angle restraints  derived from DANGLE167.  Standard
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Aria  protocols  and libraries  were  used  in  all  calculations  except  for  custom
molecular topography and parameter definitions used for the D-aspartic acid
and  both  D-  and  L-isoaspartic  acid  residues  in  αA-crystallin  isomer  peptide
which  were  based  in  energy  minimised  structures  for  the  free  amino  acid.
Structural  ensembles  were  generated  with  a  series  of  8  iterations  of  20
structures of which the 7 best structures were retained in each step. These
iterations  applied  progressively  more  strict  restraints  for  violation  threshold,
violation tolerance and weight tolerance. A final  solvent refinement step was
performed  on  the  10  best  structures.  Calculated  structure  ensembles  were
generated and visualised using UCFS Chimera168. Structural ensembles were
generated by overlying each structure using the lowest energy structure as a
template.
Amino acid trimer minimisation calculations were performed using Gaussian 09
software  package169. Full  conformational searches were performed at a 120°
resolution  using  SMD170/M06-2X171/6-31+G(d)  method.  Optimised  conformers
were sorted in order of increasing electronic energy in solution, and species in
the  bottom  20  kJ  mol-1  were  selected  for  a  subsequent  solution-phase
frequency calculation at the same level of theory. Gibbs free energies of these
species in water at 25 °C include entropies and thermal corrections, obtained
using standard textbook formulas for the statistical thermodynamics of an ideal
gas  under  the  harmonic  oscillator  approximation172 in  conjunction  with  the
optimised geometries and scaled173 frequencies174.
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Raw data for several  temperature ramped unfolding,  urea induced unfolding
and kinetic aggregation assays were fitted to a sigmoidal function for two state
unfolding:
S=AF+(AU−AF )(1−exp
−kA)n
 
Where derived value  AF represents the spectroscopic value of folded or non-
aggregated  protein,  AU represents  the  spectroscopic  value  of  unfolded  or
aggregated  protein  and  k is  the  slope  of  the  curve  at  Tm,  the  midpoint  of
unfolding or aggregation. Sigmoidal function for two state unfolding was fitted to
raw  data  using  Differential  Evolution  and  Particle  Swarm  Optimisation
(DEPSO)175.
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Structural Characterisation of Crystallin Short
Peptide Truncation Products
3.1: Introduction
The crystallin proteins of  the eye lens are subject to a wide range of post-
translational modifications over the course of their lifetimes4,5,7,101. One common
modification is truncation, or cleavage of the peptide chain, at a protein's N- or
C-terminus4,106. In most tissues, truncations are the result of protease activity,
often as part of protein degradation and recycling pathways109,110.  This is not
generally true in the lens, as mature fibre cells lack metabolic activity and such
enzymes are  typically  absent  or  deactivated112.  There  are,  however,  several
spontaneous,  non-enzymatic,  interconversion  processes  that  can  result  in
peptide cleavage. One notable truncation pathway is the N,O-acyl shift that can
occur  at  the  N-terminal  side  of  serine  residues116.  Post-translational
modifications tend to accumulate in the lens over an individual's lifetime and it is
common to find both truncated proteins and the corresponding small peptide
products in aged lens fibre cell protoplasm120. One common location for such
truncations is the unstructured C-terminal region of the α-crystallins, which has
been well characterised176,177. Both αA- and αB-crystallin are prone to loosing
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residues  from  their  C-terminus  over  the  lifetime  of  the  lens  and  the
accumulation  of  truncated  protein  is  associated  with  lens  opacification176,178.
Similar truncation are also common at N-terminal extensions in β-crystallins and
such modification is common in cataractous lenses179.
Two particularly notable cleavage-prone crystallins are βA3- and γS-crystallin,
whose resulting truncation peptide has been found associating with lens fibre
cell membranes. βA3- and γS-crystallin can undergo truncation via spontaneous
cleavage at serine residues, Ser200 in βA3 and Ser167 in γS, and the resulting
peptides have been found in  large quantities  in  both  aged and cataractous
lenses106,120,121. There is evidence that these peptides will undergo a change in
secondary structure when exposed to membrane-like conditions, leading to the
hypothesis that they can infiltrate and potentially weaken cell walls120. βA3- and
γS-crystallin are both major lens components. βA3-Crystallin is found in the lens
nucleus where it  forms high-mass oligomers and γS-crystallin is the primary
protein  expressed  in  the  lens  cortex4,22.  Modification  to  these  common lens
proteins has the potential to cause a disproportionate effect on the health of the
lens.
Trifluroethanol  (TFE)  is  a  protein  co-solvent  that  is  often  used  to  solublise
hydrophobic proteins and stabilise peptide structures180,181. The effect of TFE on
poly-peptides is highly concentration dependant. At concentrations lower than
30%,  TFE  solvates  the  surface  of  proteins  and  causes  a  reduction  in  the
dielectric  constant  of  the  surrounding  solvent181.  This  causes  water  to  be
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displaced  from  the  peptide  backbone  and  increases  intra-peptide  hydrogen
bonding180.  At higher concentrations, TFE promotes and stabilises secondary
structures  while  disrupting  tertiary  protein  structures  by  greatly  reducing  the
hydrophobic  effect181.  TFE  solutions  are  widely  used  to  mimic  membrane
environments  for  proteins  in  NMR  and  CD  spectroscopy  by  weakening
hydrogen bond formation with water and encouraging peptide self-association.
Such solutions often induce stable helical conformations in peptides in a similar
manner  to  a  lipid  membrane,  but  in  some  cases  this  helical  character  is
exaggerated compared to what would be found in vivo180.
Figure  3.1 shows  far  UV  circular  dichroism  spectra  for  the  βA3-  and  γS-
crystallin C-terminal truncation peptides in both water and 80% TFE (Friedrich,
Truscott et  al. unpublished work).  These spectra suggest  that  both peptides
undergo a change in secondary structure when introduced to membrane-like
conditions, showing an increase in predicted α-helical content from 8% to 88%
in both cases. α-Helices are highly stable structures and it is possible that these
free  peptides  would  favour  membrane  insertion  in  the  lens.  Many  α-helical
membrane binding peptides exist that are capable of forming pores in cell walls
and causing cell lysis182,183. If these truncation peptides exhibit similar properties,
then their build-up in the lens with age may contribute to lens opacification by
disrupting fibre cell structure.
The peptide corresponding to αA-crystallin 55-65 is another common truncation
product found in aged eye lenses106. This peptide is likely the product of two
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55
(c) γS H2O γS 80% TFE βA3 H2O βA3 80% TFE
Alpha helix 8.02% 87.59% 8.15% 87.76%
Beta Sheet 22.0% 0.48% 22.14 0.47%
Figure  3.1:  Circular Dichroism spectra of peptides from C-terminals of (a) γS-crystallin (166-
178)  and  (b)   βA3-Crystallin  (200-215)  comparing  secondary  structure  in  water  and  80%
trifluroethanol  (TFE).  (c)  Calculated  proportions  of  secondary  structure  of  each  peptide
determined from CD spectra using K2D2250. Unpublished results Freidrich, Truscott el al. 2012.
(a)
H2O            80% TFE      
γS-Crystallin 166-178
(a)
H2O   80% TFE
βA3-Crystallin 200-215
(b)
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successive  N,O-acyl shifts127, one at Thr55 and the other at Ser66. Truncated
αA-crystallin  and the  resulting peptide  are found in  large quantities in  aged
lenses and may contribute to age-related cataract formation106. This peptide is
of particular interest as it  also contains a common site of  isomerisation and
racemisation in αA-crystallin, Asp58184. 
Aspartic acid isomerisation is another common post-translational modification
found in aged eye lenses125. This modification involves spontaneous chemical
rearrangement via the formation of a succinimide ring intermediate. This ring is
capable of opening in two different locations to form either an aspartic or an
isoaspartic  acid  residue  (Figure  1.9)127.  Additionally,  this  succinimide
intermediate exhibits a high ring strain and can inter-convert between L- and D-
isomers127,128. As a result, this modification pathway has four possible products,
all of which have different structures and different implications for protein folding
and  function.  The  rate  of  isomerisation  in  proteins  and  peptides  can  vary
dramatically and appears to be highly dependent of local freedom of movement
and  adjacent  side-chains129,  to  the  extent  that  some  proteins  undergo
isomerisation  over  the  course  of  decades  but  short  peptides  have  been
measured with isomer half-lives of days125,185.
Post-translational  modifications  in  the  eye  are  typically  identified  via  a
combination  of  chromatography  and  mass  spectrometry45.  This  involves
purification of  whole  eye lens protoplasm via  multi-stage chromatography to
isolate the various crystallins that make up the majority of fibre cell protein186,187.
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These crystallins are then often subject to enzymatic digestion and the resulting
fragments are separated using reverse-phase HPLC and identified with MS/MS
mass spectrometry45. This method permits quantification and characterisation of
sites  of  post-translational  modification,  particularly  those  that  cause  a  large
change  in  mass  such  as  oxidation  and  phosphorylation55,143.  Aspartic  acid
isomerisation results in modified protein with no difference in mass, however,
making  differentiating  these  species  problematic  for  mass  spectrometry125.
Identifying and characterising sites of such modifications can be achieved using
electron  transfer  dissociation  mass  spectroscopy188 or  synthesised  peptides
containing each isomer as HPLC standards5. In may, however, be possible to
distinguish  between  such  peptides  using  a  chemically  sensitive  analytical
technique such as NMR spectroscopy.
This chapter details the extensive NMR characterisation of several truncation
peptides.   In  section  3.2,  the  structural  characterisation  of  peptides
corresponding  to  the  C-termini  of  βA3-  and  γS-crystallin  under membrane
mimicking solvent conditions is detailed. The aim of this study is to determine if
membrane-like conditions promote a more stable secondary structure that might
encourage these peptides to infiltrate fibre cell walls.
Section 3.3 of this chapter details the NMR characterisation of the αA-crystallin
57-65 peptide for the four possible isomers of deamidation in Asp58.  These
synthetic  peptides  were  used  as  an  analogue  of  the  αA-crystallin  55-65
truncation fragment found in aged eye lenses. NMR is sensitive to changes in
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local chemical environment and peptides display structurally specific patterns
that  allow residues to  be matched to  resonances using standard sequential
assignment  methods189.  The  intention  of  this  characterisation  is  first,  to
determine if the four isoforms of aspartic acid are distinguishable using NMR
techniques,  and  second,  to  investigate  any  structural  characteristics  or
differences shown by these peptides in solution. These results may give insight
into what role, if any, the presence of these peptides play in age-related cataract
formation.
3.2: Membrane Peptide Characterisation
The  proteins  βA3-  and  γS-crystallin  are  prone  to  a  spontaneous  truncation
pathway on the N-terminal side of serine residues in their C-terminal region 190.
Two  observed  products  of  these  truncations  are  the  short  peptides
SPAVQSFRRIVE,  corresponding  to  γS-crystallin  167-178  (γS),  and
SHAQTSQIQSIRRIQQ, corresponding to βA3-crystallin 200-215 (βA3). There is
evidence  that  these  peptides  form  stable  secondary  structural  motifs  in
membrane-like  conditions (Figure  3.1).  Such structures  could  stabilise  these
peptides and encourage them to  infiltrate  membrane in  the  lens,  potentially
weakening fibre cell walls and causing pore formation or lysis191. A structural
characterisation  using  NMR spectroscopy was performed on these peptides
under  a membrane-mimicking solvent  system consisting of  20% H2O /  80%
TFE.  This  solvent  system  mimics  membrane  environments  for  polypeptide
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chains by encouraging intra-molecular hydrogen boding and solvating non-polar
residues180,192.
3.2.1 NMR Spectroscopy
The γS and βA3 peptides were
analysed via NMR spectroscopy
in  20%  H2O  /  80%  deuterated
TFE solvent system. The proton
and  carbon  chemical  shifts  of
both  peptides  were  assigned
using  a  combination  of  1H  and
13C  2D NMR  spectroscopy.
Proton  resonances  were
assigned  to  the  spin  system  of
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Figure  3.2: Example  diagram  of  sequential
assignment of  a peptide backbone from  1H NOESY
spectrum189.
Figure 3.3: Assignment of the NH to backbone region of the 1H TOCSY spectrum for the γS
peptide. The spin-systems assignments for residues 167 to 178 are labelled.
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each peptide residue by referencing
each  1H  TOCSY  cross-peak  to
characteristic  amino  acid  chemical
shifts  from  the  Biomagnetic
Resonance  Databank  (BMRD)193.
1H NOESY experiments were used
to  distinguish  duplicate  residues
using  sequential  backbone  NOE
assignment  (Figure  3.2)189.  Carbon
resonances were assigned from 1H-
13C HSQC and HMBC experiments
by matching proton chemical shifts
to the corresponding cross-peaks in
each spectrum.  The chemical  shift
assignments for these NMR spectra
can be found in Appendix 2.
Figure  3.3 shows an excerpt of the
TOCSY spectrum for the γS peptide
with assignments. This region of the
spectrum contains cross-peaks that
arise from the spin system of each
amino acid side-chain coupling with
the backbone NH resonance. Ten of
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Figure 3.4:(a) Assigned H1 TOCSY spectrum for
199-215  βA3-crystallin  showing  the  fingerprint
region.  All  cross-peaks  are  the  result  of  intra-
residue  NH-αCH  coupling  unless  noted.  (b)
Assigned  1H-13C HSQC  spectrum  showing  the
same  x axis  proton  dimension  as  (a)  which
contains the αH-C cross-peaks and the resolved
βH-C peaks.
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the twelve residues of γS show cross-peaks in this region, with the absence of
Ser167 due to line broadening from N-terminal -NH3+ exchange with solvent and
Pro168 due to proline lacking an NH proton. 
Figure 3.4(a) shows the fingerprint region from the 1H TOCSY spectrum of the
βA3 peptide and the corresponding αCH region from a 1H-13C HSQC spectrum.
All  residues of  the peptide show peaks in  these regions,  except  for  His201
which lacks an observed NH resonance in any recorded spectrum and Ser200
which lacks an NH signal due to solvent exchange at its N-terminus. Other than
these absent spin systems, all residues are distinguishable in these spectra and
each show the expected characteristic chemical shifts for amino acids of their
type193.  This gives the necessary foundation to begin determining secondary
structural information for the two truncation peptides. 
3.2.2 Inter-Residue NOEs
A very  useful  source  of  secondary  structural  information  in  peptides  and
proteins  is  inter-residue NOE cross-peaks189.  These  cross-peaks  result  from
through-space dipolar interaction between atoms of non-adjacent residues and
would  not  be  expected  to  occur  in  the  absence  of  any  protein  folding  or
secondary  structure194.  Each  type  of  secondary  structure  exhibits  its  own
distinctive  pattern  of  inter-residue NOEs189.  If  an  α-helix  is  present  in  these
peptides as hypothesised, we would expect to find patterns of NOE interactions
along the backbone that are 3 to 4 residues apart and series of strong NHi to
61
3.2.2 Inter-Residue NOEs
NHi+1 NOEs, caused by the stable repeating coil structure bringing these atoms
into proximity195.
Figure  3.6 summarises  the  NOE connectivities  for  the γS peptide  fragment,
determined from the  1H-1H NOESY experiment. The magnitude of each NOE
was determined from relative total cross-peak volume of the assigned spectra.
Figure  3.6 shows many moderately  strong,  short  range,  inter-residue NOEs
along the backbone of the peptide. Such a pattern is indicative of a closely
folded  structure  such  as  a  helix195.  Figure  3.6 also  shows  the  presence  of
several longer-range NOE cross-peaks in a small  region of the peptide from
residues 168 to 172. This region exhibits a short series of NOEs between NH
and αCH resonances 2 residues distant as well as some cross-peaks between
NH  and  βCH2 protons  3  residues  distant.  These  NOE  patterns  are  less
characteristic of α-helical structure and more in line with a turn-like structure or
a nascent helix195. This short region of structure is limited to residues 168-172,
meaning any structural motifs present are likely only small and weakly defined.
Figure 3.5 shows a summary of the NOE cross-peaks for the βA3 peptide. This
peptide  exhibits  many more  sequential  NOEs than the  γS peptide,  possibly
indicating the βA3 peptide is less dynamic in solution. Of more interest is the
large number of longer-range NOEs present in the region between residues 204
to 213. This region exhibits a distinct series of NOEs between the NH and αCH
resonances of  residues 3 amino acids distant along the backbone,  which is
consistent with the presence of an α-helical motif195. This region also exhibits
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other  inter-residue  NOEs  between  various  atoms  that  are  2  to  4  residues
remote. Taken together, this suggests that a short region α-helix exists in the
centre of the polypeptide chain.
3.2.3 Secondary Chemical Shifts
Secondary chemical shifts of αCH 1H and 13C resonances were determined by
comparing  experimental  results  with  reference  chemical  shifts  for  those  in
unstructured random coil peptides193. In the absence of any secondary structure
we would expect the observed chemical shifts to match the reference shifts,
meaning any pattern of deviation from the reference shifts is suggestive of a
structured region. An α-helix results in a negative secondary shift in backbone
αCH resonances and a corresponding positive shift in carbon resonances189.
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Figure  3.5:  Summary  of  inter-residue  NOE cross-peak connectivity  from the  1H NOESY
spectrum  of  the  βA3-crystallin 200-215  peptide.  Bar  width  for  sequential  connectivities
indicates relative intensity of NOE cross-peak.
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3.2.3 Secondary Chemical Shifts
Figure  3.7 shows the secondary chemical  shifts  for  the γS-crystallin peptide
fragment compared to those of unstructured peptides194.  Ser167 and Glu178
show large secondary shifts, likely due to the proximity of the N- and C-termini
of  the  peptide.  The  remainder  of  the  peptide  exhibits  a  small  negative
secondary  shift  trend  in  the  region  of  residues  170  to  174  for  the  1H αCH
resonances and a corresponding slight positive trend in the same region of the
13C αCH resonances. These trends match those expected of either an α-helix or
a nascent helical structure and would be consistent with a turn-like motif. These
trends appear in the same region of the peptide that exhibits non-sequential
NOE connectivities, which reinforces the presence of secondary structure in the
centre of the peptide chain.
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Figure  3.6:Summary  of  inter-residue  NOE  cross-peak  connectives  from the  1H  NOESY
spectrum  of  the  γS-crystallin  167-178  peptide.  Bar  width  for  sequential  connectivities
indicated relative intensity of NOE cross-peak.
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3.2.3 Secondary Chemical Shifts
Figure 3.8 shows the 1H and 13C αCH secondary shifts for the βA3 peptide. As
with  the  γS  peptide,  the  N-  and  C-termini show large  secondary  shifts. Of
greater interest is the large negative trend displayed in the 1H αCH secondary
shifts from residues 204 to 212 and the corresponding positive  13C secondary
shifts from residues 203 to 211. This trend is similar in direction to that shown
by the  γS peptide, but covers a greater region of its backbone and is much
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Figure 3.7: Secondary chemical shifts of 1H and 13C  αCH resonances from the γS-crystallin
167-178 peptide. Shifts are calculated as the difference compared to reference shifts194. The
Bars  indicate  the  absolute  difference  for  each  residue  whereas  the  line  shows trend  ±2
residues, ignoring peptide termini.
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3.2.3 Secondary Chemical Shifts
larger in magnitude. This trend also corresponds to the region of the peptide
that exhibits inter-residue NOEs  that were previously noted as indicating the
presence of secondary structure. Together this suggests that the βA3 peptide
has a well defined region of structure in the centre of its chain, likely possessing
α-helical qualities. 
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Figure 3.8: Secondary chemical shifts of 1H and 13C  αCH resonances of βA3-Crystallin 200-
215 peptide fragment. Shifts are calculated as the difference of observed shifts compared to
reference shifts of unstructured residues194.The bars indicate the absolute difference for each
residue whereas the line shows trend ±2 residues, ignoring peptide termini.
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In summary, analysis of the NMR NOE patterns in the two peptide indicates that
the βA3 peptide has the greater secondary structure and shows distinct helical
character, whereas the γS peptide contains some secondary structure but this is
likely much weaker and more disordered.
3.2.4 Structure Calculations
Solution  NMR  data  from  peptides  and  proteins,  such  as  NOE  cross-peak
intensities can be used as restraints in computational structural calculations for
determining  their  secondary  and  tertiary  structures.  Molecular  dynamics
calculations were performed on both truncation peptides using the ARIA 2.3165
and CNS Solve 1.21166 software suites. The calculations used restraints derived
from  NOE  cross-peaks,  chemical  shift-matching  and  dihedral  bond  angle
calculations  from  DANGLE167.  These  structure  simulation  consisted  of  eight
iterations of 20 structures, followed by a solvent refinement step of the 10 best
structures.  The final  10  structures  for  each peptide  were  overlain  using  the
lowest energy structure as a template. These ensembles are shown in Figure
3.9.  Both  peptide  structural  ensembles  have  the  region  that  showed  the
greatest structure from NOEs and secondary shifts highlighted in red for ease of
comparison.
As was predicted from the experimental  NMR data, the γS-crystallin peptide
shows  the  lower  secondary  structure  of  the  two.  The  calculated  ensemble
shows a slightly twisted, turn-like structure in the peptide between residues 170
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Figure  3.9:  Ensembles of the 10 best calculated structures and corresponding root mean
squared deviation for (a) γS crystallin 167-178 and (b) βA3 crystallin 200-215.The N-terminal
of  each  peptide  is  marked  blue  and  the  region  of  the  greatest  apparent  structure  from
experimental results (γS 170-175 and βA3 203-210) are marked red.
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3.2.4 Structure Calculations
and 174. Notably, the highlighted region shows poor overlap and high deviation
in some structures, consistent with the presence of disorder in the peptide. 
In contrast to the γS peptide, the calculated ensemble for the βA3 peptide show
a well structured region between residues Thr204 and Arg211 that matches with
experimental  observations.  The  highlighted  region  shows  a  distinct  helical
structure  that  is  particularly  well  defined  towards  the  C-terminal  end  of  the
peptide.  This  matches  with  the  inter-residue  NOE patterns  observed  in  the
region  of  residues  204-212  and  the  large  secondary  chemical  shift  trend
observed across the bulk of the peptide chain.
The presence of stable secondary structural motifs in these truncation peptides
under membrane-mimicking conditions suggests a potential for an interaction
with fibre cell walls in the eye lens.
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3.3: Aspartic Acid Isomerisation in Peptides
Asp58 in human αA-crystallin is a major site of spontaneous isomerisation over
the  lifetime  of  the  protein184.  This  region  of  the  protein  is  also  subject  to
spontaneous peptide cleavage at serine ans threonine residues with age106. To
characterise the effects of isomerisation on truncation peptide structure, NMR
spectroscopy was performed on peptides corresponding to human αA-crystallin
57-65  with  sequence  LXSGISEVR,  where  X  corresponds  to  the  point  of
isomerisation  at  Asp58.  The  four  isomers  investigated  correspond  to  the
possible  products  of  succinimide ring opening in  aspartyl  (Asx)  residues;  L-
aspartic  acid  (L-Asp),  L-isoaspartic  acid  (L-isoAsp),  D-aspartic  acid  (D-Asp),
and D-isoaspartic acid (D-isoAsp). 
3.3.1 NMR Spectroscopy
NMR  spectra  were  acquired  for  the  four  aspartic  acid  isoform  containing
peptides.  The  1H  NMR  resonances  for  each peptide  were  identified  using
sequential  assignment  from the  two dimensional  1H-1H-TOCSY and ROESY
spectra189,  an example of  which is  shown in  Figure  3.10.  The through-bond
cross-peaks were divided into spin systems and each amino acid residue was
identified by matching spin systems with chemical shift data from the Biological
Magnetic  Resonance  Data  Bank  (BMRB)193,  except  for  the  isoaspartic  acid
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residue cross-peaks which were referenced to Lacroix et al. (2012)196. Duplicate
serine residues were distinguished using  sequential  backbone assignment of
inter-residue NOEs from ROESY spectra189. The chemical shift assignments for
the amino acid resonances of each peptide are listed in Appendix 2. 
All 1H atoms in each peptide were assigned to NMR resonances based on the
relevant reference data, with two exceptions. The resonances corresponding to
Leu57 NH and Asx58 αCH were  absent  in  the spectra  of  all  peptides.  The
absence of  the  Leu57 NH is  expected as  the  residue is  situated at  the  N-
terminus of the peptide and free amino group would exchange with solvent at
pH 7.4, and cause the peak to broaden beyond the detection limit. The typical
random coil chemical shift of the Asp αCH is 4.63 ppm194 which would place the
resonance in proximity to the solvent (H2O) peak at 4.79 ppm and the absence
of this resonance in the spectra may be due to the solvent suppression included
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Figure 3.10: Cross-peak assignment for the NH to side-chain region for the L-Asp peptide in
a  1H TOCSY spectrum at 25°C with 60ms mixing time. This spectrum is typical of all such
spectra recorded.
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in the pulse sequence.
As  expected,  the  chemical  shifts  of  each  of  the  four  peptides  show  little
difference, with variation mostly limited to the site of isomerisation at residue 58.
The largest difference in chemical shift between the four peptides is the Asx2
NH resonance,  with the L- and D-Asp residues exhibiting shifts  of  8.95 and
9.01ppm while the L- and D-isoAsp residues show a comparative upfield shift of
8.65  and  8.72ppm  respectively.  Variation  in  NH  chemical  shifts  are  often
indicative  of  hydrogen  bonding  interaction  and  the  differences  between  the
peptides appear to be the result of isoaspartic isomerisation, but without the
αCH chemical shifts for comparison there is little structural information available
from these values.
In order to further investigate structural differences between the peptides, the
ROESY spectra were assigned via the distinctive NHi+1 to αCHi NOEs using the
sequential assignment  procedure189. This NOE progression connects each  1H
resonance in the backbone sequence, beginning at the C-terminal Arg65 αCH,
progressing through each residue in order, and ending at the Ser59 NH. The
ROESY  NOE  cross-peaks  also  show  some  longer-range  inter-residue
interactions which, in conjunction with secondary chemical shifts, can be used
to determine secondary structural characteristics in  peptides189. Selected NOE
interactions and secondary chemical shifts for the αCH signals of each residue
are presented in Figure  3.11. Secondary chemical shifts were determined as
the  difference  between  experimental  results  and  reference  random  coil
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Figure 3.11: Selected NOE signals and αCH secondary chemical shifts for peptides 1 to 4.
bar  thickness  represents  relative  intensity  of  NOE cross-peak.  Secondary  chemical  shifts
calculated relative to reference shifts for unstructured peptide 194. 
(b): NOE connectivities and  αCH  secondary
shifts for the L-isoAsp peptide
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3.3.1 NMR Spectroscopy
chemical  shift  values193,196.  Regions  of  the  peptide  showing  secondary  shift
trends are indicative of the presence of secondary structure189.
The individual ROESY spectra show few of the longer range NOE cross-peaks
along the peptide backbone that  might suggest any α-helical  or β-sheet like
secondary structure in these peptides. In general, these peptides exhibit mostly
short-ranged interactions between adjacent residues along with some  i to  i+2
interactions. All peptides show similar secondary chemical shifts, with a positive
trend in  the  region  of  residues 60 to  63,  which  suggests  a  small  region  of
secondary structure in the middle of each peptide. These shared patterns of
NOEs and secondary shifts may indicate a common structure between each of
peptides.
The L-Asp peptide has many short range NOEs as well as several longer-range
i to i+2 and an i to i+3 NOE. The majority of the non-sequential NOEs appear
between residues 59 to 64, a region that shows a positive secondary chemical
shift trend. These patterns imply the presence of some structure to the L-Asp
peptide. A short series of NOE between residues two and three positions distant
along  the  peptide  backbone  are  consistent  with  a  turn-like  nascent  helix
structure195. The combination of NOE connectivities and secondary shifts in the
region  of  residues  58-63  suggests  the  peptide  is  occupying  a  disordered
nascent helix structure in its central region.
The L-isoAsp peptide has a similar pattern of NOEs to the L-Asp peptide. Both
74
3.3.1 NMR Spectroscopy
of these peptides show several non-sequential NOEs in the region of positive
secondary shift trend between residues 59 and 62. For the L-isoAsp peptide,
these consist several i to i+2 and i to i+3 connectivities between backbone and
side-chain resonances. The L-isoAsp peptide has slightly more non-sequential
NOEs in this region but exhibits far fewer short-range sequential NOEs than the
L-Asp. This suggest that the L-isoAsp peptide has a similar overall structure to
the L-Asp peptide, but the reduced number of short range NOEs suggests an
increased disorder and disruption in its structure upon isomerisation.
The D-Asp and D-isoAsp peptides, overall, show similar secondary structural
indicators to the L-peptides. Compared to the L-Asp peptide, the D-Asp has a
similar pattern of non-sequential NOE in its central region and shows several i
to i+1 connectivities along its length. Likewise, isomerisation to D-isoAsp results
in fewer short-range NOEs and fewer inter-residue NOEs. The reduction in the
number of sequential NOEs between Asp and isoAsp peptides suggests that in
general the presence of isoaspartic acid causes a disruption to structure.
The αCH resonance of the Asx58 residue is missing in all spectra, most likely
due  to  it  being  coincident  with  the  water  peak  at  4.79  ppm.  This  makes
differentiating between the Asp and isoAsp residues problematic as we expect
the two aspartic acid isoforms would show their most distinct differences in the
strength of the NHi to αCHi to NHi+1 NOE cross-peaks. In an effort to observe
the Asx58 αCH resonance, ROESY experiments were performed on all  four
peptides at 5ºC. A reduction in temperature has the effect of inducing downfield
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shift in the residual water peak, to 4.99 ppm at 5°C197, theoretically causing the
water and Asx2 αCH resonances to be separated sufficiently so that the αCH is
no longer suppressed.
3.3.2 Isomer Identification
Figure 3.12 shows a comparison of two ROESY experiments, one performed at
25°C  and  one  at  5°C.  This  comparison  shows  the  chemical  shift  changes
associated with the lower temperature, plus two new cross-peaks caused by the
now detectable Asp58 αCH resonance. Both the residual water peak and the
NH  resonances  of  this  peptide  show  downfield  shift  due  chemical  shift
temperature dependence197.  The downfield shift of the water peak is sufficient
to separate it from the Asp58 αCH resonance such that it is no longer affected
by the pulse sequence solvent suppression.
Asparagine  and  aspartic  acid  can  spontaneously  form  a  cyclic  succinimide
species which can ring-open to form both aspartate and isoaspartate residues
(Figure  1.9)198.  Figure  3.13 shows  each  of  the  hydrogen  atoms  capable  of
producing  NOEs  at  the  site  of  rearrangement  in  these  peptides.  The
isomerisation from Asp to isoAsp causes the βCH2 of the asparagine side chain
to be incorporated into the peptide backbone, leading to an increase in length of
the polypeptide chain. As Figure  3.13 shows,  we would expect  the average
distance between Aspi αCH and NHi+1 to increase and the distance between
Aspi βCH2 and NHi+1 to decrease upon isoaspartate isomerisation. 
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Figure 3.12: Assigned 1H ROESY spectrum of the fingerprint region of the L-Asp peptide at
25ºC (●) and 5ºC (●). The Asp58 αCH cross-peaks are circled. This spectrum is typical of all
isomers.
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Figure 3.13: Diagram of energy minimised tri-peptide Ala-Asx-Ser showing the difference in
potential NOEs between Asp and isoAsp residues. These consist of inter-residue NOEs Ser3
NH-αCH (1) and NH-βCH2 (2 and 3) and intra-residue NOEs Asx2 NH-αCH (4) and NH-βCH2
(5 and 6). This shows the large difference in distance for inter-residue NOEs between Asp
and isoAsp residues.
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3.3.2 Isomer Identification
The strength of the NOE between two atoms is dependent on their inter-atomic
distance189.  This  dependence  is  inversely  proportional  to  distance  between
atoms to the sixth power and is measurable as the volume of NOE cross-peaks
in a through-space experiment such as a ROESY spectrum189. If the distances
shown in Figure 3.13 are consistent with experiment, we would expect to see an
increased distance between the Asx58 αCH and Ser59 NH upon isomerisation,
which would manifest as a decrease in NOE cross-peak intensity. Likewise, we
would expect a decrease in the distance and an increase in the NOE between
the Asx58 βCH2 and Ser59 NH. The relative volumes of the cross-peaks form
the relevant  Asx resonances for  each peptide from the ROESY spectra are
shown in Table 3.1. 
The inter-residue NOEs of the L-Asp and L-isoAsp isomers show the predicted
pattern of peak volume, with the Ser59 NH to L-Asp58 αCH cross-peak showing
a 12 times larger NOE than the Ser59 NH to L-Asp βCH2  cross-peak and the
Ser59 NH to L-isoAsp αCH cross-peak showing a 12 times smaller NOE than
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L-Asp L-IsoAsp D-Asp D-isoAsp
Asp58 NH- αCH 160,708 134,180 41,118 55,987
βCH1 163,786 77,813 61,864 120,913
βCH2 86,779 43,488 26,716 44,429
Ser59 NH- αCH 573,623 14,903 208,974 70,519
βCH1 41,731 227,129 7,139 278,813
βCH2 54,411 133,862 31,367 229,841
Asp58 NH - α:β 1.28 : 1 2.21 : 1 1 : 1.08 1 : 1.48
Ser59 NH - α:β 11.93 : 1 1 : 12.11 10.85 : 1 1 : 3.61
Table 3.1: Spectral volume of NOE cross-peaks between Asx αCH and βCH2 resonances and
both adjacent NH resonances in each peptide. The ratio of each NH-αCH peak to the average
of each NH-βCH2 peak is listed for comparison.  Data were extracted from ROESY spectra
acquired at 5°C using truncated box sum of data points in each spectrum in arbitrary units for
each assigned cross-peaks.
3.3.2 Isomer Identification
the Ser59 NH to L-isoAsp βCH2. The D-Asp and D-isoAsp isomers also show
the predicted differences in NOE strength, with the Ser59 NH to D-Asp58 αCH
exhibiting an NOE 3.6 fold larger than to the Ser59 NH to D-Asp58 βCH2 cross-
peak and the Ser59 NH to D-isoAsp58 αCH showing an NOE 11 fold smaller
than to the Ser59 NH to D-isoAsp58 βCH2. These values indicate that the Ser59
NH is much further away from αCH the upon isomerisation and that the βCH2 is
much closer, consistent for both the L- and D- isomers.
Figure  3.14 shows the volume of NOE cross-peaks arising from Asx58 αCH,
βCH2 and the Asx58 and Ser59 NH resonances. The cross-peak volumes for
each peptide are normalised to the Asx58 NH-αCH peak as this peak should be
the least affected by isomerisation. This diagram clearly shows the predicted
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Figure 3.14: The volume of NOE cross-peaks between both Asx58 αCH and βCH2 atoms and
the Asx58 and Ser59 NH resonances from 5°C 1H ROESY spectra. Cross-peak volume for
each peptide is normalised to the Asx59 NH-αCH cross-peak.
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3.3.2 Isomer Identification
differences in volume between αCH and βCH2 to NH NOE cross-peaks of the
aspartic and isoaspartic acid isomers for both enantiomers. The NOE cross-
peak  volumes  show little  difference  between  the  L-  and  D-  isomers  in  the
relative  strength  of  the  Asx58  αCH  and  βCH2 to  Ser59  NH  NOEs.  There
appears  to  be  a  large  difference  in  absolute  NOE strength  between  these
resonances for the L-isoAsp and D-isoAsp residues but this is not repeated with
the L- and D-Asp residues. D-amino acids are characterised as disruptive to
local  secondary  structure199 but  do  not  change  intra-residue  inter-atomic
distance like Asp to isoAsp isomerisation.
In  order  to  test  the  validity  of  this  approach  to  distinguishing  between  the
various aspartic  acid  isomers,  computational  modelling  was performed on a
simplified  analogue of  the  isomerisation  site  in  collaboration  with  Dr  Ganna
Gryn’ova  and  Prof.  Michelle  Coote  of  the  Australian  National  University.  To
simplify calculations and reduce search space, each peptide was represented
by  an  amino  acid  trimer  of  the  sequence  Ala-Asx-Ser.  Calculations  were
performed using  the  Gausian  software  package169 such  that  the  Gibbs  free
energies of each tri-peptide in water at 25 °C include entropies and thermal
corrections,  obtained  using  standard  textbook  formulas  for  the  statistical
thermodynamics of an ideal gas under the harmonic oscillator approximation172
in  conjunction with  the optimised geometries and scaled  frequencies173.  The
abundance of the various conformers was calculated using Boltzman averaging
and the atomic distances between the Asx αCH and βCH2 with adjacent NHs
were determined for all conformers of greater than 5% abundance. A weighted
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average  distance  based  on  these  conformers  was  used  to  calculate  the
theoretical relative NOE strength for each isomer based on the principle that the
NOE  is  inversely  proportional  to  the  distance  between  atoms  to  the  sixth
power189. The correlation of these distances with the experimental results are
shown in Figure 3.15.
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Figure  3.15:  Correlation  of  experimental  NOEs and inter-atomic  distances from quantum
calculations.  Figure shows a comparison of experimental values based on NOESY cross-
peak volume and calculated effective NOE strength from atomic distances as d -6. βCH2 values
were calculated as the average contribution of  both atoms. Values are normalised to the
mean of each set and are shown with a line of best fit which excludes the one major outlier. 
-1.0 -0.5 0.0 0.5 1.0 1.5 2.0
-0.6
-0.4
-0.2
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
f(x) = 1.58x + 0.18
R² = 0.66
Correlation of Experimental and Calculated NOEs
Calculated NOEs
E
xp
er
im
en
ta
l N
O
E
s
3.3.2 Isomer Identification
The experimentally determined NOEs show a correlation with the inter-atomic
distances derived from the calculated tri-peptide structures, with the exception
one  outlier  caused  by  differences  between  experimental  and  calculated
distances in the L-isoAsp βCH2 to SerNH NOE. The calculated structures show
the predicted decrease in NOE cross-peak volume for Asx2 αCH to Ser3 NH
resonances and an increase for the βCH2 to Ser3 NH upon isoaspartic acid
isomerisation. These structures also suggest that the isomerisation will cause a
reduction  in  Asx2  NH  to  αCH  NOE  upon  isomerisation,  perhaps  due  to  a
change in  the freedom of  movement  between the  side-chain  and backbone
atoms. These results, however, show little difference associated with the L- to
D-isomerisation in comparison with the Asp to isoAsp. A direct comparison of
the various effective NOEs based on calculated inter-atomic distances is shown
in Figure 3.16.
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Figure  3.16: Relative effective NOE strengths between protons of  Asx αCH,  βCH2 and the
adjacent NHs in each tri-peptide Ala-Asx-Ser. Values generated from Gausian calculations as
inter-atomic distances as d-6, normalised to the L-Asp NH to αCH cross-peak in each set.
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3.3.2 Isomer Identification
The close match between the NOE patterns from experimental data and the
calculated  structures  suggests  that  this  NOE  based  approach  to  isomer
determination had validity. Both of these data sets match the predicted NOE
strength patterns and it is relatively easy to distinguish the aspartic acid and
isoaspartic acid residues from one another. There is little to distinguish the L-
and D-isomers, however, which could potentially limit the practicality of an NMR
based approach to isomer identification.
3.3.3 Structural Calculations
The four  αA-crystallin  57-65 peptides  each  exhibit  a  small  positive  trend in
secondary chemical shift  and several short- to mid-range NOE connectivities
that are indicative of the presence of secondary structure. To further investigate
the  structural  implications  of  aspartate  isomerisation,  structures  for  these
peptides were generated via  torsion angle dynamics simulations using NOE
distance and chemical shift-matched restraints from NMR spectra and dihedral
bond angle restraints generated by DANGLE167. The structures were generated
using  ARIA 2.3165 and  CNS  Solve  1.21166 software  suites.  This  modelling
involved 8 iterations of 20 structures, with a further water refinement step of the
10 structures  of  the  lowest  energy.  These structures  were  superimposed in
UCFS Chimera168 using  the  lowest  energy  structure  as  a  template  and  the
resultant structural ensembles are shown in Figure 3.17. 
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Figure  3.17: Structure ensembles for each peptide along with root mean square deviation
(RMSD) of he backbones of each. These structures are the product of 8 iterations of torsion
angle dynamics simulations of 20 structures each, followed by a solvent refinement of the 10
best  structures.  It  is  these  structures  that  are  shown  overlaid  using  the  lowest  energy
structure as a template and as reference for RMSD calculations. Asx residue in each structure
is highlighted in red. 
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3.3.3 Structural Calculations
Generated structural ensembles for each peptide and their backbone RMSD are
presented in Figure 3.17. The generated ensembles for all four peptides show a
turn-like structural motif in the vicinity of the Gly60. This residue is also present
in the region of minimal RMSD for all four structures, implying that this residue
plays a defining role in the shape of these peptides. The L-Asp peptide shows
the least internal deviation of the four peptide ensembles and both L- to D- and
Asp  to  isoAsp  isomerisation  appears  to  lead  to  an  increase  in  structural
disorder.
The  L-Asp  peptide  shows  the  most  well-defined  structure  and  the  least
deviation of the four peptides (Figure 3.17(a)). This is consistent with the large
number of sequential and short-ranged inter-residue NOEs the peptide displays
(Figure 3.11). The L-Asp ensemble shows a distinct turn-like motif around Gly60
consistent with the series of i-i+2 and i-i+3  NOEs observed between residues 58
and 63.
Compared to the L-Asp peptide, the L-isoAsp peptide has a significant increase
in RMSD in the region of residues 61-63 (Figure 3.17(b)). The structure retains
the turn motif present in the L-Asp peptide in the region of Gly60, but overall the
ensemble shows a much less ordered peptide structure. This is consistent with
isomerisation  causing  destabilisation  of  the  peptide  but  this  destabilisation
appears to occur further along the chain from the isoAsp residue.
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Both the D-Asp and D-isoAsp peptides exhibit the turn-like structure observed
for the L-isomer peptides in the central region of their chain, except that both D-
peptides posses a different  topology.  Both the D-peptides manifest  this  turn
much closer to their  N-terminus than the L-peptides and they both exhibit  a
much more twisted structure overall, almost appearing helical in nature. The D-
isomer peptides show the same general differences between Asp and isoAsp
isomers as the L-peptides,  exhibiting an increase in  RMSD in the region of
residues 61-63 and a general  decrease in structural  convergence within the
ensemble. Unlike the L-isomers, however, these structures show a much higher
RMSD in general and the difference between the Asp and isoAsp isomers is
much less pronounced.
Overall,  these  results  show  that  the  aspartic  acid  to  isoaspartic  acid
isomerisation  is  readily  identifiable  via  the  strength  of  NOE  cross-peaks
between backbone residues, particularly via the marked difference in NH i+1 to
Asxi βCH2 NOEs, whereas there is little to distinguish the respective L- and D-
isomers.  The  structures  generated  from  NMR-derived  restraints  show  a
relatively well defined turn-like structure for the L-Asp peptide and increasingly
disordered structures in each other peptide. These ensembles suggest that the
inclusion of an isoAsp residue leads to a destabilisation of the peptide structure
that L- and D-isomer containing peptides exhibit efferent structural topologies. It
appears that the inclusion of non-native aspartic acid isomers causes structural
disruption  in  these  peptides,  a  pattern  which  may  also  hold  true  for  whole
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proteins. This suggests that age-related isomerisation could cause disruption in
the structure of the crystallins and could contribute to cataract formation.
3.4: Discussion
Small  peptides  are  a  common  occurrence  in  the  aged  lens  as  a  result  of
spontaneous, non-enzymatic truncation pathways106,116,120. The concentration of
these peptides builds up over time and they may play a role in lens ageing and
opacification5,106. It has been proposed that some of these products of protein
cleavage are able to infiltrate the lipid membranes of fibre cells in the lens190.
Such infiltration has the potential to cause membrane damage or pore formation
and could potentially weaken the fibre cell  walls enough to cause partial  or
complete  lysis183,191.  Such  damage  would  cause  increased  stress  to  the
crystallins  and  could  potentially  trigger  protein  aggregation.  The  specific
peptides corresponding to the C-termini of  γS- and βA3-crystallin have been
isolated  from  lipid  fractions  of  fibre  cells  taken  from  the  nucleus  of  aged
lenses5,106. These peptides are most likely the result of spontaneous cleavage at
serine residues116 and their build-up is a consequence of the lack of protein
turnover in the lens4. CD spectra suggest that these peptides posses increased
α-helical  secondary  structure  under  membrane-mimicking  conditions  (Figure
3.1). There are many examples of α-helical peptides that cause disruption in cell
walls  by  binding  to  lipid  membranes  and  many  have  antimicrobial
properties183,200.  Such  peptides  are  typically  water  soluble  but  show  high
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propensity for membrane insertion. There are several  mechanisms by which
such small  α-helical peptides can damage cell walls, including by a detergent-
like  carpeting  the  surface of  the  membrane201,  by  deforming the  membrane
surface and causing increased positive curvature strain202 or  by formation of
discrete  pore  structures182.  If  either  the  γS  and  βA3  truncation  peptide  is
capable of behaving in this manner, then their build-up over time in the lens may
contribute to its age-related damage.  
NMR structural characterisation of γS-crystallin 167-179 and βA3-crystallin 200-
215 in a membrane-mimicking solvent system of 20% H2O / 80% TFE shows
several secondary structural indicators in both peptides. The γS peptide NOESY
spectrum exhibits some short range NOE connectivities in the region between
P168 and S172 in the central region of the peptide chain (Figure  3.6). These
consist mostly of i-i+2 and a few i-i+3 connections between backbone atoms. This
same region of the peptide shows a series of secondary chemical shifts for the
backbone αCH resonances, exhibiting a positive trend in the region of residues
170-174 in  the proton dimension and a corresponding negative trend in  the
same region of the carbon dimension. These results indicate the presence of
secondary structure,  but  the number of  NOE connectivities is small  and the
magnitude  of  the  secondary  shifts  is  low.  This  therefore  suggests  that  any
structure in this region of the peptide is either transient or poorly defined.
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Preliminary CD spectroscopy indicated 80%  α-helix content in the  γS peptide
(Figure 3.1).  The characteristic NOE pattern caused by α-helix is a series of i-
i+3 and i-i+4 connectivities between residues along the peptide backbone189. Such
a pattern is absent for the γS peptide and it instead shows several i-i+2 and i-i+3
NOEs in a small region, a pattern consistent with turn-like nascent coil motifs195.
A solution structure for the peptide was generated using NMR-derived restraints
which shows the presence of such a motif in the region of residue 170 to 175
(Figure 3.9). The ensemble of calculated structures exhibits a high deviation at
the N-terminus and in the region of residues 172-173 which is consistent with
the secondary structure of this peptide being poorly defined.
The peptide γS-crystallin 167-178 may be capable of association with fibre cell
membrane in aged eyes120,190. Friedrich, Truscott et al. (2012) have isolated this
peptide and several others in large quantities from the membrane fraction of
aged eyes120. Samples of  this  peptide have been extracted from membrane
pellets taken from lens nucleus in quantities that increase with the age of the
individual.  In  eyes  younger  than  20  years  there  are  negligible  quantities  of
peptide, but as the eye ages this increases from ~0.1 μg/mg at 40 years of age
and up to ~0.7 μg/mg at 80 years120. Characterisation of this peptide shows that
it interacts with lipid vesicles as determined by laurdan dye fluorescence120. This
interaction is attributed to the presence of an RR motif towards the C-terminus
of the peptide as the equivalent peptide with the arginine residues mutated to
threonine shows no membrane affinity. The RR amino acid sequence is known
to aid peptide and protein binding to membranes by forming strong associations
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with the charged head of phospholipids203. A membrane stable α-helix structure
was proposed for this peptide from CD spectroscopy and a helical minimum
energy structure was calculated with an internal diameter of 4.3Å120. 
The original CD results (Figure 3.1) suggested that the γS peptide has a high
proportion of α-helix in 80% TFE, however the CD spectra for α-helix motifs and
nascent helices have a high degree of similarity195.  α-Helix is characterised by
double minima at 208 and 222nm in CD spectroscopy. A turn-like nascent helix,
however, will show a similar minimum at 208 but lacks a well defined minima at
222nm195. Figure 3.1 shows the γS peptide with a well defined minimum in the
region  of  204nm but  the  minimum at  222nm is  less  well  resolved.  This  is
consistent with presence of a nascent helix in the peptide but may also indicate
the  presence  of  a  loosely  structured  α-helical  region.  The  paucity  of  NOE
connectivities and the relative weakness of secondary chemical shifts suggest a
poorly defined structure. 
The  structure  shown in  Figure  3.9 was  generated  partially  from such  NOE
distance restraints and the dispersion and disorder within the ensemble may be
a result of this absence of connectivities. The structure generated for the  γS
peptide lacks any degree of α-helical character and instead consists of a small
region of turn-like nascent helix in an otherwise poorly-structured peptide. Such
a turn structure would likely be incapable of forming pores in the membrane
directly via a barrel-stave mechanism found in many membrane-lysing α-helical
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peptides182. This structure does, however, retain the lipid binding RR motif of the
peptide, which is exposed to solution near its C-terminus. As such, the peptide
is  likely  still  capable  of  interacting  with  membrane  and  a  large  build-up  of
peptides on the surface of cell walls would likely cause damage similar to the
behaviour of detergent200. In spite of the absence of strong secondary structure,
the  truncated  C-terminal  region  of  γS-crystallin  may  still  contribute  to  age-
related damage in the eye lens via weakening lens fibre cell walls.
In  contrast  to  the  γS  peptide,  βA3-crystallin  200-215 has  much  stronger
indicators of secondary structure under membrane-mimicking conditions. This
peptide  shows  many  i-i+3 and  i-i+4 NOE  connectivities  along  the  peptide
backbone  in  the  region  of  residues  204  to  212.  Likewise,  the  secondary
chemical shifts of the peptide show a strong positive trend in the 1H dimension
and a corresponding negative trend in the  13C dimension for backbone  αCH
resonances between residues 204-211. These NMR results are characteristic of
α-helical  secondary structure195 and suggests the presence of a well-defined
region  of  helix  in  the  central  region  of  the  peptide  chain.  The  structural
ensemble generated from NMR based restraints likewise indicates the presence
of a region of α-helix between residues 204 and 211, showing a short but well
defined helical region with low deviation between each structure (Figure 3.9(b)).
The  βA3 peptide  was isolated  from eye  lens membrane fractions  in  similar
quantities  to  the  γS  peptide  but  has  not  been  biophysically  or  structurally
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characterised to the same extent5,190.  Both peptides contain the phospholipid
binding  RR  motif  near  their  C-terminus203 and  show  changes  in  secondary
structure under membrane conditions (Figure 3.1). The secondary shifts, NOE
connectivities and the calculated structural ensemble for the  βA3 peptide are
consistent with the presence of a region of  α-helix in its central region. If the
peptide forms such a stable structure in the presence of lipids in the lens, then
membrane binding may be favoured over bulk solution and the peptide may
infiltrate  cell  walls.  Helical,  membrane binding peptides are often capable of
forming pores in cell  walls  by insertion and formation of  a  barrel-stave type
structure200. Pore formation disrupts the osmotic balance of cells and can cause
swelling that increases cell surface area. Such osmotic swelling can potentially
encourage further peptide binding and eventually weakening the cell to the point
of lysis200.  If  the  βA3 peptide is capable of such disruptive binding, then the
build-up of peptide that appears over time could potentially disrupt the walls of
the lens fibre cells.  Notably  however,  the length of  the helical  region in  the
peptide as shown in the generated structural ensemble is shorter than the width
of a typical cell wall and the formation of discrete pores may not be possible191.
Nevertheless, bulk infiltration of peptides into the walls of fibre cells would likely
contribute  to  the  age-related  damage  of  the  lens  and  may  be,  in  part,
responsible for cataract formation.
Unlike  the  C-terminal  truncation  peptides  form  γS-  and  βA3-crystallin,  the
truncation  fragment  corresponding  to  αA-crystallin  55-65  has  not  been
implicated in membrane infiltration. This peptide is, however, commonly found in
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high concentrations in aged lenses106. This peptide is a likely a product of two
spontaneous  truncation  events,  one  at  Thr55  and  the  other  at  Ser66,  and
contains  one  of  αA-crystallin's  primary  sites  of  isomerisation,  Asp58184.  The
effect  of  aspartic  acid  isomerisation  at  this  site  in  αA-crystallin  is  not  well
characterised, but it could potentially contribute to cataract formation by causing
instability and loss of chaperone function. Likewise, neither the impact of high
concentrations of the  αA 55-65 fragment on the stability of  the lens nor the
effect of aspartic acid isomerisation in this peptide is known. 
Solution structures of the αA-crystallin 57-65 for each potential aspartic acid 58
isomer  (L-Asp,  L-isoAsp,  D-Asp  and  D-isoAsp)  were  determined  from NMR
derived restraints (Figure  3.17).  These structural  ensembles show a general
turn-like structural  motif  with  varying degrees of  disorder  and deviation.  The
most well defined of these structures is the native L-Asp peptide, which exhibits
a twisted nascent helix motif with low deviation within the ensemble. Each other
peptide shows a much less well defined structure with both increased deviation
and disorder. The L-isoAsp peptide exhibits the same turn-like motif as the L-
Asp which is consistent with the similar pattern of inter-residue NOEs shown by
the peptides. The L-isoAsp structure does, however, show high deviation in the
region following Ile61 and higher general disorder.  
In general, the presence of D-amino acids in peptides causes a disruption of the
local  structure  without  changing  the  peptides'  solution  stability199,204,205.
94
3.4: Discussion
Compared  to  the  L-Asp  peptide,  the  D-Asp  and  D-isoAsp  peptides  show
generally high disorder and deviation and both structural ensembles exhibit a
change in their secondary structural topology. Both D-amino acid peptides have
a much less well-defined turn-like structure and the generated ensembles of
both show structures with a much higher resemblance to  α-helix than the L-
peptides. The presence of D-Asx appears to be disruptive to the nascent helix
of the native L-Asp. The isomerisation from D-Asp to D-isoAsp likewise results
in an increase in deviation within the ensemble like that seen with the change
from L-Asp to  L-isoAsp.  In  general,  the  change from Asp to  isoAsp isomer
appears  to  cause  an  overall  increase  in  disorder  in  these  peptides  without
greatly altering their secondary structure, whereas the isomerisation form L- to
D-amino acid causes a change in overall structure of the peptide from a turn-
like nascent helix to a highly discorded α-helix-like motif. 
Asp58 is located in the unstructured N-terminal region of αA-crystallin which has
been described as being necessary for proper oligomerisation of the protein  and
it has been suggested that the region plays a role in substrate specificity10,70,206.
The structured central domain of αA-crystallin begins with Ser62 and truncation
at  Ser66  likely  has  a  significant  effect  on  the  structure  and  function  of  the
protein71. The area immediately prior to the α-crystallin domain is unstructured,
however,  and  isomerisation  at  Asp58  may  have  no  significant  effect  in  the
structure or function of the intact protein10. There is so far no evidence that the
αA-crystallin 55-65 peptide has any function or activity in the lens and the state
of isomerisation for the peptide may have no overall effect on lens ageing. In
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general, the effect of high concentrations of αA-crystallin 55-65 in the aged lens
is not well understood and the effect of isomerisation on these same peptides is
unclear.
By  comparing  the  spectra  of  the  various  aspartic  acid  isomer  containing
peptides,  it  is  clear  that  the  Asp  to  isoAsp  rearrangement  is  readily
distinguishable via NMR but the L- to D-isomerisation is not. The rearrangement
of Asp to isoAsp results in Asxi βCH2 and NHi+1 groups begin much closer in
space and increases the distance between  Asxi αCH and NHi+1. As shown in
Figure  3.14,  the  NOE cross-peak  volume for  these resonances mirrors  this
rearrangement of atoms closely. Likewise, the theoretical effective NOE results
from quantum calculations of a tri-peptide analogue show high correlation with
experimental results (Figure 3.15). This suggests that an NOE strength based
approach to distinguishing isoAsp isomerisation would be generally applicable
to all peptides. L- to D-isomerisation does not involve a similar change in atomic
bond connectivity and thus does not exhibit any similarly identifiable change in
local NOEs. L- and D-amino acids are effectively identical to NMR spectroscopy
in  isolation  due  to  all  atoms  in  both  isomers  inhabiting  the  sane  chemical
environment. In peptides and proteins, L- to D-amino acid substitution has been
shown  to  cause  disruption  in  local  secondary  structure,  especially  in
helices204,205, but such substitutions in unstructured regions result in no change
in structure or NMR chemical shifts199. The D-Asp and D-isoAsp peptides both
exhibit a change in secondary structure compared to the L-isomer peptides that
is consistent with D-amino acid behaviour but show no distinct differences in
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either  chemical  shift  or  short-range  NOE  patterns  that  would  allow  their
presence to be identified easily.
The difference in NOE strengths between Asp and isoAsp isomers provides the
potential  for  an  alternative  method  of  identifying  aspartate  isomerisation  in
proteins.  The standard method for  analysing and characterising lens protein
post-translational modifications involves mass spectrometry of tryptic digests45.
This is highly effective for identifying sites of modifications that involve large
changes in mass such as oxidation and phosphorylation but is of little use in the
case of isomerisation, as modified residues will have the same mass as native
residues. The typical workaround to this problem is the use of synthetic peptide
analogues  of  these  regions  that  contain  each  possible  isomer  as
chromatography standards45. It may instead be possible to identify the presence
of  isoaspartic  acid  isomerisation via  this  NMR based method and avoid the
need  to  synthesise  special  peptides,  potentially  simplifying  the  isomer
identification process. 
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The  combination  of  experimentally  derived  NOEs  and  chemical  shifts  with
calculated structural ensembles show that the protein fragment βA3-crystallin
200-215 adopts a well defined helical  secondary structure under membrane-
mimicking  conditions.  The  γS  crystallin  167-179  instead  adopts  a  turn-like
nascent  helix  that  is  less  well  defined.  We  would  expect  that  these
conformations would show improved stability over an unstructured peptide in
aqueous solution, and that this increase in stability would promote membrane
infiltration for both peptides. The intrusion of large quantities of peptide into the
membrane of fibre cells may weaken cell walls, potentially forming pores and
causing cell lysis. The two peptides studied here are believed to be the result of
spontaneous truncations at serine residues and their prevalence in fibre cell
protoplasm is highly correlated with the age120. Thus, there is a potential for a
flow-on effect whereby this truncation causes a partial or complete lysis of the
cell with age. This would subject the eye lens crystallins to increased stress
which  may  result  in  their  aggregation.  Thus,  these  truncations  have  the
potential to cause protein aggregation and lens opacification.
By using  NMR spectroscopy, we have show that an aspartate to isoaspartate
isomerisation can be easily distinguished experimentally using differences in
intensity  of  NH to  αCH and βCH2 NOE cross-peaks.  These differences are
highly correlated between experimental and theoretical results and are constant
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for both the L- and D- isomers of aspartate. There appears to be little means to
distinguish between the L- and D-isomers themselves using NMR, however, as
the  distances  between  the  relevant  atoms  are  roughly  the  same  for  both
enantiomers.  This  potentially  provides  a  spectroscopic  means  of  identifying
sites of isomerisation in peptides and proteins. This technique could be viable
for  examining  the  extent  of  modification  in  proteins  extracted  form  lens
protoplasm  that  complements  existing  chromatographic  and  spectrometric
methods106,161.
The molecular dynamics simulations performed using NMR restraints suggests
that isomerisation of aspartic acid can have a significant effect on the structure
of  αA-crystallin  55-65 (Figure  3.9).  Simulated  peptide  structural  ensembles
show notable differences in solution structure between L- and D-isomers and an
increase in disorder upon isomerisation from the native L-Asp residue. This may
indicate a difference in activity or function in these peptides and could have
implications for lens ageing. Other similar truncation peptides from aged lenses
have been found to infiltrate membrane by undergoing structural changes and
are implicated in membrane pore formation190. The αA-crystallin 55-65 peptide
may have a similar structure related effect on the lens, in this case controlled by
the isomerisation of Asp59. The build-up of this peptide in aged lenses may
therefore have a contribution to lens destabilisation and cataract formation.
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Chapter 4: γS-Crystallin Asn76 Deamidation
The Effects of Deamidation of Asparagine 76 on the
Structure and Function of Human γS-Crystallin
4.1: Introduction
The  protein  γS-crystallin  is  an  early  evolutionary  offshoot  of  the  γ-crystallin
family and is one of the most abundant proteins in the eye lens34. While the
other members of this protein family are typically found in the water-poor lens
nucleus, γS-crystallin is expressed in high concentration in the water-rich cortex
and is the primary structural protein found in the younger lens fibre cells44. Like
other  βγ-crystallins, γS-crystallin is a two domain protein consisting of four β-
sheet rich Greek-key structural motifs in a highly stable arrangement (Figure
4.1)4,99.   γS-Crystallin  is  differentiated  from  the  other  γ-crystallins  by  the
presence  of  a  short,  unstructured  and  flexible  N-terminal  extension  of  4
residues, the absence of a C-terminal extension and a 1-2 residue longer linking
region between the two domains207.
Like  all  eye  lens  proteins,  γS-crystallin  is  prone  to  accumulating  post-
translational modifications over time120,159. Such modifications build up with age
and can result in protein instability and aggregation101,104. As γS-crystallin is one
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of  the most common proteins in  the eye lens cortex,  any modifications that
impact  on  its  stability  could  have  a  disproportionate  effect  on  eye  lens
opacification. It  has  been shown by Hooi  et  al. (2012)102 that  Asn76 of  γS-
crystallin is particularly prone to deamidation with age. In healthy lenses, Asn76
can exhibit 20% deamidation as early as 15 years of age and can exhibit up to
40% deamidation at age 60 without cataract symptoms. In cataractous lenses,
however, this residue can show 50% deamidation at 40 years of age and 70%
deamidation at 80 years102. Likewise, Wilmarth  et al.(2006)101 have estimated
this  site to  be ~20% deamidated in  water soluble and ~50% deamidated in
water insoluble protein from lenses aged 70-93 years, some of which displayed
cataract symptoms. The substantially higher deamidation found in cataractous
lenses may indicate a causative relationship between Asn76 deamidation and
age-related cataract.
The deamidation of Asn76 in γS-crystallin is a good target for structural study
for two reasons. The first is that the prevalence of deamidated γS-crystallin in
cataractous eye lenses may indicate some causal relationship with cataract and
could  serve  as  a  target  for  preventative  intervention  and  therapeutics.  The
second  advantage  is  that  deamidation  is  relatively  easy  to  study.  This
modification is effectively a chemical interconversion between asparagine and
aspartic acid, a modification that can be reproduced under laboratory conditions
with  recombinant  protein.  As  such,  N76D  γS-crystallin  can  be  used  as  an
analogue for age damaged eye lens protein in in vitro studies.
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Figure  4.1: Secondary structural arrangement of γS-crystallin.  The β-strands of each of the
Greek-key structures have been individually colour coded, the short α-helical regions marked in
purple and the site of modification at residue 76 marked black. (a) Solution structure of γS-
crystallin with regions of defined secondary structural motifs highlighted. (b) Interconnectivity of
the β-strands of each Greek-key motif in γS-crystallin with each β-strand numbered in order of
sequence. (c) Sequence of γS-crystallin with secondary structural motifs marked to scale.
90°
(c)
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4.1: Introduction
The aim of this chapter is to study the structural and functional implications of
deamidation at  Asn76 in  γS-crystallin  and to  characterise any differences in
stability that may have implications for cataract formation. If the deamidation of
Asn76 in γS-crystallin has a disproportionately large effect on the formation of
cataract in the eye we would expect it to either cause a decrease in the stability
of  the  protein  to  stress-related  unfolding  or  to  induce  stress  and  promote
aggregation of other lens crystallin proteins in response.
4.2: Results
4.2.1 Expression and Purification
Both the wild type (WT) and the deamidated (N76D) versions of γS-crystallin
were expressed recombinantly from BL21(DE3) strain  E.coli cells transformed
with a pET24(c) plasmid vector encoding the human γS-crystallin gene. The
subsequent over-expressed protein was separated from the bacterial cell lysate
and purified  via  a  two-step  chromatographic  method.  The first  step  was  an
anion  exchange  purification  over  a  DEAE  column  to  separate  the  cell
components by charge. The chromatogram (Figure 4.2) shows that γS-crystallin
did not bind strongly to the DEAE media and thus elutes very early from the
column. This is still sufficient to separate the protein from most other species
present as shown by SDS PAGE analysis in Figure 4.3.
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Figure 4.2: Chromatograms from the purification of bacterial cell lysate from expression of WT 
and N76D γS-crystallin via anion exchange. These proteins were purified on an FPLC system 
using a DEAE-sepherose fast flow column in 50mM Tris HCl buffer at pH 8.5 with an ion 
gradient from 0M to 1M NaCl over 8 column volumes. The chromatograms show the UV 
absorbance as 280nm, the conductivity and the fractionation of the elutant for both the WT and 
deamidated proteins.
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4.2.1 Expression and Purification
The  second  purification  step  utilised  size  exclusion  chromatography  over  a
superdex-75 gel filtration column to separate any remaining species by size.
The chromatogram for this step is shown in Figure 4.4 where both γS-crystallin
proteins  eluted  in  a  single  major  peak  after  roughly  0.65  column  volumes.
These peaks show high protein purity as determined by SDS PAGE (Figure 4.5)
and were used in experiments following desalting and freeze-drying.
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Figure 4.3:  SDS PAGE of fractions corresponding to anion exchange chromatography 
fractions from Figure 4.2. The gel marker lane is labelled with approximate effective molecular 
mass in kDa
γSγS
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Figure 4.4: Chromatograms from the final purification of  WT and N76D γS-crystallin. Proteins
were purified via FPLC system using a superdex-75 gel filtration column in 50mM phosphate
100mM NaCl buffer at pH 7.4. The chromatograms show the UV absorbance as 280nm and the
fractionation of the elutant for both the WT and deamidated proteins
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The thermal stability of both WT and N76D γS-crystallin was determined using a
combination  of  light  scattering,  intrinsic  tryptophan  fluorescence  and  CD
spectrophotometry.  
Figure 4.6 shows the results of thermal stability assays for WT and N76D γS-
crystallin, monitored via light scattering at 350nm, where an increase in turbidity
of solution indicates the formation of high molecular mass aggregates. For both
the WT and the deamidated proteins, a  rapid increase solution turbidity was
observed once a  sufficient  temperature  was reached to  trigger  aggregation.
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Figure 4.5: SDS PAGE of fractions corresponding to the size exclusion chromatogram in Figure
4.4.
4.2.2 Protein Stability
Notably  the  WT protein  exhibits  aggregation  at  a  slightly  lower  temperature
than N76D (~1.4°C), implying that the deamidation lead to an increase in the
thermal stability of γS-crystallin. This is counter to what was expected by the
prevalence of  this  modification in  cataractous eye lenses where large mass
aggregates are common. Other than the higher aggregation temperature, the
deamidation does not appear to change the behaviour of the protein, as both
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WT N76D
Max Absorbance 2.34 ±0.02 2.44 ±0.03
Aggregation Midpoint (°C) 65.1 ±0.3 66.5 ±0.9
Aggregation Rate (1/°C) 0.352 ±0.002 0.345 ±0.005
Figure  4.6: Light  scattering at  350nm as a function of  temperature for  WT and N76D γS-
crystallin, product of 3 experiments. Spectra where performed with 1mg/ml protein solution in
50mM phosphate, 100mM NaCl at pH 7.4. Temperature was increased in 1°C increments with 1
minute  equilibration  between  steps.  Aggregation  metrics  were  derived  from  fitted  sigmoid
curves.
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4.2.2 Protein Stability
WT and  N76D  show  roughly  the  same  rate  of  aggregation  and  the  same
quantity of total aggregate formed.
Figure  4.7 shows  the  fluorescence  spectra  of  WT  and  N76D  γS-crystallin
alongside  the change in  fluorescence as a  function  of  temperature  for  both
proteins. These experiments were performed with excitation at 295nm where
the only major contribution to fluorescence in protein is the tryptophan residues.
As  with  the  other  γ-crystallins,  γS-crystallin  has  4  tryptophan  residues,  two
located  in  each  domain41.  Figure  4.7(a)  shows  the  tryptophan  fluorescence
spectra of both the WT and N76D proteins at high and low temperatures. The
Greek-key structure of the γ-crystallins induce efficient quenching in all four of
the protein's tryptophans, but as these proteins unfold this quenching effect is
lost41. Both the WT and N76D proteins show increased fluorescence at higher
temperatures and a shift  in the fluorescence maximum due to the change in
environment of the tryptophan residues as the protein unfolds. Both the change
in fluorescence intensity and the shift in fluorescence maxima can be used to
track the unfolding of γS-crystallin. 
Figures 4.7(b) and (c) show the change in the fluorescence of the proteins as a
function of temperature. Figure 4.7(b) presents the fraction of unfolded protein
as  the  difference  between  the  fluorescence  maxima  of  the  folded  protein
(320nm) and unfolded protein (345nm). This analysis eliminates any reduction
of  fluorescence  yield  caused  by  quenching  at  high  temperature  but  also
discards  much  of  the  available  data.  Figure  4.7(c)  presents  the  change  in
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Figure 4.7: Fluorescence spectra and unfolding curves for WT and N76D γS-crystallin. These
spectra were recorded with 295nm excitation with 1mg/ml protein solution in 50mM phosphate
100mM NaCl pH 7.4 buffer. 1°C increments with 2 minute equilibration between steps. (a) Total
fluorescence spectra for  WT and N76D at 30 and 70°C. (b) Fraction unfolded as a function of
temperature shown as the difference between the folded peak at 320nm and the unfolded peak
at 345nm.  (c)  Unfolding as a function of  temperature tracked via  total  integration of  each
spectrum.
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fluorescence with temperature as the total integral of each spectrum, using all
available data but showing the drop in fluorescence caused by thermal effects.
Intrinsic fluorescence spectroscopy gives results similar to the light scattering
observations in Figure 4.6, with the WT protein unfolding at a lower temperature
than N76D. Unlike the results of the light scattering assay, however, the WT and
N76D γS-crystallin show distinctly different unfolding characteristics.
Both Figure 4.7(b) and (c) show the WT protein unfolding in two distinct stages
as temperature increases, whereas the N76D only exhibited one continuous
unfolding  curve.  This  two step unfolding  has previously  been observed with
other members of the γ-crystallin family and was attributed to two domains of
the protein unfolding independently, with the N-terminal domain the more stable
of the two208. The absence of a two-step unfolding in the deamidated protein
suggests  that  the  modification  is  having  an  effect  on  the  structure  and/or
stability of γS-crystallin. The deamidation may be changing the stability of one
of the domains, presumably the N-terminal domain where the modification site
is located, such that they unfold simultaneously. Another possible explanation is
that the modification causes the two domains of the protein to interact more
strongly with one another and prevents them from unfolding independently.
Figure  4.8 shows circular  dichroism (CD) of  WT and N6D γS-crystallin. The
primary structural feature of these CD spectra is the large negative the mean
residue ellipticity at 220nm. This feature of CD spectra is characteristic of β-
sheet  secondary  structure  in  proteins,  which  is  expected  as  γS-crystallin
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Figure 4.8: Circular dichroism spectroscopy as a function of temperature for WT and N76D γS-
crystallin. These spectra were recorded with 0.5 mg/ml protein solution in 20mM phosphate pH
7.4 buffer.  1° increments with 1 minute equilibration between steps.  (a) CD spectra for both
protein at 40°C and 80°C showing the loss of ellipticity at high temperature.  (b) normalised
ellipticity at 220nm as a function of temperature showing fraction of protein unfolded.
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contains 16 β-strands in its two structured domains. The loss of this negative
ellipticity at high temperature indicates unfolding of the protein under thermal
stress. The N76D protein exhibits slightly less ellipticity at 220nm than the WT
at 30°C which may indicate that deamidation causes a small loss of structure in
the folded protein.
Monitoring the unfolding of the proteins by the loss of ellipticity at 220nm gives
similar results to the light scattering and fluorescence experiments. Both WT
and  N76D  proteins  show  a  rapid  loss  of  secondary  structure  once  the
temperature is sufficient to begin the protein unfolding. The WT protein begins
to unfold at a lower temperature than the deamidated N76D, however it appears
that the N76D unfolds at greater rate once the unfolding begins. Examining the
WT unfolding curve shows a suggestion of a stable intermediate like that seen
in fluorescence as there is a brief change in rate of unfolding at roughly 68°C.
This is only a small change, however, and may be the result of noise or error
rather than a real intermediate state. 
Together, these thermal stability experiments indicate that the deamidated γS-
crystallin is more stable to heat stress than the WT. The fluorescence data also
suggest that the deamidated protein has a different unfolding mechanism than
the WT, which suggests a structural difference between the two proteins. The
apparent increase in stability of  γS-crystallin upon deamidation is counter to
expectations given that high quantities of deamidation is strongly correlated to
cataract  formation  in  aged  lenses.  If  there  is  a  connection  between  this
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modification and cataract disease then the mechanism of this action is more
complex than simple thermal instability induced protein aggregation. It may well
involve subtle  structural  damages that  lead to  cooperative unfolding of  both
domains  in  N76D  γS-crystallin  rather  than  the  sequential  unfolding  of  the
individual domains that occurs for the WT protein.
Having  characterised  the  effect  of  deamidation  on  temperature  induced
unfolding  of  γS-crystallin,  the  effect  of  chemical  denaturant  on  the  protein's
structure was examined. Figure  4.9 shows the result of guanidinium chloride
induced unfolding experiments monitored via intrinsic tryptophan fluorescence.
These  unfolding  curves  are  similar  to  the  thermal  unfolding  experiment
presented  in  Figure  4.7,  with  the  proteins  showing  a  rapid  increase  in
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Figure  4.9:  Total fluorescence as a function of GndCl concentration for WT and N76D γS-
crystallin. The fluorescence was rerecorded using light filters of 294±5 for excitation and 360±20
for emission. Protein was of 1mg/ml concentration in 50mM phosphate 100mM NaCl pH7.4
buffer at 25°C. Data has been fitter to a sigmoid two state unfolding curve.
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Figure 4.10: Unfolding of WT and  N76D γS-crystallin monitored by tryptophan fluorescence as
a function of  GndCl  concentration for  temperatures from25 to  60°C.  The fluorescence was
rerecorded using light filters of 294±5 for excitation and 360±20 for emission. Protein was of
1mg/ml concentration in 50mM phosphate 100mM NaCl pH7.4 buffer Curve fit is to sigmoid
two-state unfolding function.
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fluorescence once  a  sufficient  denaturant  concentration  is  reached  to  begin
cause  unfolding  to  commence.  Unlike  the  temperature-induced  unfolding,
however, the deamidated protein shows significantly less stability to denaturant
than the WT. N76D γS-crystallin unfolds at ~0.3M lower guanidinium chloride
concentration than the WT and shows a higher rate of fluorescence increase as
a function of guanidinium chloride concentration.
The  combined  effect  of  both  guanidinium  chloride  and  thermal  stresses  is
shown in Figure  4.10.  Despite the different  relative stability  the two proteins
exhibit under thermal and denaturant induced unfolding, is appears the these
two sources of stress add together to cause earlier unfolding in both proteins.
The deamidated protein shows less stability than the WT at each temperature
point both as a function of guanidinium chloride concentration and in the rate of
unfolding. Notably this rate does not appear to increase with temperature and
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Figure 4.11: Temperature and GndCl concentration at midpoint of protein unfolding for WT and
N76D γS-crystallin based on the fitted curves in Figure 4.10.
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4.2.2 Protein Stability
the heat stress has no effect on the folding of either protein when below 40°C.
Figure 4.12 shows the guanidinium chloride concentrations and temperatures at
which both the WT and N76D  γS-crystallin reach their unfolding midpoint. As
was apparent from Figure 4.10 and 4.11, the N76D is much more susceptible to
chemical  unfolding  than  the  WT  at  each  temperature  measured  and
temperature has no effect on the unfolding of either protein below 40°C. As
temperature increases, the thermal effect begins to add with the chemical stress
to  unfold  the  both  proteins,  but  the  relative  stability  of  WT and  N76D  γS-
crystallin remains similar throughout. At temperatures above 55°C, the relative
stability of the two proteins begins to converge, but at this point both proteins
are likely fully unfolded due to heat stress alone and the denaturant would have
little  further  effect.  Overall  the  presence  of  any  concentration  of  denaturant
appears to reverse the increase in thermal stability shown by the deamidated
γS-crystallin.
4.2.3 Aggregation Kinetics
Further thermal stress experiments were conducted to study the unfolding and
aggregation  of  the  proteins  over  time.  Figure  4.12 shows  the  kinetics  of
aggregation  of  WT  and  N76D  γS-crystallin  when  subjected  to  a  constant
temperature of 55°C, monitored as increasing solution turbidity.  Under these
conditions, both proteins begin to aggregate due to stress after approximately
an hour of heating. During this lag period it is expected that both proteins are
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unfolding in solution and that the rapid increase in light scattering observed is
the result of aggregation of the protein around nucleation sites9. This sigmoidal
aggregation  curve  is  typical  of  a  nucleation  dependent  aggregation
mechanism209.
The  WT and  N76D  γS-crystallin show  some  significant  differences  in  their
aggregation  kinetics.  As  was  previously  observed  in  the  previous  thermal
stability experiments, the WT protein shows aggregation sooner than the N76D.
Notably  however,  once  aggregation  of  the  deamidated  protein  begins  it
proceeds at a much faster rate, approximately twice that of the WT protein, and
reaches maximum turbidity plateau significantly earlier. The N76D γS-crystallin
also  exhibits  a  much  higher  total  solution  turbidity  than  the  WT  protein,
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Figure 4.12: Kinetics of aggregation of WT and N76D γS-crystallin as monitored by turbidity of
solution. Aggregation assay was performed with 1mg/ml protein in 50mM phosphate, 100mM
NaCl  buffer  at  pH 7.4  and  55°C,  measuring  lightscattering  at  360nm.  These  data  are  the
combination of 3 experiments.
0 20 40 60 80 100 120 140 160 180 200
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
γS-Crystallin
Aggregation Kinetics at 55°C
WT
N76D
Time (min)
Tu
rb
id
ity
 (3
60
nm
)
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consistent with it forming larger amounts of aggregate. 
This differences in aggregation profile along with the apparent higher thermal
stability  of  deamidated  γS-crystallin  suggest  that  the  N76D  has  a  higher
resistance to initial unfolding and aggregation than WT but once aggregation
begins,  the  modified  protein  possesses  a  much  higher  propensity  to  form
aggregate. 
In the eye lens, the aggregation of unfolding protein is prevented by the action
of the molecular chaperone α-crystallin. These proteins, members of the sHsp
family, bind to and sequester unfolding target proteins to prevent the formation
of high-mass aggregates4,9. Figure 4.13 shows aggregation of γS-crystallin WT
and N76D in the presence of  varying concentrations of  αL-crystallin  isolated
from  the  bovine  eye  lens.  The  αL-crystallin  shows  concentration  dependent
chaperone  ability  and  a  high  effectiveness  at  preventing  the  formation  of
aggregate under thermal stress conditions. 
For  WT  γS-crystallin,  these  curves  show  suppression  of  the  temperature-
induced aggregation in the presence of increasing concentration of chaperone.
The aggregation lag period increases and the aggregation rate is reduced in the
presence  of  αL-crystallin  and  at  high  concentrations  the  aggregation  is
suppressed  entirely.  α-Crystallin  is  a  highly  effective  chaperone  but  has  no
mechanism of  re-folding  or  rescuing  aggregated  proteins9,  so  this  complete
prevention of aggregation is necessary for the lens to remain transparent.
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Figure  4.13: Kinetics  of  aggregation  of  WT and  N76D γS-crystallin  tracked  by  turbidity  of
solution with bovine lens αL-crystallin fraction acting as chaperone. Aggregation assays were
performed with 1mg/ml protein in 50mM phosphate, 100mM NaCl buffer at pH 7.4 ant 55°C,
measuring change in absorbance at 360nm. This figure is the combination of 3 experiments.
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The N76D γS-crystallin shows several differences to WT in its interaction with
chaperone protein while aggregating. At low concentrations, the chaperone still
reduces the aggregation rate and increases the lag period as with to WT γS-
crystallin, however, the N76D shows increased overall turbidity in the presence
of  moderate  concentrations  of  chaperone,  suggesting  a  larger  amount  of
aggregate is being formed by the two proteins in combination. The αL-crystallin
also shows overall reduced effectiveness as a chaperone for the deamidated
protein and higher concentrations of chaperone are necessary to fully suppress
the aggregation of the N76D γS-crystallin compared to WT. The increase in
solution  turbidity  observed  at  low  to  moderate  concentrations  of  chaperone
suggests that N76D γS-crystallin co-aggregates with the αL-crystallin to form a
greater  overall  quantity  of  aggregate.  As  α-crystallin  is  the  primary  defence
against aggregation in the eye, this co-aggregation may explain the correlation
of N67D γS-crystallin with cataract. If the deamidated protein were to aggregate
in the lens, this co-aggregation could result in both an increased formation of
high  molecular  weight  species  and  a  reduction  in  the  population  of  viable
chaperone. This would reduce the health of the organ and potentially lead to
lens opacification.
Figure  4.14 is  a  collection  of  various  metrics  associated  with  γS-crystallin
aggregation generated by fitting sigmoid curves to the light scattering assay
results.  Figure  4.14(a)  shows the  total  light  scattering  in  each assay at  the
aggregation endpoint. The increase in total light scattering caused by the co-
aggregation  of  N76D  and  αL-crystallin  is  evident  at  moderate  chaperone
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Figure 4.14: Aggregation metrics for for WT and N76D γS-crystallin for each concentration of
chaperone showing: (a) The turbidity at the aggregation endpoint of each protein, (b) the time at
which each protein reaches the midpoint of its aggregation and (c) the rate of aggregation of
each mixture.
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concentrations. The  WT  protein  shows  a  steady  drop  in  aggregation  as
chaperone  concentration  increases.  Comparatively,  the  deamidated  protein
exhibits increasing aggregation at moderate chaperone concentration due to co-
aggregation, followed by a decrease in the quantity of aggregate as chaperone
concentration further increases.
The presence of chaperone during aggregation also increases the lag period of
both the WT and N76D as shown in Figure 4.14(b). The α-crystallin appears to
act on the aggregation lag period at a lower concentration than it acts on total
aggregate formation, possibly by preventing nucleation sites from forming. The
chaperone is still capable at increasing this lag period in deamidated protein but
is much less effective compared to WT.
The most dramatic difference between the proteins is seen in the aggregation
rate as shown in Figure  4.14(c). The N76D γS-crystallin exhibits significantly
faster  aggregation  than  WT in  the  both  the  absence  and  presence  of  αL-
crystallin. Both proteins show the highest rate of aggregation in the absence of
chaperone, with the N76D aggregating roughly twice as fast as the WT. The
introduction  of  chaperone  suppresses  this  aggregation  rate  with  increasing
concentration but the N76D has a much higher rate at each equivalend quantity
of chaperone.
Overall,  it appears that the deamidation of Asn76 in γS-crystallin causes the
protein  to  be  more  prone to  aggregation  due to  heat  stress  once unfolding
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begins.  The deamidated protein  shows a  higher  aggregation rate  and more
overall  aggregate  formation  than  the  WT  and  the  eye  lens  chaperone  α-
crystallin shows worse performance in preventing this aggregation. Is has been
previously  reported  that  α-crystallin  is  much  more  effective  as  a  chaperone
against  slowly  aggregating  species and looses effectiveness as  aggregation
rate increases210 It is also apparent that the chaperone will co-aggregate with
the  deamidated  γS-crystallin  at  low  concentrations.  A  similar  effect  has
previously  in  αB-crystallin  that  had been modified  to  mimic  phosphorylation.
These chaperones co-aggregated and co-precipitated with various aggregating
target proteins211. This was attributed to the modified chaperone having a much
higher binding affinity to the unfolded targets such that the binding sites became
saturated157.  Deamidation of  γS-crystallin  may be increasing its  affinity  to  α-
crystallin  binding  and  the  rapid  aggregation  it  exhibits  may  be  reducing
chaperone effectiveness. In the lens, these proteins are the first line of defence
against  aggregate  formation.  Substantial  deamidation  of  γS-crystallin  could
significantly  reduce  the  effectiveness  of  this  natural  aggregation  prevention
mechanisms and  contribute  to  lens  protein  aggregation  and  hence  cataract
formation.
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Multi-angle laser light scattering is a technique for determining absolute average
molecular mass of species in solution by measuring differences in intensity of
scattered light at different angles, via the relationship between excess Rayleigh
ratio,  refractive  index  increment  and  molecular  mass212.  SEC-MALLS
experiments  were  performed  to  investigate  any  effects  of  deamidation  on
oligomer forming properties of γS-crystallin. Figure 4.15 shows chromatograms
of WT and N76D γS-crystallin as 90° light scattering (LS 90) and differential
refractive index (dRI) curves. What is immediately apparent from this data is
that two species of different mass eluted from the gel filtration column in both
samples. This is unexpected as γ-crystallins are reported as monomeric and do
not form oligomers4. 
Figure  4.16 shows  an  SDS  PAGE  gel  of  the  two  peaks  for  both  proteins
alongside an overloaded sample of the injected protein. The injection samples
show  no  impurities  of  higher  mass  that  could  account  for  the  presence  of
multiple species with different molecular masses. Likewise, both elution peaks
from the WT and the N76D proteins only show bands at the same molecular
mass consistent with the mass of γS-crystallin (~20kDa). This means that the
higher-mass  elution  peak  form the  SEC can  only  be  accounted  for  by  the
presence of an oligomeric γS-crystallin species. 
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(c) Low Mass Peak (abundance) High Mass Peak (abundance)
WT 19.0 ± 0.8 kDa (89.6%) 47.0 ± 1 kDa (10.4%)
N76D 20.1 ± 0.8 kDa (63.0%) 44.4 ± 2 kDa (37.0%)
Figure 4.15: SEC-MALLS experimental results for WT and N76D γS-crystallin using an s75 gel
filtration column with 5mg/ml protein in 50mM phosphate 100mM NaCl buffer at pH7.4. (a) Size
exclusion  chromatogram of  protein  elution  peaks  from light  scattering  at  90°  (LS  90)  and
differential refractive index (dRI). (b) Mass distribution from multi angle static light scattering at
69.3°,  90°,132.3° and 152.8°,  fitted to first  degree polynomial  curve.  (c) Summary of mass
distribution peaks as weight average for each region and fraction of total protein.
60 65 70 75 80 85
0
0.1
0.2
0.3
0.4
0.5
0
0.05
0.1
0.15
0.2
SEC MALLS of γS-Crystallin
(a) Size Exclusion Chromatography
WT
LS 90
dRI
N76D
LS 90
dRI
Elution Volume (ml)
R
ay
le
ig
h 
R
at
io
 (1
/m
)x
10
^3
D
iff
er
en
tia
l R
ef
ra
ct
iv
e 
In
de
x 
(m
R
IU
)
15 20 25 30 35 40 45 50 55
0
0.02
0.04
0.06
0.08
0.1
0.12
0.14
0.16
0.18
0.2
0
10
20
30
40
50
60
70
80
90
100
(b) Molar Mass DIstribution
WT
Mass Distribution
Cumulative Mass
N76D
Mass Distribution
Cumulative Mass
Molecular Mass (kDa)
D
iff
er
en
tia
l M
ol
ar
 M
as
s 
Fr
ac
tio
n 
(m
ol
/m
g)
C
um
ul
at
iv
e 
M
as
s 
(%
)
4.2.4 Size Analysis
The  elution  profile  of  the  WT
protein  from  Figure  4.15(a)
shows a large difference in the
concentration  of  these  two
species, with the low mass peak
(WTL)  showing ~5 times higher
refractive  index  than  the  high
mass  peak  (WTH).  The  high
mass species of the deamidated
protein  (N76DH)  is  much  more
abundant, with a refractive index
only ~60% smaller than the low
mass peak (N76DL). Both N76D
species elute at a slightly lower
volume than the WT which may
indicate  a  slightly  larger
hydrodynamic  radius  in  the
deamidated protein.
Figure  4.15(b) shows the mass distribution of the WT and N76D γS-crystallin
species derived from static light scattering. Both proteins show two species, one
with  a  mean  mass  of  ~20kDa  and  one  with  a  mean  of  ~44kDa  which
approximately  correspond  to  γS-crystallin  monomer  and  dimer.  The  MALLS
data appears to slightly overestimate the mass of the dimer by 15% for the WT
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1 WT injected protein (overloaded)
2 WT 66ml peak
3 WT 77ml peak
4 N76D injected protein (overloaded)
5 N76D 65ml peak
6 N76D 76ml peak
Figure  4.16: SDS PAGE of peaks from SEC-MALLS
experiment.  Marker  labelled  with  approximate
molecular  weight  in kDa. The bands for the injected
peaks  have  been  deliberately  overloaded  and  the
intensity of the elution peaks are in proportion to their
elution concentration.
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and 10% for the N76D which is likely the result of baseline noise present in the
region of dimer elution.
WT γS-crystallin is primarily monomeric. The calculated mass distribution shows
only 10% of the protein elutes as a high mass species. γS-Crystallin, like the
other γ-crystallins, is widely reported to exclusively form a monomer in solution4,
however  the  relatively  small  amount  of  dimer  observed  here  may  have
previously  escaped notice.  The deamidated N76D γS-crystallin  on  the  other
hand, appears to form large quantities of dimer, with 37% of total protein eluting
as a high-mass species. One would expect this to have a significant effect on
the properties of this protein and it may explain the inconsistency in stability of
the deamidated protein  observed between the turbidity assays,  fluorescence
spectrometry, CD spectrometry and aggregation kinetics.
The oligomerisation of deamidated γS-crystallin was further investigated using
AUC. Figure 4.17 shows sedimentation velocity (SV) experiments for both WT
and N76D γS-crystallin at 40,000 rpm. The data is presented as the change in
protein concentration as a function of distance from the axis of rotation at 30
minute time-points during spinning.
Based on examination of the SV results, it is apparent that the N76D protein
contains a greater quantity of high mass species than the WT. At early time-
points,  the  N76D  γS-crystallin  exhibits  sedimentation  close  to  the  axis  of
rotation sooner than the WT. Likewise, at late time-points the soluble protein
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WT (abundance) N76D (abundance)
1st Component 20.2 ± 2 kDa (76.8%) 20.1 ± 2 kDa (49.1%)
2nd Component 43.2 ± 3 kDa 23.2%) 44.3 ± 3 kDa (50.9%)
Figure 4.17: Sedimentation velocity ultracentrifugation experiment for both WT and N76D  γS-
crystallin. Experiment was performed at 40000 rpm on 0.6mg/ml protein in 50mM phosphate
100mM NaCl buffer at pH 7.4 and 20°C. Graphs show sedimentation at half-hourly time-points.
The mass and abundance of species in solution was determined by fitting centrifugation curves
to a two species system.
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Figure 4.18: Sedimentation equilibrium results for WT γS-crystallin, 0.6mg/ml 50mM phosphate
buffer, 100mM NaCl pH 7.4, 20°C for (●) 7,000rpm (◾) 12,000rpm with (a) no denaturant, (b)
2M urea  and  (c)  4M urea.  Data  were  fitted  to  a  two-species  equilibrium  to  calculate  the
dimerisation constant (K) with monomer mass set at 20.6 kDa.
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has migrated further  away from the axis  in the N76D sample than the WT.
These sedimentation curves were analysed using Lamm equation modelling of
an interacting system163, which resolved into two species for each protein.
As with the SEC-MALLS results, The AUC SV experiment shows both proteins
form a low-mass species that corresponds to a monomer at ~21kDa and a high
mass species at ~42kDa that corresponds to a dimer. Both the WT and N76D
protein  show a  greater  proportion  of  dimer  in  AUC  SV  compared  to  SEC-
MALLS. When modelled as a two species system the WT protein fits as 76%
monomer and 24% dimer which is slightly  more than twice the dimerisation
observed by SEC-MALLS. Similar analysis of the N76D protein shows roughly
half of the protein is dimeric under centrifugation compared to slightly more than
one third seen via dynamic light scattering.
Figure  4.18 shows  the  results  of  sedimentation  equilibrium  (SE)  AUC
experiments  for  WT  γS-crystallin  with  varying  concentrations  of  urea
denaturant.  When fit  two a  two-species  system, these sedimentation  curves
show a dimerisation constant that decreases in proportion to increasing urea
concentration.  The  formation  of  dimer  is  disrupted  by  the  presence  of
denaturant, indicating a reversible monomer-dimer equilibrium and rules out the
presence of covalent cross-linking between the dimer subunits. A similar trend
was seen for the denaturant effect on the monomer to dimer formation for N76D
γS in sedimentation equilibrium AUC experiments. However, these did not give
consistent results, with even higher molecular weight species indicated in earlier
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samples but not seen in later experiments. These data are not presented.
Further analysis of the oligomeric properties of γS-crystallin have shown this
high-mass species to be absent in both reducing and non reducing SDS PAGE
gels,  suggesting  that  the oligomer is  sensitive  to  chemical  stress  from both
reducing agent and detergent. Furthermore, when γS-crystallin is incubated in
the presence of reducing agent immediately prior  to SEC, the elution profile
shows an additional peak that corresponds to the dimeric species observed in
the SEC MALLS experiments (results not shown). These observations, coupled
with the AUC SE results,  suggest that  this dimeric species is not covalently
bound. 
The SEC-MALLS and AUC SV results show the presence of dimer in samples
of both WT and N76D γS-crystallin. However, both of these methods report a
different monomer to dimer ratio for each species. Likewise, the AUC SE results
for  WT  γS-crystallin  suggests  a  reversible  equilibrium  is  present  between
monomer and dimer species. The difference in abundance between the low and
high mass species in SEC-MALLS and AUC SV may be due to a concentration
dependence  for  dimer  formation.  Under  the  conditions  of  the  SEC-MALLS
experiment the proteins will be significantly diluted over the volume of the gel
filtration column whereas in the AUC SV experiment all concentrations remain
constant. This is consistent with the comparatively higher proportion of dimer
observed in the AUC experiment for both proteins. The greater quantity of dimer
seen  for  the  N76D  γS-crystallin  may  be  a  precursor  to  further  protein
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aggregation and if so this could be responsible for the presence of cataract in
lenses with substantial deamidation.
4.2.5 NMR Spectroscopy
There is currently no crystal structure for γS-crystallin available, although crystal
structures have been determined for other γ-crystallins such as γD213 and γE214.
The flexible N-terminal extension of the protein and the longer domain linker
peptide may be contributes to the inability of the protein to crystallise. However,
γS-crystallin has had its NMR spectra assigned and a solution structure based
on  these  assignments  exists100.  This  makes  it  possible  to  relatively  easily
analyse  NMR spectra  for  the  WT and  deamidated  protein  based  on  these
existing assignments. By comparing the assigned spectra of the WT protein to
the  N76D  any  local  structural  changes  caused  by  deamidation  should  be
identifiable as chemical shift differences between the spectra.
NMR spectra of the WT and N76D proteins consisting of  15N-1H HSQC, 1H-1H
TOCSY and 15N-1H-1H HSQC-TOCSY experiments were assigned based on the
existing  NMR  assignments  of  γS-crystallin100.  Only  134  (75%)  of  the  174
residues of the proteins were positively identified in the spectra, mostly due to
ambiguous cross-peaks. HSQC cross-peaks were assigned by matching with
spectral assignments from Kingsley et al. (2013)100 which were cross referenced
using TOCSY and TOCSY-HSQC cross-peaks. Many resonances that were not
readily distinguishable from the HSQC spectrum alone were identifiable from
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characteristic  side-chain  chemical  shifts  but  several  resonances  showed  no
corresponding TOCSY cross-peaks and were unable to be assigned.
Figure  4.20 shows regions  from the  15N-1H HSQC spectra  for  the  WT and
deamidated proteins with assigned cross-peaks. These spectra show the high
degree of overlap in the chemical shifts of the two proteins, a property shared
with the  1H-1H  TOCSY spectra. The spectrum of the WT protein shows high
correlation with the existing assignments (Kingsley  et al. (2013))100 and while
the  deamidated  protein  spectrum  has  some  divergence,  particularly  for  the
residues close to 76, the spectra are similar enough to suggest that both the
WT and N76D proteins share the same overall structure.
The  presence  of  secondary  structure  in  proteins  will  cause  characteristic
chemical shifts in that region away from those expected for an unstructured
peptide194.  The  secondary  chemical  shifts  across  the  backbone  of  WT and
N76D γS-crystallin are shown in Figure 4.19. There are several regions in these
graphs with strong upfield or downfield trends and these generally correspond
to regions of β-sheet structure shown in Figure 4.1. The secondary shifts for the
WT and N76D proteins show a high degree of overlap in most regions of the
protein. The high correlation of the secondary shifts in the NH and αCH protons
is a strong indicator of β-sheet structure189 and the similarity of the two spectra
indicates  that  the  primary  Greek-key  fold  of  the  protein  is  preserved  upon
deamidation. For both the NH proton and nitrogen resonances the only location
discernible difference is the region directly adjacent to the point of modification
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Figure  4.20: Selected regions of  HSQC NMR spectra  for  both  WT (●)  and N76D (●) γS-
crystallin highlighting position of residue 76. Various other cross-peak assignments indicated for
both proteins.
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Figure 4.19: NMR secondary shifts across the backbone of both WT and N76D γS-crystallin.
Values  shown  are  the  differences  between  the  observed  resonances  from  15N-1H  HSQC,
TOCSY and HSQC-TOCSY experiments  and  the  expected  chemical  shifts  for  unstructured
protein194. Graphs show these secondary shift for backbone NH proton, NH nitrogen that αCH
proton, both as point difference and trend ±2 residues.
2
10
812 22 32 42 52 70 81 92 12
0
13
5
15
6
17
1
-15
-10
-5
0
5
10
15
NH Nitrogen
WT Shift
N76D Shift
 WT Trend
 N76D Trend
S
ec
on
da
ry
 S
hi
fts
 (p
pm
)
2 13 24 35 46 58 73 84 97 11
0
12
2
13
7
15
0
16
6
17
8
-2.5
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
2.5
NMR Secondary Chemical Shifts
NH Proton
WT Shift
N76D Shift
 WT Trend
 N76D Trend
S
ec
on
da
ry
 S
hi
fts
 (p
pm
)
2 13 24 35 46 57 69 80 92 10
3
11
4
12
5
13
9
15
0
16
5
17
6
-3
-2
-1
0
1
2
3
4
αCH Proton
WT Shift
N76D Shift
WT Trend
N76D Trend
S
ec
on
da
ry
 S
hi
fts
 (p
pm
)
4.2.5 NMR Spectroscopy
at residue 76. Notably none of the regions of secondary structure seem to be
greatly affected by the deamidation, with only the linker region between the first
α-helix and β-strand 8 (residues 74-83) exhibiting any change. The secondary
shifts  of  the  αCH shows  the  smallest  difference  between  the  two  proteins,
effectively limited to residue 76 and a small region of the N-terminal.
To distinguish the differences between the two spectra, the absolute deviation in
chemical  shift  across  the  proteins'  backbone  is  shown in  Figure  4.21.  This
shows more detail on a smaller scale than seen via secondary chemical shift
and many changes caused by the deamidation at Asn76 are evident. In general,
these differences appear to be highly localised in the N-terminal domain of the
protein,  especially  in  the  region  immediately  surrounding  the  point  of
modification. There are a few localised differences in the C-terminal domain but
the changes to this region are much smaller in magnitude.
The NH protons for each protein show the largest differences in chemical shift
in the regions of β-strand 2 (residues 18-26), the region around the first half of
β-strand 4 (34-40) and the linker region between the first α-helix and β-strand 8
that contains the point of modification (74-80). This region unsurprisingly shows
the largest difference between the two proteins, most likely due to the addition
the negative charge caused by deamidation. Similar differences appear with the
NH nitrogen resonances, showing large difference in residues 34-40, 56-64 and
74-90 but  there  is  also a large difference around  β-strand 1 at  residue 12.
These backbone nitrogen resonances also show differences in the C-terminal
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domain  around  β-strand  12 (residues  124-130)  and  β-strand  16 (164-170).
These are much smaller differences than observed in the N-terminal domain
which may indicate some changes in the interaction between the two domains
as these regions are remote from the domain interface. The αCH protons show
only small  differences between the two proteins which mostly  correlate with
differences in the NH backbone resonances. The largest difference is observed
in the N-terminal extension of the protein, changes to which may indicate an
altered solubility in the N76D.
Overall the two protein show high similarity in their spectra which is consistent
with a similar structure. There are, however, several key secondary structural
elements  that  show  differences  in  their  chemical  environment  upon
deamidation. These could be indicative of a subtle change in the structure of
this protein when subject to modification.
To get a better appreciation of the spacial arrangement of these differences the
changes were superimposed on the solution structure of γS-crystallin100 (Figure
4.22).  This  structure  has  been  highlighted  with  the  residues  that  show  the
greatest differences between the WT and N76D γS-crystallin. As indicated by
Figure 4.21 these differences are primarily located in the N-terminal domain of
the  protein  and  are  for  the  most  part  spatially  adjacent  to  the  point  of
modification (marked in blue). One region that shows change and isn’t directly
adjacent to residue 76 is β-strand 6 and 8. These β-strands are part of  the
second Greek-key of the N-terminal domain and form the main interface point
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between  the  two  domains  of  the  protein99.  If  this  region  of  the  protein  is
disrupted then the normal two domain monomeric structure that is characteristic
of γ-crystallins may be altered and this might explain the previously observed
presence of oligomeric species. 
Another region of interest that shows differences between the two proteins is
the region around first Greek-key motif. This region is relatively remote form the
point of deamidation and my indicate further changes in structure of the protein.
The series of β-strands that define the first Greek-key motif  form one of the
faces of the protein and any structural changes to this region could alter the
shape of the entire domain. Finally, there is a small but distinct region of the C-
terminal domain that shows difference between the two spectra. The residues in
the spacial  region of  β-strand 12 show a small  but  noticeable change upon
deamidation.  This  part  of  the  protein  is  remote  from residue  76  in  the  WT
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Figure  4.21: Difference  between  WT  and  N76D  γS-crystallin  NMR  spectra.  Graph  shows
difference in  chemical  shifts  of  backbone  1H and  15N residues between both proteins as a
function of residue number. For the purposes of representation the glycine αCH2 chemical shift
differences are shown as an average of the two proton residues and the graph is smoothed
across ±1 residue.
1 13 25 37 49 61 73 85 97 10
9
12
1
13
3
14
5
15
7
16
9
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.14
0.16
0.18
0.20
0.00
0.10
0.20
0.30
0.40
0.50
0.60
0.70
0.80
0.90
1.00
NH Proton
NH Nitrogen
αCH Proton
Residue
P
ro
to
n 
C
he
m
ic
al
 S
hi
ft 
D
iff
er
en
ce
 (p
pm
)
N
itr
og
en
 C
he
m
ic
al
 S
hi
ft 
D
iff
er
en
ce
 (p
pm
)
4.2.5 NMR Spectroscopy
140
Figure 4.22: Structure of WT γS-crystallin100 with the location of the regions of high chemical
shift difference from Figure 4.21 indicated. Colours indicate residues with difference in average
chemical shift of back-bone atoms:  ● > 0.1 ppm < ● ≥ 0.05 ppm < ● ≥ 0.025 ppm. ● indicates
point of modification (Asn76).
90°
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protein and may indicate a change in how the two domains are interacting. The
small size of this difference would mean that any interaction in this area must be
minor.
4.3: Discussion
The abundance of deamidated γS-crystallin found in eye lenses with cataract
symptoms and the relatively low instances of it in healthy lenses of the same
age implies  that  this  modification  is  having  a  disproportionate  effect  on  the
health of the lens102. If this is the case, then deamidation should cause either
γS-crystallin to become significantly less stable when subjected stress, or cause
the presence of the protein to have a destabilising effect on others in its vicinity
in the lens. 
The  biophysical  characterisation  of  the  deamidated  (N76D)  γS-crystallin
involved multifaceted analysis to determine the thermal stability of the protein
and the effect of denaturant on its unfolding. Unfortunately the results of these
experiments did not give one clear answer. The deamidated γS-crystallin shows
distinctly  lower  stability  to  GndCl  induced  denaturation  as  determined  by
changes  in  intrinsic  fluorescence,  shown  in  Figure  4.9.  Likewise,  the
susceptibility of the deamidated γS-crystallin to unfolding and aggregation under
heat  stress  is  increased  according  to  aggregation  kinetics  results  shown  in
Figure  4.12.  When  the  protein  is  exposed  of  both  denaturant  and  thermal
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stress,  the two effects combine additively  to increase unfolding and in each
instance the N76D exhibits lower stability  than the WT (Figure  4.10).  These
results together would suggest that deamidation causes a clear reduction in the
stability in γS-crystallin and increases the protein's tendency to aggregate. Such
a loss of stability would be expected to contribute to the formation of cataract.
While the deamidated γS-crystallin shows a reduced stability and an increased
tendency to aggregate in kinetic and denaturant unfolding assays, the results of
several thermal stability experiments show the relative stability of the WT and
N76D  reversed.  The  thermal  stability  protein  was  determined  by  solution
turbidity  (Figure  4.6),  intrinsic  fluorescence change (Figure  4.7)  and circular
dichroism ellipticity (Figure 4.8) and in all cases the N76D γS-crystallin shows
greater stability to thermal stress and unfolds a higher temperature than the WT.
This indicates a level of complexity in the behaviour of the deamidated protein
in response to stress that goes beyond simple destabilisation.
One of the notable differences between the WT and N76D γS-crystallins is seen
in the intrinsic fluorescence emission of the protein as a function of temperature
(Figures 4.7(b) and (c)). The γ-crystallins each contain four tryptophan residues
with two per domain. These residues are buried deep within the hydrophobic
core of the protein and are only exposed to solvent with extensive unfolding.
Unlike  many  proteins,  the  βγ-crystallins  exhibit  an  increase  in  intrinsic
tryptophan  fluorescence  when  unfolding  due  to  the  fold  of  their  Greek-key
domains inducing a very efficient system of fluorescence quenching at each
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tryptophan  residue41.  This  is  the  result  of  transfer  of  photoelectrons  from
tryptophan  side-chains  to  a  backbone  amide  via  H-bond  formation  to  two
nearby  water  molecules.  This  feature  is  highly  conserved  across  the  βγ-
crystallins and is attributed to a need to protect the tryptophan residues from UV
damage  due  to  photoionisation41.  The  fluorescence  change  with  respect  to
temperature shown in Figure 4.7 indicates that the N76D protein unfolds via a
typical  two  state  mechanism  while  the  WT  exhibits  a  transition  point  that
indicates the presence of a stable intermediate. Close observation of the CD
spectra in Figure 4.8 also shows a drop in the rate of unfolding with respect to
temperature at around 70°C that may be the result of this same intermediate
species.  A bimodal  unfolding  mechanism  has  been  previously  observed  in
bovine γII-crystallin208 with the conclusion that the two domains of the protein
were able to fold and unfold independently, giving rise to a stable intermediate
species  with  the  N-terminal  domain  fully  folded  and  the  C-terminal  domain
unfolded.
The loss of this bimodal unfolding upon deamidation could be the result of one
of several effects. One possible explanation is that deamidation causes the two
domains  to  become much more  tightly  bound such that  they are  no longer
capable of unfolding independently. This would be consistent with the unfolding
seen  in  Figure  4.7(b)  were  the  entire  N76D  protein  unfolds  at  a  similar
temperature to the more stable of the two domains in the WT. Unfortunately this
does not match with the NMR data (Figure 4.22). If the two domains were much
more  strongly  interacting  we  would  expect  to  see  large  differences  in  the
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domain interface region on both sides, however, the NMR results show only the
N-terminal side of the domain interface is significantly different.
Another possible explanation is that the deamidation is changing the stability of
just  the N-terminal  domain such that  the independent  regions of  the protein
happen to have roughly the same stability. This would be consistent with the
increase in thermal stability shown by N76D γS-crystallins, but both the kinetic
aggregation and GndCl unfolding results indicate that the protein is less stable
overall.  This Suggests that a more complex model  is needed to explain the
protein's behaviour.
One  of  the  most  interesting  differences  between  the  WT  and  N76D  γS-
crystallins is the tendency of the deamidated protein to form a dimer in solution.
Like the other members of  the γ-crystallin family  of  proteins,  γS-crystallin is
reported to form a monomer both in vitro and in vivo4,9. The oligomeric state of
the WT and N76D was determined via both SEC-MALLS (Figure 4.15) and AUC
SV measurements (Figure  4.17). Both of these analytical  methods show two
protein species present in solutions of γS-crystallin and SDS PAGE analysis
shown in Figure  4.16 eliminates the possibility of a second protein of higher
mass  being  present  in  the  sample.  Remarkably  the  presence  of  a  dimeric
protein  species  is  identified  in  both  the  WT and  N76D  γS-crystallin  which
suggests a previously unnoticed and unreported property of γS-crystallin. The
protein γS-crystallin is distinct from the other members of the γ-crystallins and
represents the only member of an early evolutionary offshoot from the main
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family4,87. γS-Crystallin shares some structural features with the β-crystallins not
seen  in  the  other  six  γ-crystallins,  such  as  the  presence  of  an  N-terminal
extension, the lack of a C-terminal extension, and a 1-2 residue longer linking
region  between  the  two  domains.  γS-Crystallin  is  similar  enough  to  the  β-
crystallins that  the protein was originally classified βS-crystallin based on its
biophysical properties before its gene was sequenced4,87. It is possible that the
properties of γS-crystallin are closer to the β-crystallins than was realised and
that under certain condition the protein will naturally form a stable dimer. The
protein may occupy a niche within the poly-disperse lens fibre cell protoplasm
for a species somewhere between an entire monomer and an entire dimer that
complements the strictly monomeric γA-D crystallins and the various oligomers
formed by the β-crystallins.
The deamidation of Asn76 in γS-crystallin significantly increases the amount of
dimer present in solution. Both the SEC-MALLS and AUC SV results indicate
elevated levels of a larger mass protein species in the samples of N76D γS-
crystallin compared to the WT protein. The two methods differ greatly in the
quantity  of  dimer  they  report  present  in  solution,  which  may  indicate  a
concentration  dependent  equilibrium  for  dimer  formation.  During  AUC  SV
experiments, each protein sample is isolated in individual cells whereas elution
from a gel filtration column during SEC-MALLS experiments dilutes the protein
by an order of magnitude. Under the lower concentration conditions of SEC-
MALLS the WT shows a 56% reduction and the N76D shows a 27% reduction
in  dimer  compared  to  the  AUC  SV  results.  AUC  SE  results  (Figure  4.18)
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likewise  show  a  reduction  in  dimer  concentration  for  WT γS-crystallin  with
increasing concentration of denaturant, which suggests the two species are in
equilibrium.
The  deamidation  of  γS-crystallin  also  appears  to  have  an  effect  on  other
proteins  in  its  immediate  environment  based  on  its  interactions  with  the
molecular chaperone α-crystallin. In the eye lens, the natural defence against
aggregate formation is the presence of high concentrations of small heat-shock
proteins that  act as molecular chaperones and prevent  protein aggregation4.
These proteins bind to partially unfolded proteins and prevent their aggregation
by sequestering and solublising them73,76. The aggregation WT and N76D γS-
crystallin in the presence of bovine lens α-crystallin is shown in Figure 4.13. WT
γS-crystallin  aggregation  is  prevented  by  α-crystallin  in  fairly  typical
concentration dependent manner. α-Crystallin is a very efficient chaperone and
it easily achieves full suppression of aggregating γS-crystallin at ratios of 1:1
chaperone to target  in situ, just as it prevents aggregation in the healthy eye
lens.
The presence of deamidated γS-crystallin results in different behaviour, not only
does it take a greater quantity of total chaperone protein to prevent aggregation
than the WT, but at low to moderate concentrations the N76D γS-crystallin and
α-crystallin  co-aggregate.  Co-aggregation  of  chaperone and its  target  is  not
uncommon215,216 and this behaviour may explain the correlation of cataract and
deamidated γS-crystallin in the eye lens, as instead of binding and sequestering
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unstable  N76D  γS-crystallin,  the  presence  of  the  chaperone  increases  the
amount of aggregate being formed. At high concentrations of α-crystallin the
aggregation is still fully suppressed, so any deamidation that occurs in a young
lens with large quantities of α-crystallin is unlikely to aggregate. However, as the
lens ages and the concentration of viable chaperone drops, this co-aggregation
will  have  the  potential  to  trigger  lens  opacification.  If  sufficient  deamidation
occurs  in  γS-crystallin  in  the  lens  to  trigger  protein  instability  and  there  is
insufficient viable chaperone protein to fully suppress this aggregation, then the
observed  co-aggregation  effect  would  result  in  both  the  formation  of  large
quantities  of  aggregated  protein  and  the  removal  of  viable  chaperone  from
solution. This loss of chaperone would further weaken the natural defences of
the eye against aggregation, likely triggering further aggregate formation and
the further chaperone loss. Such a feedback cycle would likely lead to rapid
cataract formation.
The  general  reported  effect  of  deamidation  on  the  crystallin  proteins  is  a
reduction in stability and an increased tendency to unfold.  γD-Crystallin has a
similar two-domain monomeric structure to γS-crystallin and its domain interface
is maintained by inter-domain side-chain interactions. There are two glutamine
residues  that  are  critical  to  this  interaction,  Gln54  and  Gln143217,  and
deamidation of these locations causes increased instability and the unfolding of
the  N-terminal  domain  of  the  protein218.  βB1-Crystallin  exhibits  similar
behaviour, showing destabilisation of one domain and reduced ability to form
oligomers  after  deamidation  of  Gln204107,219.  The  deamidation  of  several
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asparagine and glutamine residues in  βA3-crystallin likewise disrupts oligomer
formation  but  without  altering  the  protein's  secondary  structure220,  whereas
deamidation of Gln70 and Gln162 of  βB2-crystallin preserves dimer formation
but destabilises the proteins structure and promotes unfolding221.  Additionally,
the deamidation of Gln85 and Gln180 in the domain interface of βA3-crystallin
results  in  a  disruption  of  the  protein's  ability  to  form  homo-oligomers  and
reduces  its  thermal  stability222.  Recently,  however,  it  has  been  shown  that
double deamidation of γS-crystallin promotes the formation of larger oligomeric
species in the protein, similar to the results found in this study223. γS-Crystallin
deamidated  at  Asn76/Asn143  and  Gln92/Gln120  resulted  in  species  that
maintain the two domain structure of WT protein but which have a lower mutual
repulsion and a greater tendency to form high-mass species223. This result is
highly similar to the behaviour of singly deamidated N76D γS-crystallin and the
two effects may have the same mechanism.
The increase in thermal stability of the N76D γS-crystallin is inconsistent with its
rapid observed aggregation and instability to chemical denaturant. To explain
this behaviour we propose a model where the N76D γS-crystallin exhibits both
reduced thermal and chemical stability compared to WT, but its tendency to
form dimers protects the protein from aggregation. N76D γS-crystallin exhibits
both  rapid  aggregation  under  thermal  stress  (Figure  4.12)  and  a  higher
susceptibility to chemical denaturant (Figure 4.9), but has greater resistance to
unfolding in temperature ramped thermal stability experiments (Figures 4.6, 4.7
and 4.8). This apparent contradiction could be explained by the tendency of the
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N76D protein to form a dimer in solution. It is not unusual for the stability of
proteins to depend on the formation of protein complexes,  such as the casein
micelle in milk224 or the hexamer formed by insulin225. If the formation of dimers
in  N76D γS-crystallin  stabilises  the  protein  against  thermal  stress,  many  of
these apparently contradictory results can be reconciled. 
Under  this  model,  the  results  for  the  thermal  stability  experiments  can  be
explained.  The  N76D  protein  exhibits  less  stability  than  the  WT protein  to
thermal stress, as evidenced by its aggregation kinetics, but is prevented from
unfolding by the stabilising effect of dimerisation. Thus, the WT protein, which is
primarily monomeric, unfolds at a lower temperature and the N76D γS-crystallin
remains stable and folded until there is sufficient heat stress to dissociate the
dimer.  Once the  dimer  dissociates,  the more  unstable N76D monomers  will
unfold and aggregate rapidly. This also explains the differences between the
two proteins observed in the fluorescence and CD spectra. In the fluorescence
spectra, the WT γS-crystallin shows a two step unfolding curve that indicates
independent unfolding in both domains. The N76D does not exhibit this same
unfolding,  as  at  the  point  of  dimer  disassociation  there  is  sufficient  thermal
stress that both domains begin unfolding immediately. Likewise, the CD spectra
show that once the N76D γS-crystallin begins unfolding, it  looses secondary
structure much more rapidly than the WT as a function of temperature, due
primarily to its increased instability upon deamidation.
This  model  also  fits  the  kinetic  experiments  shown  in  Figure  4.12.  These
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unfolding curves show a greater  delay in the aggregation for the N76D γS-
crystallin compared to WT, attributable to the increased stability of the dimer.
Once aggregation of deamidated γS-crystallin begins, however, it proceeds at
roughly double the rate of the WT protein. Additionally, the decreased stability
seen in the GndCl unfolding in Figures 4.9, 4.10 and 4.11 can be explained as
being the result of denaturant disrupting dimer formation at low concentrations,
causing  N76D  γS-crystallin  to  behave  as  a  monomer  and  unfold  at  lower
concentrations of denaturant and lower temperatures than WT.
γS-Crystallin shares many structural features with the β-crystallins, including a
long domain linking region and an N-Terminal extension. The ability of both WT
and N76D γS-crystallin to form dimer may a consequence of these features.
Oligomer  formation  in  the  β-crystallins  commonly  involves  the  N-terminal
domain  of  one  subunit  interfacing  with  the  C-terminal  of  the  other  in  an
analogue of  the monomeric  two-domain structure of  the  γ-crystallins226.  This
mode of dimer formation appears not to operate in the case of WT and N76D
γS-crystallin  as the protein  appears to maintain  its  two-domain structure,  as
evidenced by an absence of alteration in NMR chemical shifts for resonances in
the domain interface for the C-terminal domain (Figure  4.22). The location of
chemical shift difference between the WT and N76D instead suggest that the
most  likely  location for a dimerisation interface is  along the face of the first
Greek-key  region.  This  interface  would  be  somewhat  similar  to  the  lattice
structures  formed  in  some  β-crystallins  in  larger  scale  oligomers,  such  as
human βB1 and bovine βB298. Alternatively, it is possible that the WT and N76D
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γS-crystallin  are  forming dimers without  domain  swapping via  an interaction
involving the face of the first Greek-key in the N-terminal domain, and perhaps
the region around the α-helix in the C-terminal domain, in a manner similar to
the  large  scale  oligomer  assembly  in  βB1-  and  βB3-crystallin.  The  large
difference  in  chemical  shift  seen  in  the  N-terminal  extension  of  the  protein
suggests that this region is also playing a role in dimer formation. One of the
primary differences between the various members of the β-crystallin family is
the length of their N-terminal extension227. It has been shown that modifications
made to the length of this region can alter the size of oligomers these proteins
form228. The N-terminal extension of γS-crystallin may be playing a similar role
in regulating the dimer formation in the N76D γS-crystallin. It  has also been
shown by Harms  et  al. (2004)  that  Q146  deamidation  in  βB1-crystallin  can
encourage the formation of higher order oligomers in what may be a similar
effect to what we have observed for N76D  γS-crystallin229. Overall, the small
differences between the spectra of WT and N76D γS-crystallin suggest that any
dimer forming interaction would be weak and transient,  potentially permitting
rapid association/dissociation between monomer to dimer.
Under the various conditions used in this investigation, we were able to readily
subject both proteins to sufficient stress to cause aggregation, even the more
thermally stable N76D γS-crystallin dimer. Under the conditions found in the eye
lens  this  may  not  always  be  the  case.  We  would  expect  that  under  the
extremely  high  concentrations  of  protein  within  the  eye  lens  fibre  cells,  the
formation of the dimer would be highly favoured. It is plausible that in the lens,
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the loss of stability caused by deamidation of γS-crystallin would be entirely
counteracted by the stability gained from the formation of dimer, at least when
only  a  small  fraction  of  the  protein  is  deamidated.  This  is  reflected  in  the
composition of the eye, with lenses as young as 15 years of age showing 20%
deamidation but being perfectly healthy for another 40 years102. It is not until
60% or more of the protein is deamidated that cataract symptoms are seen102.
At old age, the proteins of the eye are extensively modified and many of these
alterations cause instability4,5,7. It may be that in young lenses, the aggregation
resistance caused by this dimerisation dominates the behaviour of γS-crystallin,
but as the eye ages other sources of stress occur and cause protein instability.
As the aggregation kinetics results show (Figure  4.12), once the deamidated
γS-crystallin begins to aggregate it does so rapidly. If this stress threshold is
crossed in an extensively deamidated eye lens then large amounts of aggregate
can be expected to form, both from the unfolding γS-crystallin and due to co-
aggregation with α-crystallin.
It is a possibility that the dimer formation shown by deamidated γS-crystallin is
an  adapted  response  to  this  modification.  Deamidation  is  one  of  the  most
common  post-translational  modifications  found  in  proteins  and  has  been
described as one of the limiting factors affecting their lifetime in all tissues230.
Due to the long expected lifespan of the crystallins it would be almost inevitable
that any residue capable of undergoing deamidation would do so given enough
time. Asn76 appears highly prone to deamidation and its presence is correlated
with cataract102,  so it  would not be unexpected that the lens would adapt to
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counteract any instability caused by this modification. This would represent a
'good enough' adaptation that, like many of the systems in the eye lens, lasts for
most of the lifetime of an individual but breaks down with age. Under this model,
it is not so much the presence of deamidation that causes cataract formation
but  the  combination  of  deamidated  protein  and  sufficient  other  stresses  to
disrupt the formation of the stable protein dimer.
4.4: Conclusion
The deamidation of Asn76 in human γS-crystallin appears to cause a reduction
in  the  protein's  stability  to  thermal  and  chemical  stress  but  promotes  the
formation of a dimeric species that partially counteracts this instability. Once this
dimer  dissociates,  the  deamidated γS-crystallin  aggregates  rapidly  and  to  a
greater extent than the WT protein. The rapid aggregation of deamidated γS-
crystallin reduces the effectiveness of α-crystallin as a chaperone and causes
co-aggregation of the two proteins. The implications for cataract is that, as the
build-up of this modification occurs, aggregate formation become more likely.
This effect of Asn76 deamidation would be expected to add to the wide range of
post-translational modifications and changes in the environment of the lens as it
ages.  We  would  expect  that  in  a  highly  damaged  and  stressed  lens,  the
presence of deamidated γS-crystallin would increase the probability of protein
aggregation and accelerate the formation of cataract.
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Chapter 5: αA-Crystallin Gln147 Deamidation
The Effects of Deamidation of Glutamine 147 on the
Structure and Chaperone Ability of Human αA-
Crystallin
5.1: Introduction
Deamidation  is  one  of  the  most  common  post-translational  modifications  in
long-lived proteins128,230. The crystallin proteins of the eye lens are susceptible to
deamidation at many locations and this modification is correlated with cataract
in several  instances6,107,125.  αA-Crystallin,  a major lens protein and molecular
chaperone, is prone to undergo deamidation at a number of sites as it ages231.
One  location,  Gln147,  has  been  identified  as  having  significantly  higher
deamidation  in  cases  of  cataract  when  compared  to  age-matched  healthy
lenses125. Thus, there may be a causal link between deamidation of Gln147 in
αA-crystallin and the development of cataract.
The  α-crystallins,  which  consist  of  αA-  and  αB-crystallin  in  mammals,  are
members of the small heat-shock family of molecular chaperone proteins and
are expressed in high concentrations in lens fibre cells4,10. Via their chaperone
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action,  these  proteins  serve  as  one  of  the  primary  mechanisms  preventing
protein  aggregation in the lens, maintaining this function in the ageing eye is
vital  for  proper vision8.  Mature lens fibre cells lack any protein turnover and
have no mechanisms to reverse age-related damage. As a result, the lens relies
on  the  inherent  stability  of  the  lens  crystallins  and  the  presence  of  high
concentrations of molecular chaperone proteins to prevent aggregation caused
by age-related damage4. If the α-crystallins themselves become subject to post-
translational  modifications  that  reduce  their  effectiveness  as  molecular
chaperones, then the lens may be put at increased risk of protein aggregation
and opacification156.
This chapter details the investigation of deamidation at Gln147 in human αA-
crystallin. The role of this protein is two-fold, (i) it acts as molecular chaperone
for the structural crystallin proteins of the lens to prevent aggregate formation
and (ii) it is part of the aggregation and crystallisation-resistant heterogeneous
lens structure that generates the high transparency and refractive index of the
lens4,9. The molecular chaperone function of the deamidated αA-crystallin was
investigated  via  activity  assays  utilising  several  model  protein  aggregating
systems.  Additionally,  the  structural  stability  of  the  protein  was  studied  by
various biophysical and spectroscopic methods.
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5.2.1 Expression and Purification
Both the wild type (WT) and the deamidated (Q147E) versions of αA-crystallin
were expressed recombinantly from BL21(DE3) strain  E.coli cells transformed
with a pET24(c) plasmid vector encoding the human αA-crystallin gene. The
subsequent over-expressed protein was separated from the bacterial cell lysate
and purified via a two-step chromatographic method232. The first step consisted
of an anion exchange purification over a DEAE column to separate the cell
components  by  charge.  This  chromatogram  (Figure  5.1)  shows  that  αA-
crystallin  binds  well  to  DEAE  media  and  elutes  with  ~0.25M  NaCl.  This
separates the protein from many of the other cell  components but significant
impurities still remain. The purity of the eluent was determined by SDS PAGE
analysis, shown in Figure 5.2.
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Figure 5.1: Chromatograms from the purification of bacterial cell lysate from expression of WT
and Q147E αA-crystallin via anion exchange chromatography. The proteins were purified on an
FPLC system using a DEAE-sepherose fast flow column in 50mM Tris HCl buffer at pH 8.5 with
an ion gradient from 0M to 1M NaCl over 8 column volumes. The chromatograms show the UV
absorbance as 280nm, the conductivity and the fractionation of the eluant for both the WT and
deamidated proteins.
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5.2.1 Expression and Purification
The  second  purification  step  utilised  size  exclusion  chromatography  over  a
superdex-300 gel filtration column to separate any remaining species by size.
The chromatogram for this step is shown in Figure 5.3. Both proteins eluted in a
single major peak after roughly 0.4 column volumes. The elution peaks are very
broad, likely due to the polydisperse nature of αA-crystallin oligomers, and are
of high protein purity as determined by SDS PAGE (Figure  5.4). The purified
proteins were desalted by dialysis into water, freeze-dried and stored at -20°C.
The resulting protein powder was used in all experiments.
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Figure 5.2: SDS PAGE corresponding to anion exchange chromatography fractions from Figure
5.1. The gel marker lane is labelled with molecular masses in kDa.
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Figure 5.3: Chromatograms from the final purification of WT and Q147E αA-crystallin. Proteins
were  purified  on  an  FPLC  system  using  a  superdex-300  gel  filtration  column  in  50mM
phosphate 100mM NaCl buffer at pH 7.4.  The chromatograms show the UV absorbance at
280nm and the fractionation of the eluant for both the WT and deamidated proteins
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A major function of αA-crystallin in the lens is the prevention of aggregation of
the  β-  and  γ-crystallins10.  These  proteins  are  normally  highly  stable  but
exposure to stress and modification with age can cause them to unfold and
aggregate. Such aggregation results in the formation of high mass species that
cause light scattering and degrade vision quality4. The deamidation of Gln147 in
αA-crystallin induces the addition of a negative charge which may influence the
function of the protein. To investigate the effect of deamidation, the chaperone
action of both the WT and Q147E protein was compared using several model
protein  aggregation systems, i.e.  amorphous protein  aggregation under  both
heat and reductive stress and amyloid fibril formation.
160
Figure  5.4:  SDS  PAGE  of  fractions  corresponding  to  the  gel  filtration   chromatographic
fractions from Figure 5.3. The gel marker lane is labelled with molecular masses in kDa.
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Figure  5.5 shows the light scattering profiles of  aggregation of insulin in the
presence of various concentration of WT and Q147E αA-crystallin.  Insulin is
prone to aggregation when subjected to chemical stress caused by reducing
agent233. In the presence of DTT, the insulin B chain will aggregate along the
amorphous off-folding pathway to form large quantities of insoluble, high-mass
species. Then aggregation proceeds in three stages. Initially the peptide has a
short lag period where no aggregation is observed and the insulin B chain is
partially unfolding and forming nucleation sites. This lag period is followed by an
exponential  growth phase in  which the rapid formation of  aggregate can be
observed  by  increasing  solution  turbidity.  This  turbidity  increase  ends  once
aggregation is complete and thereafter remains at a constant plateau value.
The insulin B chain aggregation assay used in this thesis exhibits a lag period of
~20 minutes, followed by another ~20 minute growth phase, after which the
aggregation is complete and the solution turbidity reaches a plateau of ~0.32
absorbance units at 360nm.
Figure  5.5 show the presence is low concentrations of chaperone causes an
increase in solution turbidity, suggesting that the αA-crystallin is co-aggregating
with insulin. Such co-aggregation is common for α-crystallins when interacting
with rapidly aggregating target proteins210 and both the WT and Q147E proteins
show a similar increase in aggregate formation. The presence of αA-crystallin
has little effect on either the rate or lag period of insulin aggregation at low
concentrations.  As  chaperone  concentration  increases  insulin  aggregation  is
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Figure  5.5: Reductive stress-induced aggregation of insulin in the presence of both WT and
Q147E αA-crystallin. Aggregation of 0.25mg/ml insulin was induced by chemical stress in the
form of reducing agent DTT at 10mM in 50mM phosphate 100mM NaCl buffer at pH 7.4 and
37˚C. 
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Figure  5.6: Metrics of aggregation of insulin as chaperoned by WT and Q147E αA-crystallin.
Rate and endpoint determined by fitting a sigmoidal curve to the raw absorbance data. Data
presented are the result of three experiments.
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partially  suppressed  as  indicated  by  both  an  increased  lag  period  and  a
reduction  in  total  endpoint  turbidity.  The  formation  of  insulin  aggregates  is
reduced significantly at the highest concentration of αA-crystallin assayed.
The  WT  and  Q147E  αA-crystallin  show  similar  chaperone  ability  at  low
concentrations  However,  as  concentrations  increase,  Q147E exhibits  poorer
suppression  of  aggregation.  Insulin  in  the  presence  of  the  deamidated
chaperone exhibits a higher total turbidity and a shorter aggregation lag period
compared to equivalent concentrations of WT αA-crystallin. Likewise, the WT
protein begins to show aggregation suppression at lower concentrations than
seen for Q147E αA-crystallin.  Overall,  this suggests that the deamidation of
Gln147 is reducing the ability of  the αA-crystallin to function as a molecular
chaperone but that the protein nevertheless retains some effectiveness.
Figure  5.6 summarises  the metrics  of  insulin  amorphous aggregation  in  the
presence of WT and Q147E αA-crystallin. As seen in Figure 5.5, the presence
of chaperone causes a small increase in total aggregation of the insulin at low
concentrations but there is no significant difference between the WT and Q147E
at  concentrations  at  and  below  0.1mg/ml  of  the  protein.  When  higher
concentrations are compared, the deamidated αA-crystallin shows significantly
worse ability to prevent the aggregation of insulin compared to the WT protein in
terms of total solution turbidity at the plateau value. The lowest concentration at
which WT αA-crystallin shows suppression of aggregation is 0.32mg/ml and the
protein exhibits high chaperone effectiveness at 1mg/ml. Q147E comparatively
164
5.2.2 Chaperone Properties
does not show any significant suppression of aggregation at any concentration
below 1mg/ml. The deamidation of αA-crystallin appears to have no significant
effect on the rate of aggregation of insulin compared to the WT protein.
Similar to the aggregation of insulin, the milk protein α-lactalbumin can be used
as a model of an amorphously aggregating system under reduction stress234.
Figure 5.7 shows the aggregation over time of α-lactalbumin in the presence of
the reducing agent DTT. Both insulin and α-lactalbumin show a similar three-
phase  aggregation  profile  except  that  α-lactalbumin  aggregates  much  more
slowly and has a longer lag phase.
αA-Crystallin  exhibits  highly  efficient  suppression  of  aggregation  of  α-
lactalbumin  compared  to  insulin.  At  low  concentrations,  the  WT  protein  is
capable of reducing both the rate of aggregation during the growth phase and
the total  amount of aggregate at the endpoint. The presence of αA-crystallin
appears to have little effect on the length of the lag phase of  α-lactalbumin
aggregation.  As  with  insulin,  the  deamidated  αA-crystallin  shows  reduced
effectiveness  as  a  chaperone  for  α-lactalbumin.  Where  WT  protein  shows
suppression of aggregation even at the lowest concentrations tested, Q147E
exhibits co-aggregation between the chaperone and its target.  Α-Lactalbumin,
however, shows much less co-aggregation than insulin, most likely as a result of
its  slower  aggregation  rate  and  at  higher  concentrations  the  Q147E shows
similar suppression to the WT protein. This suggests that while the deamidated
chaperone  is  less  effective  than  the  WT  at  preventing  aggregation  in  this
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Figure 5.7: Chemical stress induced aggregation of α-lactalbumin as chaperoned by WT and
Q147E αA-crystallin. Aggregation of 2mg/ml  α-lactalbumin was induced by the reducing agent
DTT at 20mM and 2mM EDTA in 50mM phosphate, 100mM NaCl buffer at pH 7.4 and 37˚C. 
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Figure 5.8: Aggregation of α-lactalbumin as chaperoned by WT and Q147E αA-crystallin. Rate
and endpoint were determined by fitting a sigmoidal curve to the raw light scattering data. Data
presented are the result of three experiments.
α-Lac 0.02 0.05 0.16 0.5
0.00
0.01
0.02
0.03
0.04
0.05
0.06
0.07
Aggregation Rate
WT
Q147E
Chaperone Concentration (mg/ml)
A
gg
re
ga
tio
n 
R
at
e 
(1
/s
)
α-Lac 0.02 0.05 0.16 0.5
0.00
0.05
0.10
0.15
0.20
0.25
0.30
0.35
0.40
0.45
0.50
α-Lactalbumin Aggregation Metrics
Total Light Scattering at Aggregation Endpoint
WT
Q147E
Chaperone Concenetration (mg/ml)
Tu
rb
id
ity
 (3
60
nm
)
5.2.2 Chaperone Properties
system, the protein will still achieve comparable suppression if present in higher
concentrations. 
The metrics of α-lactalbumin aggregation are summarised in Figure  5.8. It  is
apparent that  there is little effective difference between WT and Q147E αA-
crystallin in chaperoning reduced α-lactalbumin. Both chaperone proteins show
the same effective suppression of aggregation at higher concentrations and the
difference between the aggregation curves seen at the lowest concentration is
variable, making the observed difference insignificant. αA-Crystallin in general
shows  high  effectiveness  as  a  chaperone  for  α-lactalbumin,  even  at  low
concentrations. 
As is the case for chemical stress, proteins are susceptible to unfolding and
aggregation as a result of elevated temperature. Alcohol dehydrogenase (ADH)
is a useful model protein for temperature-induced aggregation as it will reliably
unfold  and  aggregate  along  the  amorphous  off-folding  pathway  at  elevated
temperatures in the presence of EDTA, which sequesters the protein's intrinsic
zinc ion and destabilises the protein's structure235.
Figure 5.9 shows the aggregation of ADH over time at 45°C, as monitored by
increase in the solution turbidity. ADH begins aggregating after a lag period of
roughly 40 minutes, after which it aggregates rapidly for two hours followed by
slower aggregation over the course of ~10 hours.
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As was observed with insulin and  α-lactalbumin, the presence of αA-crystallin
suppresses  of  ADH  aggregation.  The  presence  of  chaperone  at  low
concentrations significantly reduces the total solution turbidity at plateau and the
overall rate of aggregation while also increasing the lag phase. The ADH assay
shows none of the co-aggregation observed for the previous assays, likely due
to the significantly slower rate at which it aggregates. At High concentrations,
αA-crystallin achieves full suppression of aggregation during the time period of
this  assay.  The  deamidated  αA-crystallin  had  reduced  effectiveness  when
compared to WT, exhibiting a much shorter aggregation lag phase.
The metrics for ADH aggregation are shown in Figure 5.10. WT and Q147E αA-
crystallin both achieve full suppression of aggregation at concentrations greater
than 0.1mg/ml but show no significant difference in solution turbidity at lower
concentrations. The deamidated chaperone does, however, exhibit significantly
shorter lag phase at these concentrations. These aggregation curves do not fit
well to sigmoidal functions and the aggregation rates derived from the assay
were highly inconsistent and have not been presented.
For comparison with the previously presented amorphous aggregation models,
the  effectiveness  of  WT  and  Q147E  αA-crystallin  in  chaperoning  fibrillar
aggregation was determined. The α-crystallins prevent the formation of fibrillar
aggregates both  in  vivo  and  in  vitro9.  While the aggregates that  cause lens
opacification are generally characterised as amorphous8,  the effectiveness of
this deamidated chaperone could provide insight into the role of α-crystallins as
169
5.2.2 Chaperone Properties
170
Figure  5.9: Heat stress induced aggregation of ADH in the presence of WT and Q147E αA-
crystallin. Aggregation of 0.5mg/ml  ADH was induced by heat stress at 45˚C, in 2mM EDTA,
50mM phosphate, 100mM NaCl buffer at pH 7.4.
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Figure  5.10: Metrics of aggregation of ADH as chaperoned by WT and Q147E αA-crystallin.
Endpoint and midpoint were determined by fitting sigmoidal curve to raw light scattering data.
Metrics are the result of four experiments.
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an  extra-lenticular  molecular  chaperone  in  preventing  intracellular  fibril
formation,  such  as  occurs  in  cases  of  Parkinson's  disease9.  Insulin  has
previously been used as a model for amorphous aggregation but this protein is
also capable of forming fibrillar aggregates at low pH236 and thus was used to
further model chaperone action.
Figure 5.11 shows aggregation curves for insulin fibril formation in the presence
of  αA-crystallin  chaperone.  Fibril  formation was monitored by the  change in
fluorescence  intensity  of  the  amyloidagenic  dye  thioflavin  T  (ThT)9.  ThT  is
capable of binding to the surface of mature fibrils and this association results in
an increase in  fluorescence intensity  at  460nm.  Most  fibrillar  aggregation  is
characterised  by  three  stages9.  First  is  a  lag  phase  where  the  proto-fibular
aggregates act as nucleation sites for fibril growth from. These species do not
bind  ThT and thus no fluorescence is  observed during  this  period.  The lag
phase is followed by a growth phase characterised by fibril  elongation and a
corresponding increase in ThT fluorescence. Once this fibril growth is complete,
the aggregation ends and fluorescence reaches a plateau value. In the case of
insulin aggregation, a one hour lag period was observed, followed by one hour
growth period after which aggregation was complete.
Both  WT  and  Q147E  αA-crystallin  were  effective  chaperones  against  fibril
formation in insulin. Increasing chaperone concentration resulted in a decrease
in both the fluorescence at  plateau,  a  decrease in  aggregation rate and an
increase  in  lag  period.  As  with  amorphous  aggregation  of  insulin  and  α-
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Figure  5.11: Fibrillar aggregation of Insulin as chaperoned by WT and Q147E αA-crystallin.
Experimental conditions were 0.5mg/ml of insulin in pH 2 HCl, 100μM ThT at 60°C.  Aggregation
was monitored by the change in fluorescence of ThT at 440nm excitation and 460nm emission.
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Figure  5.12: Metrics  of  insulin  fibril  aggregation  from curves  in  Figure  5.11.  Metrics  were
determined by fitting sigmoid curves to raw data and are the result of three data sets.
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lactalbumin,  full  suppression  of  fibril  formation  was  not  achieved  at  the
concentrations used.  Both the WT and Q147E show very similar effectiveness
in increasing the lag period of fibril formation with no discernible difference at
concentrations below 0.1 mg/ml and with the Q147E exhibiting slightly better
suppression  at  concentrations  greater  than  0.32  mg/ml.  Likewise,  the  two
chaperones show only small  difference in  total  fluorescence at  their  plateau
values,  again  with  the  Q147E  protein  showing  a  slightly  better  ability  to
suppress aggregation at all concentrations when compared to WT. 
The metrics of insulin fibril formation are shown in Figure 5.12. This shows that
the  observed  difference  betwen  WT and  Q147E in  their  ability  to  suppress
aggregate formation and affect the aggregation lag phase is largely insignificant
due  to  dispersion  within  the  dataset.  When  the  rate  of  fibril  formation  is
compared,  however,  the  two  chaperones  show  a  large  difference  in
effectiveness. Except for the lowest concentrations, Q147E αA-crystallin has a
significantly reduced effect on the rate of fibril formation compared to WT.
Overall,  the  deamidation  of  Gln147  causes  a  slight  reduction  in  chaperone
ability for αA-crystallin. In each model the deamidated chaperone has reduced
performance in at  least  one aggregation metric when compared to WT. The
Q147E protein  remains  capable  of  preventing  aggregation  in  each of  these
model  systems  but  generally  requires  higher  concentrations  to  achieve  the
same effect as WT. Such a loss of function could potentially contribute to lens
opacification as the presence of  these molecular  chaperones is  the primary
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defence the eye has against protein aggregation. Gln147 deamidation may act
cumulatively with other age-related damage and sources of biophysical stress
to increase the overall instability of the lens crystallins.
5.2.3 αA-Crystallin Structure and Stability
The  primary  role  of  αA-crystallin  in  the  lens  is  to  prevent  stress-induced
aggregation of other crystallin proteins. As a protein itself, however, αA-crystallin
will  unfold  and aggregate when exposed to  high temperatures9.  Figure  5.13
shows  thermal  stability  assay  results  for  WT  and  Q147E αA-crystallin,
monitored  by  a  change  in  solution  turbidity  as  a  function  of  temperature.
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Figure 5.13: Thermal stability assays for WT and Q147E αA-crystallin showing the change in
solution turbidity at 360nm as a function of temperature. 0.5mg/ml protein was used in 50mM
phosphate 100mM NaCl pH 7.4 buffer. Temperature was ramped in 1° increments with 2 minute
equilibration at each step.
50 55 60 65 70 75 80 85 90
0
0.02
0.04
0.06
0.08
0.1
0.12
αA-crystallin Thermal Stability
WT
Q147E
Temperature (C)
Tu
rb
id
ity
 (3
60
nm
)
5.2.3 αA-Crystallin Structure and Stability
Intriguingly,  Q147E αA-crystallin  exhibits  significantly  higher  thermal  stability
than the WT,  remaining stable in  solution to  much higher  temperatures and
when aggregating, it forms much less aggregate. Deamidation typically results
in protein destabilisation of affected proteins231, however in the case of Q147E
αA-crystallin we observe an increase in thermal stability which suggests that
this modification does not directly lead to the formation of protein aggregates
despite its correlation with cataract125.
Figure  5.14 shows the CD spectra  for  both WT and Q147E  αA-crystallin  at
neutral pH. Both proteins exhibit the large negative mean residue ellipticity in
the region of 215nm that is characteristic of β-sheet rich secondary structure195,
as is expected due to the presence of the protein's β-sheet rich immunoglobulin
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Figure  5.14: CD spectra  of  WT and Q147E αA-crystallin.  The spectra  were recorded with
0.6mg/ml of protein solution in 25mM phosphate buffer pH 7.4 at 30°C.
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5.2.3 αA-Crystallin Structure and Stability
folded α-crystallin domain10,70. The CD spectra show a slightly smaller ellipticity
minimum in this characteristic region for Q147E αA-crystallin compared to the
WT protein  which  suggests  that  the  protein  loses  some  β-sheet  secondary
structure upon deamidation. This may indicate a disruption in the structure of
the central  α-crystallin domain of the protein. As this region contributes to the
chaperone action  of  the  protein73,  such a  loss  of  structure  may explain  the
slightly  reduced  chaperone  function  observed  in  the  chaperone  assays  for
Q147E αA-crystallin (Figures 5.5, 5.9 and 5.11).
αA-Crystallin contains only one tryptophan residue, Trp9, located near the N-
terminus in the unstructured N-terminal region of the protein4,10.  The intrinsic
tryptophan  fluorescence  of  both  WT and  Q147E  αA-crystallin  are  shown in
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Figure  5.15: Intrinsic tryptophan fluorescence spectra of WT and Q147E αA-crystallin.  The
spectra were recorded with 295nm excitation with 1mg/ml protein solution in 50mM phosphate
100mM NaCl pH 7.4 buffer at 30°C.
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5.2.3 αA-Crystallin Structure and Stability
Figure 5.15.  The strong similarity of these spectra suggests that deamidation at
Gln147 has no effect on the structure in the vicinity of Trp9 and is causing no
change to the environment around Trp9, which is consistent with the distance in
primary sequence between the two residues. 
The α-crystallins form large heterogeneous oligomers of varying numbers of
subunits9,10.  The  large  size  of  these  oligomers  means  that  studying  the  α-
crystallins  via  NMR  spectroscopy  is  problematic.  The  only  region  of  these
proteins that is readily observable in NMR spectra is the highly dynamic and
unstructured C-terminal extension found in both α-crystallin subunits207. In αA-
crystallin, this region consists of the final 12 residues of the C-terminal domain
and  contains  mainly  charged  and  polar  residues  that  are  important  for  the
solubility of the protein92. 1H TOCSY and 1H-13C HSQC NMR spectroscopy was
performed to investigate the effects of  Gln147 deamidation in the C-termianl
extension  of  αA-crystallin.  Figure  5.16 shows  TOCSY spectra  for  WT  and
Q147E αA-crystallin for the NH resonance cross-peaks. Cross-peaks of the 12
residues of the C-terminal extension of αA-crystallin were assigned from these
spectra using characteristic chemical shifts from each amino acid spin system
and by comparison with previously assigned spectra92. Residues from Glu164 to
Ser173 were assigned unambiguously in both the proton and carbon dimension,
except for  Ser169 and Pro167. These two residues could not be definitively
identified but are likely coincident with Ser172 and Pro171 respectively. Glu164
and 165 are likewise highly coincident and could not be distinguished from one
another. Arg163 and Val161 were tentatively assigned based on several cross-
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peaks  but  these  residues
show  a  paucity  of  peaks
compared  to  those  from
amino acids closer to the C-
terminus.
The  TOCSY  NMR  spectra
of  WT  and  Q147E  αA-
crystallin  are  almost
identical,  with  each  cross-
peak  showing  the  same
chemical  shift  and  the
various  cross-peaks
exhibiting  little  variation  in
volume or broadening. The
point of modification, Q147,
is  located  near  the
beginning of the C-terminal
region  of  αA-crystallin,  at
the end of the structured α-
crystallin  domain231.  The
high  similarity  of  these
spectra  indicates  that  the
point  of  deamidation is  too
180
Figure 5.16: 1H TOCSY NMR spectra for WT (●) and Q147E
(●)  αA-crystallin  showing assignments of  each cross-peak
from their  NH resonance. Ser169, Arg163 and Val161 are
assigned tentatively.
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far removed from the C-terminal extension to directly affect its chemical shifts
and that this modification does not alter the flexibility of this region.
αA-Crystallin,  like  other  sHsps,  self  associates  into  large,  highly  dynamic
oligomers  in  solution9,10.  These  oligomers  are  highly  heterogeneous  and
dynamic, and are constantly undergoing subunit exchange. The mass of these
oligomers is variable but is typically between  30 and 40 monomer subunits237
with homo-aggregates of recombinant αA-crystallin exhibiting an average mass
of ~650kDa238. Figure 5.17 shows results of SEC-MALLS experiments for both
WT and Q147E αA-crystallin alongside mass distributions calculated from static
light scattering. The size exclusion chromatogram for both species suggests the
presence of two major species in solution, a species of high mass that elutes at
38ml and a species of lower mass that elutes at 50ml. The low mass species
corresponds the highest refractive index change in both proteins and has the
higher abundance in solution.
The mass distributions of these elution peaks as determined from multi-angle
static light scattering resolve into three components, i.e. minor component of
low abundance that has the approximate mass of αA-crystallin dimer,  a low
mass component with an average mass of ~650kDa that accounts for ~80% of
the protein, and a component of much higher mass and lower abundance. The
majority of αA-crystallin oligomers for both species fit within a broad range of
masses  between  140  and  1160  kDa  which  is  consistent  with  the  highly
heterogeneous and dynamic nature of this protein10. Both the WT and Q147E
181
5.2.3 αA-Crystallin Structure and Stability
182
(c) Minor Component Mean Low Mass Component Mean High Mass Component
WT 36 ±0.7 kDa 650 ±10 kDa 1800 ±40 kDa
Q147E 38 ±0.7 kDa 680 ±10 kDa 2130 ±40 kDa
Figure 5.17: SEC-MALLS experimental results for WT and Q147E αA-crystallin. Results were
obtained using a sepherose 300 gel filltration column with 5mg/ml protein in 50mM phosphate,
100mM NaCl buffer at pH7.4.  (a) Size exclusion chromatogram of protein elution peaks from
light scattering at 90° (LS 90) and differential refractive index (dRI).  (b) Mass distribution from
multi angle static light scattering at 51°, 69.3°, 90°,132.3° and 152.8°, fitted to a first degree
polynomial curve with detail of minor component peak shown to the left. (c) Summary of mass
distribution peaks as mass average for each region and fraction of total protein.
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αA-crystallin also show a smaller proportion of particularly high mass oligomers
that account for 10-15% of protein, but for the Q147E protein this species is of
significantly higher mass than the WT. Figure  5.17(c) summarises the mean
masses of these distributions. This shows that for both the low and high mass
species,  Q147E has  larger  mean  masses  than  the  WT.  For  the  low  mass
species this difference is small but significant, with the Q147E protein showing a
mean  mass  30  kDa  higher  than  the  WT.  Thus,  on  average  each  Q147E
oligomer contains almost the equivalent mass of one extra dimer compared to
the WT protein.
Both WT and Q147E αA-crystallin also show the presence of a very high mass
species  in  solution.  This  species  shows  significantly  higher  mass  for  the
deamidated protein compared to the WT. This high mass oligomer may be a
precursor  to  aggregate formation and the difference in relative mass of  this
species between the two proteins may suggest that the Q147E is more prone to
from aggregate and may be less stable than the WT. 
5.3: Discussion
Gln147 of human αA-crystallin is a site of significant deamidation in eye lenses
as they age125.  The build up of  post-translational  modifications in  the eye is
believed to be the primary cause of the protein destabilisation and aggregation
which causes lens opacification4,7. The prevalence of deamidation at Gln147 in
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αA-crystallin may indicate that this modification plays some causative role in
age-related  cataract  formation.  Previous  studies  of  deamidation  in  lens
crystallins have shown that this modification can cause destabilisation and loss
of structure in proteins220,221,239. In  αA-crystallin, such a change could increase
the  propensity  of  the  protein  to  aggregate  or  cause  a  loss  of  molecular
chaperone function. Either of these effects would increase the risk of aggregate
formation in the lens and could trigger opacification.
The chaperone properties of WT and Q147E αA-crystallin  were investigated
using both amorphous and fibrillar aggregating model systems, with an overall
conclusion that deamidation results in slightly reduced chaperone functionality
compared  to  the  WT  protein.  This  reduced  functionality  is  not  consistent
between model systems as they each show reduced performance in different
metrics.  These  variations  may  be  due  to  differences  in  rate  of  aggregation
between the various models or may indicate that αA-crystallin has a different
mechanism of action in each system. Similar differences in effectiveness have
been observed in αB-crystallin's chaperone action on amorphous and fibrillar α-
lactalbumin  aggregation,  with  the  observed  differences  attributed  to  the
chaperone binding strongly to amorphously aggregating proteins but  forming
weak  transient  interactions  with  fibrillar  aggregates240.  αA-Crystallin  may  be
showing similar behaviour and the difference between the chaperone action of
WT and Q147E for amorphous and fibrillar aggregation may be the result of
changes to  chaperone/target  interaction  upon deamidation.  The reduction  in
chaperone  function  shown  by  Q147E  αA-crystallin  for  insulin  and  ADH
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amorphous  aggregation  is  consistent  with  reduction  in  a  normally  strong
binding,  whereas  with  the  more  weakly  bound  insulin  fibrils  there  is
comparatively less loss of suppression. Despite these differences, the overall
effect of deamidation is a small reduction in the effectiveness of αA-crystallin as
a molecular chaperone. If such a loss of function were to occur in the lens in
large  quantities,  such  as  those  seen  with  age125,  it  would  reduce  the
effectiveness of this natural aggregation prevention mechanism. The quantity of
chaperone in  the lens is finite due to the lack of  protein  turnover  and such
modifications  will  build  up  over  time4.  Even  a  small  loss  of  chaperone
functionality in such an environment has the potential  to combine with other
age-related damage to  increase the chance of aggregate formation. Such a
situation would almost inevitability lead to loss of vision over time due to the
formation of aggregates causing lens opacification.
As with most proteins, the structure of αA-crystallin is vital for its function48. The
chaperone action of αA-crystallin is dependent on the immunoglobulin fold of its
central  structured  α-crystallin  domain9,10.  CD spectra of  WT and Q147E αA-
crystallin suggests that this central region of the protein undergoes a slight loss
of secondary structure upon deamidation (Figure 5.14). This a loss of structure
could be the cause of the reduced chaperone function shown by the protein
upon deamidation and may explain the correlation of Q147E αA-crystallin with
age.  The  central  structured  domain  of  αA-crystallin  is  flanked  by  two
unstructured  regions  that  influence  its  solubility,  stability  and  oligomer
formation9,10,70.  The α-crystallins form large oligomeric species of between 30
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and 40 subunits  that  undergo rapid subunit  exchange as part  of  a dynamic
equilibrium70,71,237.  The  large  size  of  these  oligomers  and  their  dynamic,
heterogeneous nature mean that the structure of these proteins is difficult  to
study  with  either  crystallography  or  NMR spectroscopy.  No crystal  structure
exists for the full sequence of either α-crystallin and the oligomers are too large
for conventional solution NMR studies70,189. 
The exception to this for NMR is the protein's C-terminal extension, i.e. residues
164-173 in αA-crystallin, which exhibits highly dynamic flexibility in solution92,207.
Figure 5.16 shows 1H-TOCSY spectra for both WT and Q147E αA-crystallin in
the  NH  cross-peak  region. The  cross-peaks  in  the  two  spectra  exhibit
substantial  overlap  in  this  region,  implying  that  the  C-terminal  extension
experiences  no  difference  in  structure  or  chemical  environment  upon
deamidation of the protein. Gln147 of αA-crystallin is located at the beginning of
the  protein's  unstructured  C-terminal  region  and  appears  to  be  far  enough
removed from the start of the dynamic C-terminal extension at residue 164 to
have no direct influence on the chemical environment of this region. The N-
terminal domain of αA-crystallin is likewise mostly unstructured10,92. This region
contains the sole tryptophan reside of the protein, located near the N-terminus
at residue 9. Intrinsic tryptophan fluorescence spectra for WT and Q147E αA-
crystallin (Figure 5.15) show no difference between the two proteins, suggesting
that deamidation has no effect on the structure or mobility of N-terminal region.
It is concluded that the unstructured flanking regions of the protein are largely
unaffected by deamidation at Gln147.
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One notable difference exhibited by αA-crystallin upon deamidation is a large
increase in the protein's thermal stability. Figure  5.13 shows that Q147E αA-
crystallin requires a much higher temperature to unfold and aggregate than the
WT protein and upon aggregation it forms much smaller quantities of aggregate.
The cause of this increase in thermal stability is not readily apparent. The point
of deamidation is located close to the end of the protein's structured α-crystallin
domain, but we would expect any disruption to the structure of the protein in this
region to decrease stability rather than increasing it. The dynamic C-terminal
extension of the α-crystallins has been implicated in the protein's solubility9,92,
however the NMR results show no additional cross-peaks or difference in cross-
peak intensity that might indicate a change in the dynamic movement of this
region.
One possible explanation for this change in thermal stability is the additional
charge  associated  with  deamidation  having  an  effect  analogous  to  proteins
found  in  extremophile  organisms.  Organisms  that  live  in  environments  of
extreme temperature, like those around deep sea vents, express proteins that
are highly resistant  to  aggregation under thermal stress241.  Proteins such as
these tend to  have high surface charge and exhibit  much greater  hydrogen
bond formation propensity and a much larger number of ion pairings than other
proteins241.  It  may be the case that  the increase the surface charge of  αA-
crystallin after deamidation mimics these proteins and increases the tolerance
of the protein to high temperatures. In doing so this may also interfere with the
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protein's ability to bind to its target proteins, thus decreasing chaperone activity.
Deamidated  αA-crystallin  exhibits  a  slightly  larger  average  oligomer  size  in
solution compared to the WT protein. The size of α-crystallin oligomers is highly
variable, typically composed of 30-40 subunits9,237. The results of SEC-MALLS
experiments shown in Figure 5.17 fall within this range, reporting a mean mass
of 650 kDa for the WT protein which corresponds to ~32 monomer subunits.
Notably, the Q147E αA-crystallin exhibits a slightly larger mean oligomer mass
of 680 kDa or ~34 subunits, suggesting that oligomers of deamidated protein
are on average one dimer larger than WT. It has previously been proposed that
the association and dissociation of α-crystallin dimers from their oligomer state
act as a control for chaperone function and that under situations of high stress
the protein will favour the dimer form70,71. The mass distribution shown in Figure
5.17(b) shows proportionately less dimeric component for the Q147E protein
compared  to  the  WT  and  suggests  that  deamidation  is  causing  sub-unit
exchange to favour oligomer over dimer in solution. Such a change in solution
equilibrium of the protein could result in both an increase in thermal stability, as
oligomer formation can often result in an increase in protein stability242, and a
decrease in chaperone function due to a lower concentration of the chaperone-
active  dimer  species.  The  combination  of  lower  concentrations  of  active
chaperone  with  the  slight  loss  of  secondary  structure  observed  via  CD
spectroscopy may explain both the slight loss of chaperone function and the
increased thermal stability shown by the deamidated protein.
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No experimentally determined structure exists for human αA-crystallin, but an x-
ray crystal structure has been generated for truncated bovine αA-crystallin71 and
both a crystal structure and an NMR derived structure exist for truncated human
αB-crystallin70,71 (Figure  5.18).  These  proteins  share  the  immunoglobulin
structured  central  domain  of  human  αA-crystallin  but  both  also  possess
differences in  their  sequences.  The length of  the C-terminal  region of  these
proteins  is  longer  in  human  αB-crystallin  and  bovine  αA-crystallin  lacks  an
equivalent  site  of  deamidation,  instead  containing  Pro147  at  the  same
location10,71. The α-crystallin domain of these proteins terminates at  β-strand 9
with Pro144 in bovine  αA-crystallin and Pro148 in  human  αB-crystallin.  This
region is close to β-strands 3,4 and 8 but remote for the dimerisation interface
at  β-strands 6 and 770,71. It is therefore unlikely that deamidation at Gln147 is
having a significant effect on αA-crystallin dimer formation. 
The α-crystallins form highly heterogeneous oligomers that undergo constant
dimer subunit  exchange9,10.  These dimeric subunits form from anti-parallel  β-
sheet associations between the 6th and 7th β-strand of the structured domain of
each monomer70.  These dimeric subunits  go on to self  associate into highly
heterogeneous,  polydisperse  oligomers  that  are  characteristic  of  sHsps.
Oligomer formation is heavily influenced by the binding of the 'IXI' motif, located
in the C-terminal  region of  the protein,  to  a hydrophobic pocket  between β-
strands  4  and  8  of  the  structured  domain70,71.  The  shape  of  this  pocked  is
influenced by pH and shows much lower binding affinity under conditions similar
to  those of  cells  under  stress70.  This  variation is  believed to  function  as an
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activation  mechanism  that  increases  the  solution  concentration  of  the
chaperone-active  dimeric  species  under  high  stress  conditions70,73.  Crystal
structures of  truncated bovine αA-crystallin and human αB-crystallin suggest
that dimers assemble into oligomers via a combination of this binding and the
formation  of  an  association  interface  at  the  flexible  loop  region  between  β-
strands 7 and 8 of the structured region71. This loop contains a large quantity or
polar residues and a single charged Asp species that may form interactions with
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Figure  5.18: Structure  of  truncated  αB-crystallin  core  domain  dimer  and  its  intermolecular
interactions  (PDB  2KLR)70.  Ribbon  representation  of  the  lowest-energy  solid-state  NMR
structure of the αB-crystallin dimer (shown in red and blue) and its intermolecular interactions
with N- and C-terminal regions of other protomers (shown in gray, labeled C-ter and β2a).
5.3: Discussion
one another.
Gln147 is  relatively  remote  from the  dimer  interface at  β-strand 7  and it  is
unlikely that deamidation at this location will  have any direct effect on dimer
formation.  The  site  of  modification  is,  however,  close  in  space  to  both  the
hydrophobic binding pocket that regulates dimer subunit binding and the loop
region that can act as an interface for oligomer formation70,71. It is possible that
Gln147 deamidation is causing a change in the structure or interactions of these
regions. If deamidation were causing an increase in binding strength of the 'IXI'
binding pocket this would be expected to reduce oligomer subunit exchange
and  may  result  both  in  increase  in  oligomer  size  and  a  reduction  in  the
concentration of chaperone active dimers in solution. Such a reduced dimer
concentration could account for the loss of chaperone function exhibited by the
deamidated proteins and an increased oligomer size may be the cause of the
protein's increased thermal stability. The proximity of the site of deamidation to
the  flexible  loop  region  that  forms  an  inter-subunit  interface  may  also  be
influencing oligomer assembly. This loop contains may polar resides that may
be capable of forming an interaction with the negatively charged glutamic acid
deamidation  product  and  could  be  increasing  inter-subunit  interactions.  Any
such increase in interaction in this region has the potential to encourage dimer
subunits to form oligomers and may be responsible for the observed increase in
oligomer size.
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The  α-crystallins  are  in  general  highly  tolerant  of  damage,  maintaining
chaperone  activity  even  after  extensive  mutations  and  post-translational
modifications108. There are many sites in αA-crystallin other than Gln147 that
are subject to deamidation over time, to the extent that most glutamine and
asparagine  residues  in  the  protein  show  some  deamidation  with  age45,125.
Notable  examples  are  Glu90  and  Glu104,  which  show  23%  and  17%
deamidation respectively  in  lenses over  50 years of  age108.  Asn101 likewise
shows extensive deamidation, but this modification is common in young lenses
as well as old104. Many of these sites of deamidation have not been extensively
characterised and their relationship to cataract formation is unclear. However,
there  are  several  characterisation  studies  on  these  modifications  in  the
literature243–245. 
αB-Crystallin shows deamidation at Asn146, located at the end of the structured
α-crystallin domain in a similar position to Gln147 in αA-crystallin245. This N146D
deamidation causes a significant loss of chaperone activity in αB-crystallin and
the protein exhibits a change in the structure that exposes hydrophobic residues
to solvent239. 
Deamidation  of  Asn101  in  αA-crystallin  has  been found  to  cause  increased
opacity in the lens cortical region of transgenic mice243. The presence of N101D
αA-crystallin causes increased tendency for aggregate formation  in  vivo and
affected  lenses  contained  a  much  larger  portion  of  water  insoluble  protein.
Notably however, the expression of deamidated protein caused morphological
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differences in the lens, with epithelial cells showing increased proliferation and
decreased differentiation and fibre cells showing slower denucleation244.  This
result therefore may not be relevant to age-related cataract formation. 
There are many examples of modifications causing loss of chaperone function
in α-crystallins143,144,211, but Q147E αA-crystallin appears to cause an increase in
oligomer  formation  and  the  corresponding  increase  in  thermal  stability.  An
increase in oligomer size and improved thermal stability upon deamidation was
also observed in N76D γS-crystallin, as discussed in Chapter 4. This increase in
stability  through  the  formation  of  larger  oligomers  may  be  a  deliberate
adaptation in both proteins to reduce any negative effects of deamidation on the
structure and clarity of the lens. This may be a general mechanism that occurs
with proteins commonly subject to age-related deamidation. It leads to a greater
stability, which is useful for the longevity of the protein. In the lens, this property,
coupled with only a small reduction in chaperone ability of Q147E αA-crystallin,
is advantageous for the stability and longevity of the organ.  
5.4: Conclusion
Overall,  the  deamidation  of  Gln147  in  human  αA-crystallin  causes  a  slight
reduction in the protein's ability to act as a molecular chaperone. As prevention
of protein aggregation is the primary function of the α-crystallins in the lens, we
would expect this loss of function to have a detrimental effect on lens stability.
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The Q147E modification is present in increasing quantities with age in lenses
and is highly correlated with age-related cataract formation125. As the lens ages,
the crystallins are subject to a wide variety of modifications and may of these
are  detrimental  to  their  stability  or  function8,46.  The  absence  of  significant
metabolic activity in the lens fibre cells means that these modifications can not
be repaired and damaged or aggregated protein is not replaced5,9.  Thus, the
loss of functions caused by Gln147 deamidation would likely have an additive
effect with other age-related damage, combining to reduce the lifetime of the
lens and increase the risk of opacification, cataract and potentially blindness.
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Chapter 6: Summary and Conclusions
This  thesis  has  detailed  several  studies  in  which  specific  crystallin  protein
modifications  that  are  common  in  aged  eye  lenses  were  characterised
biophysically and spectroscopically. There are several overall themes that are
the result of these investigations.
A  general  property  shown  by  these  proteins  when  subject  to  age-related
modification  is  destabilisation.  The  peptide  fragment  αA-crystallin  57-65
contains  a  site  of  age-related  modification  at  Asp58184.  This  location  is
vulnerable to isomerisation along the cyclic succinimide pathway that can form
both L- and D-isomers of aspartic and isoaspartic acid, with the presence of
these  isomers  being  common  in  aged  lenses115,127.  This  peptide  exhibits  a
general destabilisation of structure and increased disorder upon isomerisation,
the greatest effect of which is shown by the D-isoAsp containing peptide. Asn76
in γS-crystallin is likewise prone to modification via cyclic succinimide formation
and instances of N76D γS-crystallin are common in cataractous lenses102. This
modification causes a general destabilisation in the protein, resulting in rapid
aggregation under heat stress and increased vulnerability to unfolding in the
presence  of  denaturant.  Similarly,  deamidation  at  Gln147  in  αA-crystallin  is
possible via this same pathway and is also common in aged and cataractous
lenses125.  In  αA-crystallin,  this  modification  results  in  both  a  small  loss  of
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structure, as determined by CD spectroscopy, and a reduction in the protein's
chaperone  function.  These  results  overall  suggest  that  age-related  post-
translational  modifications  have  a  detrimental  effect  on  eye  lens  proteins,
damaging their function and destabilising their structure. Such damage could
cause  protein  unfolding  and  aggregation,  which  may  contribute  to  lens
opacification and cataract.
Age-related deamidation also affects the oligomeric structure of the crystallins.
γS-Crystallin exhibits an increased propensity to form dimer upon deamidation
at Asn76 compared to the WT protein, with results from SEC-MALLS and AUC
experiments  showing  38-51%  of  the  modified  protein  as  dimer  in  solution.
Likewise,  Q147E  αA-crystallin  forms  larger  oligomers  than  the  WT protein,
showing  a  mean  oligomer  mass  ~30kDa  larger,  suggesting  an  average  of
approximately  one  more  dimer  per  oligomer.  In  both  of  these  proteins,  the
increased tendency to form oligomers is matched with an increase in thermal
stability that renders the protein resistant to large-scale aggregation upon this
stress. Deamidation is one of the most common post-translational modifications
in long-lived proteins and often results a reduction in stability107,108.The increase
in oligomer formation exhibited by αA- and γS-crystallin upon deamidation may
be  a  deliberate  adaptation  made  by  these  proteins  to  prevent  large-scale
aggregation  under  stress.  Long-lived proteins have evolved to  be extremely
stable  over  their  lifetime  and  it  would  be  expected  for  them  to  evolve  a
mechanism for counteracting common destabilising modifications. An increase
in oligomerisation and a corresponding increase in thermal stability may be a
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common occurrence in long lived proteins in response to deamidation. Such an
adaptation would reduce aggregation and increase protein lifespan.
These  changes  to  protein  oligomerisation  upon  deamidation  suggests  a
possible future research direction. There are several sites of deamidation in the
crystallins that have yet to be extensively characterised, such as γD-crystallin
Asn137 and γS-crystallin Asn143125. In light of the increase in protein oligomer
size and thermal stability shown by N76D γS-crystallin and Q147E αA-crystallin,
it would be prudent to determine if other similarly deamidated proteins exhibit
the same tendency to form oligomers.  It has recently been shown that doubly
deamidated γS-crystallin (Asn76/Asn143 and Gln92/Gln120) has a significantly
decreased mutual protein repulsion and an increased tendency to form high-
mass species while maintaining its native two-domain structure223.  This effect
may be the mechanism for the dimer formation exhibited by N76D γS-crystallin
could be a general feature of deamidated proteins. There are several examples
in the literature of deamidation promoting the formation of high-mass species in
proteins105,220,243,246. Such oligomerisation is typically attributed the formation of
aggregation  precursors,  but  extensive  characterisation  of  these  high-mass
species is not often performed, which may be warranted in light of the results of
this thesis.
Each  of  the  various  age-related  peptides  and  proteins  characterised  in  this
thesis have little potential to cause lens opacification in isolation. The truncation
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peptides of βA3- and γS-crystallin may be capable of binding to lens fibre cell
membranes,  leading  to  lysis  and  damage  to  the  lens.  These  peptides  are,
however, the product of age-related truncation and in a young or healthy lens
there would be little such cleavage, meaning these peptides are unlikely to be
present.  Likewise,  deamidated  γS-crystallin  shows reduced  stability  and  will
aggregate  rapidly  under  stress,  but  the  deamidation  also  causes  increased
dimer formation which counteracts this instability. In a healthy lens, the stability
of  the  dimer  would  likely  entirely  counteract  the  instability  caused  by
deamidation  and the  modification  would  not  result  in  protein  aggregation  or
precipitation.  Similarly,  deamidated  αA-crystallin  exhibits  a  reduction  in
chaperone capability that could lead to ineffective prevention of aggregation in
other damaged proteins. However, this loss of function is unlikely to have an
effect on young, healthy lenses where there is little damaged protein present. 
In each case, these modifications have little potential to cause lens opacification
in isolation. They are either the result of previous damage, like the truncation
peptides, or would require the presence of other sources of stress to affect lens
clarity.  As  such,  each  of  these  modifications  likely  acts  combinatorially  with
other forms of age-related damage to cause crystallin protein aggregation. It is
possible that cataract formation is, in general, the result of many such small
sources of damage acting additively to trigger protein instability, rather than the
result of a single major destabilising modification. 
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Overall, the build up of these and other modifications in the lens over time is
likely to destabilise the crystallins resulting in protein unfolding and aggregation.
Such protein aggregates cause light scattering and are the primary reason for
lens opacification and cataract formation.
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The following publications are based on work presented in this thesis:
1. Deamidation of N76 in human γS-crystallin promotes dimer formation
 NJ Ray, D Hall, JA Carver - Biochimica et Biophysica Acta (BBA)-General, 2016 
2. Biophysical chemistry of the ageing eye lens
NJ Ray - Biophysical Reviews, 2015
Appendix 2: NMR Assignments
γS Crystallin 167-178
Chemical shift assignments for  1H and 13C resonances of γS Crystallin 167-179. Resonances
marked with asterisks consist of multiple magnetically equivalent nuclei.
γS Crystallin 167-179 Chemical Shift Assignments
NH αH αC
167 Ser - 4.09 66.78 3.62:Hba 3.66:Hbb 168.63:C 64.63:Cb
168 Pro - 4.49 63.42 1.96:Hba  2.37:Hbb  2.04:Hga  2.11:Hgb  3.73:Hda  3.73:Hdb
178.32:C 30.80:Cb 26.21:Cg 49.75:Cd
169 Ala 7.85 4.3 52.78 1.42:Hb* 175.70:C 17.26:Cb
170 Val 7.49 3.91 63.28 2.13:Hb 0.90:Hga* 1.01:Hgb* 177.50:C 31.45:Cb 19.27:Cga
19.67:Cgb
171 Gln 8.12 4.21 56.81 1.44:Hba 2.05:Hbb 2.12:Hga 2.41:Hgb 6.38:He2a 7.12:He2b
176.04:C 27.69:Cb 32.88:Cg 179.11:Cd
172 Ser 7.9 4.29 59.04 3.84:Hba 3.92:Hbb 176.13:C
173 Phe 7.78 4.49 58.47 3.18:Hba  3.18:Hbb  7.23:Hd*  7.29:He*  7.23:Hz  174.16:C
38.12:Cb 137.79:Cg 130.64:Cd* 130.47:Ce* 129.00:Cz
174 Arg 7.84 4.16 56.38 1.83:Hba  1.88:Hbb  1.65:Hga  1.66:Hgb  3.18:Hda  3.18:Hdb
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7.02:He 175.56:C 29.62:Cb 26.30:Cg 42.34:Cd
175 Arg 7.69 4.29 55.96 1.85:Hba  1.92:Hbb  1.69:Hga  1.69:Hgb  3.20:Hda  3.20:Hdb
7.06:He 175.39:C 29.67:Cb 26.34:Cg 42.34:Cd
176 Ile 7.66 4.12 61.51 1.91:Hb  1.20:Hg1a  1.56:Hg1b  0.92:Hg2*  0.88:Hd1*
175.44:C 38.13:Cb 26.74:Cg1 16.06:Cg2 11.34:Cd1
177 Val 7.49 4.13 61.6 1.01:Hb 0.91:Hga* 2.06:Hgb* 175.13:C 31.99:Cb 19.35:Cga
178 Glu 7.75 4.43 53.91 2.05:Hba  2.22:Hbb  2.46:Hga  2.46:Hgb  174.84:C  27.75:Cb
31.68:Cg 178.51:Cd
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βA3 Crystallin 200-215
Chemical shift assignments for 1H and 13C resonances of βA3 crystallin 199-215. Resonances
marked with asterisks consist of multiple magnetically equivalent nuclei.
βA3 Crystallin 199-215 Chemical Shift Assignments
NH αH αC
200 Ser - 4.26 56.55 3.31:Hba 3.33:Hbb 62.44:Cb
201 His - 4.71 56.38 3.31:Hba  3.33:Hbb  7.32:Hd2  8.47:He1  27.49:Cb  130.37:Cg
119.42:Cd2 135.30:Ce1
202 Ala 8.31 4.21 53.75 1.42:Hb* 177.83:C 17.20:Cb
203 Gln 7.98 4.28 57.55 2.18:Hba  2.18:Hbb  2.42:Hga  2.48:Hgb  27.98:Cb  33.15:Cg
179.60:Cd
204 Thr 7.91 4.1 64.27 4.28:Hb 1.28:Hg1 1.28:Hg2* 68.32:Cb 20.86:Cg2
205 Ser 8.06 4.31 60.37 3.93:Hba 3.98:Hbb 62.26:Cb
206 Gln 8.04 4.19 57.88 2.23:Hba 2.23:Hbb 2.40:Hga 2.46:Hgb 27.97:Cb 33.01:Cg
207 Ile 7.96 3.85 63.56 1.96:Hb 1.26:Hg1a 1.66:Hg1b 0.96:Hg2* 0.88:Hd1* 37.09:Cb
30.75:Cg1 16.01:Cg2 11.56:Cd1
208 Gln 8.15 4.08 58.06 2.16:Hba 2.20:Hbb 2.42:Hga 2.53:Hgb 28.30:Cb 33.01:Cg
209 Ser 7.86 4.27 60.87 3.96:Hba 4.14:Hbb 62.34:Cb
210 Ile 7.85 3.92 63.26 1.99:Hb 1.23:Hg1a 1.72:Hg1b 0.95:Hg2* 0.88:Hd1* 37.48:Cb
27.79:Cg1 16.01:Cg2 11.56:Cd1
211 Arg 8.07 4.17 57.38 1.80:Hba  1.93:Hbb  1.71:Hga  1.71:Hgb  3.17:Hda  3.21:Hdb
7.01:He 29.07:Cb 27.78:Cg
212 Arg 7.79 4.2 57.05 1.78:Hba  1.98:Hbb  1.72:Hga  1.72:Hgb  3.22:Hda  3.22:Hdb
7.09:He 29.32:Cb 26.46:Cg
213 Ile 7.73 4.1 62.04 2.01:Hb 1.27:Hg1a 0.97:Hg2* 0.89:Hd1* 37.79:Cb 27.74:Cg1
16.01:Cg2 11.56:Cd1
214 Gln 7.87 4.3 55.55 2.09:Hba  2.10:Hbb  2.38:Hga  2.50:Hgb  28.42:Cb  33.11:Cg
179.58:Cd
215 Gln 7.87 4.37 54.33 2.10:Hba 2.24:Hbb 2.42:Hga 2.42:Hgb 28.42:Cb 179.60:Cd
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αA-Crystallin 57-65 isomer peptides
Chemical  shift  assignments  for  αA-crystallin  57-65  peptides  with  isomerisation  at  Asp  58.
Chemical shifts are in units of ppm with reference to water at 4.81ppm. Resonances marked
with asterisks consist of multiple magnetically equivalent nuclei.
 L-Aspartic Acid Peptide: Chemical Shift Assignments
NH αCH Other
57 Leu - 4.06 1.74:Hba 1.77:Hbb 1.69:Hg 0.98:Hda* 0.98:Hdb*
58 Asp 8.95 - 2.84:Hba 2.97:Hbb
59 Ser 8.5 4.48 3.91:Hba 3.95:Hbb
60 Gly 8.46 4.01*
61 Ile 7.98 4.26 1.91:Hb 1.21:Hg1a 1.47:Hg1b 0.90:Hg2* 0.94:Hg2*
62 Ser 8.41 4.49 3.88:Hba
63 Glu 8.38 4.46 1.99:Hba 2.15:Hbb 2.47:Hga
64 Val 8.2 4.11 2.09:Hb 0.98:Hga*
65 Arg 8.3 4.36 1.79:Hba 1.94:Hbb 1.65:Hga 3.23:Hda 3.24:Hdb 7.21:He
L-Isoaspartic Acid Peptide: Chemical Shift Assignment
NH αCH Other
57 Leu - 4.03 1.73:Hba 1.78:Hbb 1.72:Hg 0.97:Hda*
58 Asi 8.65 - 2.86:Hba 2.96:Hbb
59 Ser 8.52 4.44 3.90:Hba 3.91:Hbb
60 Gly 8.54 4.00*
61 Ile 7.96 4.24 1.89:Hb 1.18:Hg1a 1.45:Hg1b 0.90:Hg2*
62 Ser 8.41 4.47 3.87:Hba 3.87:Hbb
63 Glu 8.35 4.44 1.97:Hba 1.97:Hbb 2.13:Hga 2.46:Hgb
64 Val 8.18 4.09 2.07:Hb 0.96:Hga* 0.96:Hgb*
65 Arg 8.3 4.35 1.77:Hba 1.92:Hbb 1.64:Hga 1.64:Hgb 3.22:Hda 3.22:Hdb 7.19:He
D-Aspartic Acid Peptide: Chemical Shift Assignments
NH αCH Other
57 Leu - 4.06 1.72:Hba 1.72:Hbb 1.64:Hg 0.95:Hda* 0.95:Hdb*
58 D-Asi 9.01 - 2.84:Hba 2.95:Hbb
59 Ser 8.51 4.48 3.91:Hba 3.91:Hbb
60 Gly 8.46 3.99*
61 Ile 8.02 4.23 1.88:Hb 1.18:Hg1a 1.45:Hg1b 0.92:Hg2* 0.90:Hd1*
62 Ser 8.4 4.47 3.85:Hba 3.85:Hbb
63 Glu 8.36 4.43 1.96:Hba 2.12:Hbb 2.45:Hga 2.45:Hgb
64 Val 8.18 4.09 2.06:Hb 0.95:Hga* 0.95:Hgb*
65 Arg 8.31 4.33 1.76:Hba 1.92:Hbb 1.62:Hga 1.63:Hgb 3.21:Hda 3.21:Hdb 7.18:He
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D-Isoaspartic Acid Peptide: Chemical Shift Assignments
NH αCH Other
57 Leu - 4.04 1.70:Hba 1.71:Hbb 1.61:Hg 0.94:Hda* 0.94:Hdb*
58 d-Asp 8.72 - 2.83:Hba 2.98:Hbb
59 Ser 8.44 4.48 3.89:Hba 3.89:Hbb
60 Gly 8.55 4.01*
61 Ile 8.03 4.25 1.90:Hb 1.19:Hg1a 1.46:Hg1b 0.90:Hg2* 0.92:Hd1*
62 Ser 8.4 4.48 3.87:Hba 3.87:Hbb
63 Glu 8.37 4.45 1.98:Hba 2.14:Hbb 2.47:Hga 2.47:Hgb
64 Val 8.19 4.11 2.08:Hb 0.97:Hga* 0.97:Hgb*
65 Arg 8.34 4.36 1.78:Hba 1.93:Hbb 1.65:Hga 1.65:Hgb 3.23:Hda 3.23:Hdb 7.20:He
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WT and N76D γS-Crystallin
Chemical shift assignments for backbone resonances for both WT and N76D γS-Crystallin from
15N-1H HSQC and TOCSY NMR experiments performed in 20mM phosphate buffer at pH 6.0
and 22.5°C, referenced to residual water peak as 4.81ppm.
γS-Crystallin WT γS-Crystallin N76D
NH N αCH NH N αCH
3 Lys 8.68 123.91 4.82 3 Lys 8.68 123.84 4.46
4 Thr 8.32 114.82 4.3 4 Thr 8.31 114.87 4.34
5 Gly 8.38 111.24 4.80 5 Gly 8.38 111.19 4.41
6 Thr 8.1 114.18 4.48 6 Thr 8.11 114.17 4.51
7 Lys 8.63 125.04 - 7 Lys 8.62 125.34 -
8 Ile 8.4 124.43 - 8 Ile 8.43 124.82 -
9 Thr 8.29 121.9 - 9 Thr 8.33 122.11 -
10 Phe 8.68 125.37 - 10 Phe 8.72 125.32 -
11 Tyr 9.01 117.71 5.5 11 Tyr 9.01 117.82 5.46
12 Glu 9.19 120.78 4.7 12 Glu 9.2 120.81 4.7
13 Asp 8.12 114.96 5.4 13 Asp 8.11 115.01 5.39
14 Lys 8.58 118 3.87 14 Lys 8.6 118.06 3.87
15 Asn 9.16 112.85 3.17 15 Asn 9.15 112.91 4.7
16 Phe 8.03 112.35 4.22 16 Phe 8.05 112.29 4.22
17 Gln 6.25 116.59 4.64 17 Gln 6.27 116.62 4.65
18 Gly 8.51 105.32 4.17 18 Gly 8.37 - 3.8
19 Arg 8.47 119.24 4.22 19 Arg 8.48 119.48 4.21
20 Arg 8.12 117.54 5.79 20 Arg 8.14 117.63 5.77
21 Tyr 8.94 123.02 - 21 Tyr 8.95 123.02 -
22 Asp 7.46 126.46 5.09 22 Asp 7.41 126.28 -
23 Cys 8.76 118.54 - 23 Cys 8.8 118.71 -
24 Asp 8.49 123.23 5.14 25 Cys 8.35 115.94 -
29 Asp 7.65 113.1 - 29 Asp 7.66 113.1 -
30 Phe 8.64 123.92 - 30 Phe 8.65 123.9 -
31 His 8.81 122.73 - 31 His 8.86 122.73 -
32 Thr 7.73 109.94 3.75 32 Thr 7.69 110.1 3.75
33 Tyr 7.31 119.9 4.44 33 Tyr 7.29 120.28 4.46
34 Leu 7.36 118.29 4.68 34 Leu 7.44 118.73 4.67
35 Ser 9.58 120.33 4.52 35 Ser 9.49 120.37 -
36 Arg 7.97 117.44 4.8 36 Arg 7.97 117.6 -
37 Cys 9.76 117.7 - 37 Cys 9.87 117.85 -
38 Asn 8.48 121.52 5.3 38 Asn - - 5.31
39 Ser 8.38 108.68 - 39 Ser 8.42 108.96 -
40 Ile 9.04 118.35 5.34 40 Ile 9.05 118.72 -
41 Lys 9.05 125.28 4.98 41 Lys 9.09 125.29 -
42 Val 9.32 126.02 - 42 Val 9.3 126.04 -
43 Glu 8.45 128.47 4.42 43 Glu 8.49 128.39 -
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46 Thr 8.13 113.74 4.88 44 Gly 8.45 - 4.1
47 Trp 8.66 127.04 - 46 Thr 8.15 113.67 -
51 Glu 9.58 123.92 - 47 Trp 8.67 126.92 -
52 Arg 8.26 114.39 - 51 Glu 9.57 124.08 -
54 Asn - - - 52 Arg 8.23 114.33 -
55 Phe 7.38 111.96 6 54 Asn - - -
56 Ala 6.33 121.38 4.92 55 Phe 7.39 112.11 -
57 Gly 8.43 105.38 - 56 Ala 6.33 121.24 4.91
58 Tyr 8.33 121.14 4.23 57 Gly 8.42 105.49 -
61 Ile 8.15 122.45 5.12 58 Tyr 8.34 121.48 4.23
62 Leu 9.63 131.94 - 61 Ile 8.16 122.61 -
64 Gln 8.61 120.61 - 62 Leu 9.64 132 -
65 Gly 8.57 111.61 - 64 Gln 8.54 120.69 3.98
66 Glu 8.31 117.18 - 65 Gly 8.59 111.66 -
67 Tyr 9.26 118.8 - 66 Glu 8.33 117.34 -
69 Glu 6.93 112.39 5.4 67 Tyr 9.27 118.7 -
71 Gln 8.49 123.37 4.45 69 Glu 6.94 112.46 5.36
72 Arg 8.03 117.34 4.39 71 Gln 8.5 123.36 4.45
73 Trp 7.27 116.37 5.31 72 Arg 8.03 117.23 4.39
74 Met 7.64 112.99 4.02 73 Trp 7.3 116.43 5.32
75 Gly 7.52 105.33 - 74 Met 7.64 113.11 4.03
76 Leu 7.61 121.16 4.32 75 Gly 7.5 105.68 -
77 Asn 7.34 111.91 3.64 76 Leu 7.57 121.13 4.23
78 Asp 7.73 114.45 4.61 77 Asp 8.87 122.38 4.48
79 Arg 7.85 118.96 4.68 78 Asp 7.71 114 -
80 Leu 7.1 122.49 4.98 79 Arg 8.06 119.91 -
81 Ser 8.57 108.87 - 80 Leu 7.01 122.15 -
82 Ser 7.6 109.68 4.66 81 Ser 8.61 108.92 -
84 Arg - - - 82 Ser 7.63 109.81 -
85 Ala 8.12 127.86 - 84 Arg - - -
87 His 8.64 126.1 4.67 85 Ala 8.14 127.52 -
88 Leu 8.66 126.62 4.56 87 His 8.66 126 4.68
90 Ser 8.71 117.91 4.38 88 Leu 8.65 126.52 4.56
91 Gly 8.64 111.28 4.17 90 Ser 8.7 117.73 4.38
92 Gly 8.04 107.33 3.95 91 Gly 8.63 111.24 4.15
93 Gln 7.85 118.17 4.5 92 Gly 8.05 107.38 3.97
94 Tyr 8.34 118.75 - 93 Gln 7.84 118.1 4.5
96 Ile 9.04 128.71 - 94 Tyr 8.34 118.8 -
97 Gln - - - 96 Ile 9.03 128.79 -
99 Phe 8.08 117.25 5.5 97 Gln - - -
101 Lys 7.85 112.68 4.51 99 Phe 8.08 117.26 5.49
102 Gly 8.61 106.52 - 100 Glu 8.91 121.2 -
104 Phe 7.91 111.38 - 101 Lys 7.86 112.92 4.5
105 Ser 6.49 113.47 4.9 102 Gly 8.61 106.55 -
106 Gly 8.35 106.02 - 104 Phe 7.92 111.38 -
107 Gln 8.8 120.61 - 105 Ser 6.49 113.44 4.91
108 Met 7.71 124.46 4.97 106 Gly 8.37 106.1 -
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109 Tyr 8.23 122.22 4.6 107 Gln 8.79 120.58 -
110 Glu 8.78 122.94 5.46 108 Met 7.72 124.56 4.97
111 Thr 8.89 118.2 5.25 109 Tyr 8.23 122.23 4.6
112 Thr 8.16 114.92 5.19 110 Glu 8.8 123 5.46
113 Glu 8.45 121.73 4.72 111 Thr 8.89 118.17 5.26
114 Asp 8.35 118.07 - 112 Thr 8.16 114.93 5.18
115 Cys 9 121.14 4.96 113 Glu 8.46 121.77 -
117 Ser 7.17 111.63 4.93 114 Asp 8.38 118.11 -
118 Ile 8.68 131.91 - 115 Cys 9.01 121.18 -
119 Met 8.95 123.63 - 117 Ser 7.18 111.66 -
120 Glu 7.67 117.68 3.89 118 Ile 8.7 132 -
121 Gln 7.29 113.85 3.88 119 Met 8.97 123.65 -
122 Phe 7.84 113.52 4.38 120 Glu 7.67 117.7 3.89
123 His 7.58 114.43 4.92 121 Gln 7.3 113.89 3.87
124 Met 6.93 115.38 4.82 122 Phe 7.86 113.56 4.4
125 Arg 8.89 118.53 4.4 123 His 7.52 114.43 -
126 Glu 7.59 115.35 4.92 124 Met 6.94 115.41 -
127 Ile 8.15 118.96 4.43 125 Arg 8.88 118.57 4.4
128 His - - - 126 Glu 7.61 115.22 4.92
129 Ser 7.98 105.95 4.64 127 Ile 8.14 118.79 -
130 Cys 9.94 115.07 - 129 Ser 8.02 106.29 -
134 Glu 8.91 125.1 - 130 Cys 9.95 115.17 -
137 Trp - - - 134 Glu 8.9 125.26 -
138 Ile 9.46 119.32 - 137 Trp - - -
139 Phe 8.96 125.23 - 138 Ile 9.46 119.36 -
140 Tyr 8.96 116.54 5.77 139 Phe 8.97 125.26 5.47
141 Glu 9.24 122.4 - 140 Tyr 8.97 116.54 -
142 Leu 8.06 113.38 5 141 Glu 9.26 122.35 -
144 Asn 9.68 112.83 - 142 Leu 8.08 113.49 5
145 Tyr 7.89 112.1 - 144 Asn 9.68 112.84 -
146 Arg 6.15 116.58 4.86 145 Tyr 7.9 112.13 -
147 Gly 8.38 105.5 - 146 Arg 6.16 116.6 -
148 Arg 8.56 120.86 - 147 Gly 8.38 105.64 -
149 Gln - - - 148 Arg 8.56 120.89 -
150 Tyr 8.74 116.64 4.94 149 Gln - - -
151 Leu 8.28 125.53 - 150 Tyr 8.76 116.66 -
152 Leu 9.32 130.98 - 151 Leu 8.31 125.59 -
156 Glu 8.01 122.27 3.86 152 Leu 9.32 130.98 -
158 Arg 8.96 124.84 - 156 Glu 8.02 122.32 3.87
159 Lys 7.86 115.1 5.3 158 Arg 8.98 124.89 -
161 Ile 7.14 113.93 - 159 Lys 7.88 115.11 5.3
162 Asp 8.17 123.98 4.6 161 Ile 7.13 114 -
163 Trp 7.62 116.72 5.34 162 Asp 8.17 123.92 4.6
164 Gly 7.82 107.95 - 163 Trp 7.62 116.71 5.34
165 Ala 7.12 123.94 4.51 164 Gly 7.82 108 -
166 Ala 8.66 121.88 4.22 165 Ala 7.12 123.92 4.51
167 Ser 7.64 114.02 4.94 166 Ala 8.67 121.94 4.22
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169 Ala 7.45 123.12 4.49 167 Ser 7.65 113.92 4.94
170 Val 7.3 126.31 4.47 169 Ala 7.47 123.24 4.48
171 Gln 8.55 118.76 - 170 Val 7.3 126.23 -
172 Ser 8.37 112.12 4.54 171 Gln 8.55 118.87 -
173 Phe 8.93 111.64 6.38 172 Ser 8.38 112.2 4.52
174 Arg 9.54 115.94 - 173 Phe 8.93 111.67 -
175 Arg - - - 174 Arg 9.54 115.98 -
176 Ile 7.87 121.41 4.13 175 Arg - - -
177 Val 8.09 124.6 4.23 176 Ile 7.9 121.45 4.1
178 Glu 7.92 127.98 4.09 177 Val 8.09 124.75 4.21
178 Glu 7.91 127.97 4.18
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WT and Q147E αA-crystallin
Chemical shift assignments for both WT and Q147E αA-crystallin from 13C-1H HSQC and 1H-1H
TOCSY NMR experiments. Spectra performed in 50mM phosphate buffer pH 7.4 at 22.5°C.
αA-Crystallin WT Chemical Shift Assignments
NH αCH αC
Val 161 8.08 4.39 - 1.80:Hb 1.32:Hga* 1.32:Hgb*
Arg 163 8.3 4.32 55.95
1.71:Hba 1.84:Hbb 1.58:Hga 1.59:Hgb 3.16:Hda 3.16:Hdb 
30.80:Cb 27.25:Cg 43.50:Cd
Glu 164 8.37 4.21 56.5 1.89:Hba 2.01:Hbb 2.22:Hga 2.22:Hgb 30.26:Cb 36.49:Cg
Glu 165 8.4 4.24 56.3 1.87:Hba 1.97:Hbb 2.19:Hga 2.19:Hgb 30.58:Cb 36.31:Cg
Lys 166 8.35 4.58 53.98
1.78:Hba 1.78:Hbb 1.41:Hga 1.42:Hgb 1.66:Hda 1.67:Hdb 
2.96:Hea 2.96:Heb 32.58:Cb 24.75:Cg 29.34:Cd 42.25:Ce
Thr 168 8.19 4.29 61.89 4.06:Hb 1.32:Hg2* 69.72:Cb
Ser 169 8.37 4.43 58.31 3.84:Hba 3.84:Hbb 63.75:Cb
Ala 170 8.29 4.59 50.63 1.32:Hb* 18.41:Cb
Pro 171 - 4.45 63.04
2.29:Hba 2.29:Hbb 1.97:Hga 1.99:Hgb 3.62:Hda 3.77:Hdb 
32.02:Cb 27.42:Cg 50.67:Cd
Ser 172 8.4 4.44 58.31 3.85:Hba 3.85:Hbb 63.75:Cb
Ser 173 7.95 4.24 59.84 3.82:Hba 3.83:Hbb 64.84:Cb
αA-Crystallin Q147E Chemical Shift Assignments
NH αCH αC
Val 161 8.09 4.39 - 1.81:Hb 1.32:Hga* 1.32:Hgb*
Arg 163 8.31 4.31 55.96
1.71:Hba 1.71:Hbb 1.59:Hga 1.60:Hgb 3.15:Hda 3.16:Hdb 
30.75:Cb 27.29:Cg 43.31:Cd
Glu 164 8.38 4.23 56.46 1.93:Hba 1.97:Hbb 2.21:Hga 2.22:Hgb 30.56:Cb 36.49:Cg
Glu 165 8.4 4.23 56.46 1.87:Hba 1.88:Hbb 2.18:Hga 2.18:Hgb 30.57:Cb 36.43:Cg
Lys 166 8.36 4.57 53.88
1.79:Hba 1.79:Hbb 1.41:Hga 1.43:Hgb 1.68:Hda 1.70:Hdb 
2.95:Hea 2.95:Heb 32.65:Cb 24.77:Cg 29.35:Cd 42.31:Ce
Thr 168 8.2 4.29 61.84 1.20:373 4.06:Hb 1.32:Hg2* 70.11:Cb 21.63:Cg2
Ser 169 8.45 4.43 58.18 3.87:Hba 3.87:Hbb 63.91:Cb
Ala 170 8.3 4.58 50.61 1.32:Hb* 18.48:Cb
Pro 171 - 4.45 63.04
2.29:Hba 2.29:Hbb 2.00:Hga 2.00:Hgb 3.62:Hda 3.76:Hdb 
31.99:Cb 27.42:Cg 50.68:Cd
Ser 172 8.4 4.44 58.18 3.84:Hba 3.84:Hbb 63.80:Cb
Ser 173 7.95 4.23 59.87 3.82:Hba 3.82:Hbb 64.84:Cb
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Appendix 3: Buffer and Culture Recipes
Phosphate Buffered Saline
1.08g Sodium Phosphate monobasic
6.25g Sodium Phosphate dibasic
5.84g NaCl
1L Milli-Q water
Reagents dissolve in water with vigorous stirring. pH adjusted to 7.4 with 32%
HCl or 5M NaOH as necessary and filtered through 8μm membrane. 
Tris Buffer for Ion Exchange Chromatography
3.05g Tris
3.94g Tris.Hcl
1L Milli-Q water
Add 58.44g NaCl for high ion strength buffer
Reagents dissolve in water with vigorous stirring. pH adjusted to 7.4 with 32%
HCl or 5M NaOH as necessary and filtered through 8μm membrane. 
LB cell culture media
5g yeast extract
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10g tryptone
10g NaCl
1L milli-Q Water
Reagents dissolve in water with vigorous stirring and autoclaved in cell culture
flask.
M9 minimal cell culture media
Final salt concentrations on minimal media for labelled expression:
50mM Sodium Phosphate dibasic
25mM Potassium Phosphate monobasic
10mM Sodium Chloride
5mM Magnesium Chloride
10mM Calcium Chloride
50μM Ferric Chloride
5μM Manganese Chloride
5μM Zinc Chloride
1μM Cobalt Chloride
1μM Copper Chloride
1μM Nickel Chloride
1μM Sodium Selenate
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1μM Boric Acid 
This cell growth media was adjusted to pH 7.4 and autoclaved in cell culture
flask. Isotope labelled reagents and antibiotic were filtered through a 0.45μm
membrane and added mediately before inoculation to a final concentration of:
0.1% Ammonium Chloride
1% Glucose
100mg/ml Ampacilin
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